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CHAPTER 1: GENERAL INTRODUCTION 
Review of the literature 
With the intensification of swine production, respiratory diseases have become more responsible for economic 
losses. One of these economic drains is caused by enzootic pneumonia (EP): a chronic respiratory disease with a 
worldwide distribution caused primarily by Mycoplasma hyopneumoniae (M. hyopneumoniae) and secondary bacterial 
pathogens (Kobisch and Friis, 1996; Kobish et al., 1993; Maes et al., 2008; Maes et al., 2017; Ross, 1999). 
Mycoplasma hyopneumoniae acts as a triggering factor for infection with these secondary bacterial pathogens (Maes 
et al., 2008). Mycoplasma hyopneumoniae is considered as a major pathogen in the Porcine Respiratory Disease 
Complex (PRDC) as well, next to other respiratory bacterial, parasitic and viral pathogens, management and 
environmental conditions (Opriessnig et al., 2011). Economic losses are mainly due to treatment and vaccination 
costs, decreased performance, such as reduced growth and increased feed conversion ratio, increased time to 
market and higher mortality rates, mostly caused by infection with secondary agents (Maes et al., 2008; Maes et 
al., 2017). 
Mycoplasma hyopneumoniae is a member of the Mollicutes and is not able to survive long outside the host, which is 
a consequence of the fact that the organism lacks a cellular wall. Nevertheless, its survival time can be extended 
for up to 31 days in water at 2-7°C (Goodwin, 1972).  
As eradication of M. hyopneumoniae is difficult and expensive (culling of pigs, costs for antimicrobial therapy) and 
reinfection of a M. hyopneumoniae-free herd is common, control of the disease is probably the best strategy, 
especially in pig dense areas such as Western-Europe (Maes et al., 2017). Optimizing housing and management 
practices, implementing vaccination strategies, not only to control M. hyopneumoniae, but also other pathogens 
considered important in PRDC, should be advised.  
This introduction aims to summarize the current knowledge on the following aspects of M. hyopneumoniae 
infections: characteristics of the pathogen, pathogenesis of the infection, parameters to assess the severity of M. 
hyopneumoniae-infection and factors influencing the outcome and severity of the disease.  
1.1. Characteristics of Mycoplasma hyopneumoniae  
Mycoplasma hyopneumoniae belongs to the division Firmicutes, class Mollicutes, order Mycoplasmatales, family 
Mycoplasmataceae, genus Mycoplasma (Peters et al., 2008). It has no cellular wall and a small genome (893-920 
kilobase pairs) (Dybvig and Voelker, 1996). As a result, a limited number of metabolic pathways are encoded by 
a small number of genes, resulting in Mycoplasma species needing to obtain essential metabolites from the host or 
the environment (Razin et al., 1998; Thacker and Minion, 2012).  
In the 1930’s Köbe described a chronic and prevalent EP in Germany. This disease was distinct from Shope’s 
swine influenza and the name ‘Ferkelgrippe’ was given to the disease (Köbe, 1936). After the report of Köbe in 
1933, several researchers reported similar EPs in several countries (Fulton et al., 1953; Hjärre et al., 1952; 
Plowright, 1953; Rislakki, 1953). The aetiology was not elucidated at that time, due to the historical misleading 
preconception that the causative agent of these EPs reported in pigs was a virus, the difficulty in obtaining pigs 
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for experimental inoculation that were free from respiratory agents and because the inoculation material often 
was infected with Mycoplasma hyorhinis (M. hyorhinis) which grows faster than M. hyopneumoniae and is a common 
secondary bacterial agent in EP (Takatori, 1970). Thirty years after the discovery of the disease EP, Maré and 
Switzer (1965), in the United States (US), and Goodwin et al. (1965), in the United Kingdom (UK), were able to 
isolate the organism on solid medium. The organisms isolated in the US and UK were called M. hypopneumoniae 
and M. suipneumoniae, respectively (Goodwin et al., 1965; Maré and Switzer, 1965). Afterwards, it was concluded 
that both mycoplasmas were serologically indistinguishable, and the name M. hyopneumoniae remained (Goodwin 
et al., 1967; Hodges et al., 1969; Rose et al., 1979; Takatori, 1970). Before the aetiology of EP was known, the J-
strain was isolated in 1963 from a field outbreak in sows experiencing a mild course of EP (Goodwin et al., 1967; 
Goodwin and Whittlestone, 1963). This strain is still considered to be the reference strain of M. hyopneumoniae. 
Mycoplasma hyopneumoniae grows very slow in vitro and requires a growth medium composed of Hank’s balanced 
salt solution, fresh acetic yeast extract from Saccharomyces cerevisiae, ampicillin, bacitracin, phenol red, 
pleuropneumonia like organism enrichment (PPLO) broth base, brain heart infusion (BHI) broth, porcine and 
horse serum (Friis medium) (Friis, 1975). The M. hyopneumoniae cultures can easily be overgrown by other bacteria 
of the respiratory tract, typically M. hyorhinis and by any environmental organism (Friis, 1975; Thacker and 
Minion, 2012). Minor fluctuations in the composition of the medium, may influence growth of M. hyopneumoniae 
(Calus et al., 2010). According to Madsen et al. (2007), especially the swine serum component is highly variable in 
supporting growth of recent M. hyopneumoniae isolates.  
1.2. Pathogenesis of Mycoplasma hyopneumoniae infections 
The pathogenesis of M. hyopneumoniae infections is complex and not yet fully elucidated. Especially the role of 
specific virulence factors needs more attention (Simionatto et al., 2013; Thacker and Minion, 2012). To date, only 
domestic pigs and wild boar are known hosts for infection with M. hyopneumoniae (Maes et al., 2017). Mycoplasma 
hyopneumoniae infections are characterized by a long lasting persistence in the airway tract, a prolonged 
inflammatory reaction, modulation and suppression of the innate and adaptive immune system, and interaction 
with other (secondary) respiratory agents (Del Pozo Sacristán, 2014; Thacker and Minion, 2012). First, M. 
hyopneumoniae needs to establish istself at the appropriate site of infection after inhalation of M. hyopneumoniae-
infected respiratory aerosols, expelled by infected pigs. A mutualistic relationship with the host is obtained when 
the pig is merely colonised, not infected (Dani, 2014;  Desrosiers, 2001; Maes et al., 2017; Simionatto et al., 2013; 
Thacker and Minion, 2012). In certain circumstances,  infection is established and disease signs are observed. It 
is unclear why in certain pigs, M. hyopneumoniae might remain in the respiratory tract without causing clinical signs, 
or which factors are involved in progressing from colonisation to infection (Dani, 2014). Colonised pigs might 
be important from point of view of disease transmission in case of M. hyopneumoniae.  
The bacterium is situated at the apex of the cilia, is adhered to the microvilli or is situated in the interciliary 
space. A minority of mycoplasmas reach the smaller bronchioles and alveoli but they do not invade the airway 
epithelium (Blanchard et al., 1992; Jaques et al., 1992; Maes et al., 2017). Debey and Ross (1994) demonstrated 
that attachment of M. hyopneumoniae to ciliated epithelium was necessary to induce ciliostasis and loss of cilia. The 
exact mechanism of adhesion to the cilia has not yet been fully elucidated. The first identified adhesin was P97, 
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but several other adhesins belonging to the P97/P102 families have been identified (Simionatto et al., 2013). An 
overview of these adhesins is provided by Simoniatto et al. (2013). The adhesin P159 is unrelated to the 
P97/P102 paralogues (Burnett et al., 2006). All members of the P97/P102 family and P159 are post-
translationally cleaved. These cleavage products on the surface of M. hyopneumoniae, including adhesins, 
lipoproteins and also cytosolic proteins ‘moonlighting’ at the cell surface represent an important mechanism for 
creating cell surface protein diversity in genome-reduced bacteria such as M. hyopneumoniae (Maes et al., 2017; 
Tacchi et al., 2016). The cleaved products of the P97/P102 paralogues families and P159 on the cell surface 
interact with the host and function as receptors for heparin, plasminogen and fibronectin (Bogema et al., 2012; 
Seymour et al., 2012; Simionatto et al., 2013). Recently, actin was demonstrated extracellularly on porcine 
epithelial monolayers (PK-15) and it was shown that M. hyopneumoniae binds to the extracellular actin exposed on 
the surface of these cells. Furthermore, P97 possesses two distinct actin-binding regions, suggesting that actin 
may be an important receptor for M. hyopneumoniae (Raymond et al., 2018). Other glycoproteins and cell surface 
features are probably also involved in binding of M. hyopneumoniae to the cilia (Chen et al., 1992; Zielinski and 
Ross, 1992). Many genes coding for the adhesins contain one or more variable number of tandem repeats 
(VNTR) regions. The C-terminal portion of P97, identified as R1 region, is responsible for cilium binding. In 
order for the R1 region to have binding capacity, it needs to contain at least eight R1 repeating units. Variation in 
number of repeats influences binding capacity (Minion et al., 2000). The P146 is an adhesion lipoprotein and is 
also extensively processed on the surface of M. hypopneumoniae (Bogema et al., 2012). It contains serine repeats, 
the number of which can vary between strains. Both P97 and P146 repeats are used for differentiation between 
M. hyopneumoniae strains (Mayor et al., 2007; Vranckx et al., 2011). The proteins P97 and P102 are able to recruit 
plasminogen and fibronectin to the surface of M. hyopneumoniae. Bound plasminogen on surface proteins of M. 
hyopneumoniae facilitates conversion to plasmin (Seymour et al., 2012). This process has consequences for tissue 
invasion and systemic infection (Bogema et al., 2012), suggesting that the adhesins may play a role in virulence 
(Simionatto et al., 2013). After adhesion to the cilia, the affected cilia clump together and ciliostasis is induced 
(DeBey and Ross, 1994) and the final stage of the infection is characterized by a marked destruction of the 
ciliated epithelium, with exfoliation of the epithelial cells (Jaques et al., 1992). This results in impairment of the 
function of the mucociliary apparatus. In this way and together with the immunosuppressive effects of M. 
hyopneumoniae (discussed further), an efficient clearance of debris and invading pathogens from the upper 
respiratory tract fails. Pigs infected with M. hyopneumoniae are therefore more susceptible to infection with other 
respiratory pathogenic bacteria such as Pasteurella multocida (P. multocida), Streptococcus suis (S. suis), Haemophilus 
parasuis (H. parasuis), Actinobacillus pleuropneumoniae (A. pleuropneumoniae), and others. These bacteria are 
consequently able to proliferate in the respiratory tract. Infection with M. hyopneumoniae as triggering factor for 
establishment of other pathogens is known as EP (Simionatto et al., 2013; Thacker and Minion, 2012).  
Production of hydrogen peroxide from glycerol was designated, as a virulence mechanism of certain other 
mycoplasmas such as Mycoplasma mycoides subspecies mycoides or Mycoplasma pneumoniae. Ferrarini et al. (2018) 
demonstrated that virulent strains of M. hyopneumoniae are able to produce the toxic metabolite hydrogen 
peroxide from glycerol. Another metabolic difference, partially explaining the different level of virulence was 
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demonstrated: in comparison with M. hyorhinis and M. flocculare, a commensal bacterium, only M. hyopneumoniae 
was able to assimilate myo-inositol, and remained viable when this was the primary energy source.    
Immune responses are important in preventing infections, although in M. hyopneumoniae-infected pigs, the 
immune response persists and is an important cause of inflammatory lesions. The pig is unable to clear the 
infection, resulting in a chronic colonisation of the airways by M. hyopneumoniae (Razin et al., 1998). It was 
demonstrated by Pieters et al., (2009) that M. hyopneumoniae can persist up to 214 days in the respiratory tract of 
the pig and total clearance was only demonstrated at 254 days post-infection. It is known that M. hyopneumoniae is 
able to alter the innate and adaptive immune response (Thacker, 2001), although the exact mechanism on how 
this immunopathological modification arises, is not yet fully elucidated (Thacker and Minion, 2012). After the 
adhesion step, the peribronchiolar and perivascular connective tissue is infiltrated by macrophages, dendritic cells 
and B and T lymphocytes (Livingston et al., 1972; Sarradell et al., 2003). However, M. hyopneumoniae is able to 
render the phagocytotic capacity of the macrophages and neutrophils less effective (Asai et al., 1996; Caruso and 
Ross, 1990) which results in a reduced clearance of M. hyopneumoniae  and a chronic colonization (Thacker and 
Minion, 2012). Mycoplasma hyopneumoniae induces macrophages also to produce pro-inflammatory cytokines. 
Normally, cytokines help in the elimination of invading pathogens by stimulating and regulating the innate 
immune response (Medzhitov and Janeway, 1997; Wooley, 2014). However a sustained production of cytokines, 
which is the case in M. hyopneumoniae infection, leads to host-mediated tissue injury in the lung (Choi et al., 2006; 
Thacker and Minion, 2012). The next step is chronic inflammation and lymphoid hyperplasia and this seems to 
be more important for the appearance of lung lesions than the pathogen itself (Thacker and Minion, 2012; 
Wooley, 2014). This massive infiltration of mononuclear cells (lymphocytes and macrophages) around the blood 
vessels, peribronchial and peribronchiolar areas and alveolar septa can cause obliteration of the soft-walled 
bronchioli and collapse of the alveoli (Baskerville, 1981; Sarradell et al., 2003). Next to influencing the 
macrophage function, it is suggested that M. hyopneumoniae is capable of causing a general immune suppressive 
effect, as the pathogen alters the function of B and T-lymphocytes (Thacker and Minion, 2012). It was 
demonstrated that M. hyopneumoniae cell membranes reduced lymphocyte transformation in response to a T-cell 
mitogen suggesting a suppression of the cell-mediated immune response (Kishima and Ross, 1985). T-cell 
dependent mechanisms may play a significant role in the development of pneumonia as thymectomized pigs or 
pigs injected with anti-thymocyte serum before infection developed less severe microscopic lesions compared to 
immunocompetent pigs. T-lymphocytes may as well be important to prevent systemic spread of M. hyopneumoniae, 
as in one thymectomized pig from the same study M. hyopneumoniae was isolated in the spleen (Tajima and Nei, 
1984).   
1.3. Epidemiology 
Mycoplasma hyopneumoniae is ubiquitously present throughout all swine producing countries in the world (Hillen et 
al., 2014; Thacker and Minion, 2012). Although the highest infection levels are found during the grower-finishing 
stage, positive pigs detected with nested Polymerase Chain Reaction (nPCR) can be found throughout all stages 
of pig production (Sibila et al., 2009; Villarreal et al., 2010). An overview of the occurrence of M. hyopneumoniae in 
pigs of different ages is given by Villarreal et al., (2010). 
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Mycoplasma hyopneumoniae can make its entrance in a herd via purchase of subclinically affected replacement gilts 
or other pigs (Sibila et al., 2009). Once established in the herd, the pathogen can be transmitted from the dam to 
their piglets via nose-to-nose contact (Desrosiers, 2001; Thacker and Minion, 2012). Gilts or low parity sows are 
the main transmitters, as they have less M. hyopneumoniae-specific immunity and therefore excrete more 
microorganisms than older sows (Lowe, 2012; Maes et al., 1996). Once this vertical transmission has occurred, 
further horizontal transmission, independent of age can take place between pen mates or between pigs from 
adjacent pens if no solid partitions between the pens are used (Maes et al., 1996; Piffer and Ross, 1984). The 
spread of M. hyopneumoniae in a stable is slow (Maes et al., 1996). Meyns et al, (2004) showed that one infected pig 
may infect a penmate within a time span of six weeks. Another route of entrance in the herd is via airborne 
transmission from other infected farms. The distance to neighbouring farms to avoid airborne transmission 
should probably be at least three km (Goodwin, 1985; Muirhead and Alexander, 1997), however this distance 
was set before it was demonstrated that M. hyopneumoniae can be transmitted over a distance of 4.7 km (Dee et al., 
2009) and 9.2 km (Otake et al., 2010). No intra-uterine transmission, nor lactogenic transmission has been 
described (Prikazsky, 1988). The role of fomites is probably not important when standard biosecurity protocols 
are followed by personnel (Batista et al., 2004). Transmission via semen is unlikely to be a route of transmission 
as well. There is only one report available where M. hyopneumoniae could be isolated from one out of 101 semen 
samples, but it is not yet clear whether infected semen can result in infection (Schulman and Estola, 1974).  
1.4. Clinical signs and lung lesions 
Epizootic Mycoplasma hyopneumoniae disease is uncommon and occurs when M. hyopneumoniae enters an 
immunological naïve herd. In this case, morbidity may reach 100%, acute respiratory distress, coughing, pyrexia 
and even death may occur.  
Within two to five months, the infection evolves in the form most commonly observed namely endemic 
mycoplasmosis (Thacker and Minion, 2012). The characteristic dry, non-productive cough appears slowly in the 
herd, peaks four weeks after initial infection, and may last for eight weeks. Non-complicated M. hyopneumoniae-
disease, although rarely seen, may take a sub-clinical course, or dry non-productive coughing may be present, 
next to slight fever and anorexia (Del Pozo Sacristán, 2014; Maes et al., 1996). Involvement of other respiratory 
agents will aggravate the clinical picture: productive cough, fever, anorexia, laboured breathing or thumping, 
prostration, higher morbidity and even mortality can be seen. Reduced feed intake will result in uneven growth 
and lower daily weight gain (Maes et al., 1996; Thacker and Minion, 2012). Clinical signs of EP are usually not 
observed in piglets younger than six weeks of age (Sibila et al., 2009), however in some cases animals of three to 
four weeks may start coughing (Maes et al., 1996).  
Catarrhal pneumonia is found in the apical, cardiac, accessory lobe(s) and the ventral portions of the 
diaphragmatic lobe in non-complicated M. hyopneumoniae infections (Maes et al., 1996; Thacker and Minion 2012). 
The lesions have a meaty consistency and are red to purple. On the cut surface of such an uncomplicated lesion, 
a catarrhal exudate is visible (Thacker and Minion, 2012). These lesions appear from seven days onwards post 
infection, reach a maximum size in four weeks post-infection (Kobish et al., 1993) and recovery occurs after 
seven to ten weeks. Instead, red to purplish or white interlobular scar retractions of connective tissue, called 
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fissures, appear (Del Pozo Sacristán, 2014; Kobish et al., 1993; Thacker and Minion, 2012; Whittlestone, 1972). 
Lung lesions originating from M. hyopneumoniae-infections, complicated by secondary pyogenic pathogens, affect 
a larger portion of the lung, have a more greyish and firm appearance, a mucopurulent exudate is seen in the 
airways and more time is needed to resolve (Osborne et al., 1981; Thacker and Minion, 2012).  
Although the lung lesions observed in complicated and non-complicated M. hyopneumoniae infections are 
suggestive for EP, they are not pathognomonic. It is well known that other pathogens, especially viral respiratory 
agents such as influenza, can cause similar macroscopic lesions (Sibila et al., 2009; Thacker, 2001).  
1.5. Parameters to assess the severity of Mycoplasma hyopneumoniae 
infections in combination with confirmation of the presence of the 
bacterium 
Assessing the severity of a M. hyopneumoniae infection is necessary to compare the virulence of different M. 
hyopneumoniae strains and it is an important tool to evaluate the efficacy of vaccines or vaccination strategies. 
Below, an overview is given of the main parameters used to assess this severity. It is recommended to use a 
combination of methods to estimate the severity of a M. hyopneumoniae-infection and it is necessary to confirm the 
presence of infection with M. hyopneumoniae in the investigated pigs, preferably by PCR. 
1.5.1. Respiratory disease score 
Coughing is the principal symptom of respiratory disease and it is stated that it is the main clinical sign of EP 
(Kobish and Friis, 1996; Maes et al., 1996; Nathues et al., 2012; Ross, 1992). Coughing can be caused by many 
infectious agents, although a dry non-productive cough is a typical symptom of EP, especially in finishing pigs. 
When presence of M. hyopneumoniae can be confirmed in the same herd with other diagnostic procedures, such as 
PCR, assessing the occurrence of coughing might be a useful parameter to assess the severity of EP as the 
likelihood of a high coughing index was increased with 76% in herds with ≥50% of the bronchoalveolar lavage 
fluids positive for M. hyopneumoniae (Nathues et al., 2012). Leon et al. (2001) found that in fattening pigs of 
farrow-to-finishing farms, coughing started around the same time as when these pigs seroconverted to M. 
hyopneumoniae.  
Several techniques to record coughing in pigs have been described. One technique determines the number of 
coughing incidents per pig per minute during a total period of three minutes in rest, without arousing the pigs 
(Mombarg et al., 2002; Straw, 1986). Other techniques describe the number of coughing bouts per pig after 
encouraged move. In the coughing index from Bahnson (Bahnson, 1993; Nathues, 2011; Nathues et al., 2012), a 
pen or two neighbouring pens within a compartment with at least 20 pigs is/are selected. Subsequently, the pigs 
are forced to move by shouting and clapping and onsets of coughing are counted for a period of three minutes. 
Multiple coughing bouts of the same pig are included in the scoring if coughing was absent for 10 seconds 
before reappearing of the next cough. The same procedure as above is repeated in the same pigs one minute later 
and next the whole procedure of two times three minutes is repeated with a second batch of at least 20 pigs at 
another location in the same compartment, but in a different pen/adjacent pens. The average coughing index is 
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subsequently calculated as the number of coughing bouts divided by the actual number of pigs observed, 
multiplied by the minutes of observation time. The coughing index from Bahnson, gives the percentage of pigs 
coughing within one minute after encouraging them to  move (Bahnson, 1993; Nathues, 2011; Nathues et al., 
2012). A fairly comparable coughing score was applied by Mateussen et al., (2001). The pigs were observed for 
10 minutes after an arousal period of 2 minutes. The number of pigs that coughed is counted and is divided by 
the total number of pigs present in the pen. This number was subsequently multiplied by 100 to obtain the 
coughing index. A combination of counting the coughs in rest and after arousal was proposed by Halbur et al., 
(1996). This scoring system requires to be performed daily by the same person, always at the same moment and 
preferably in the morning as scoring in rest is facilitated before the pigs start to be active. This scoring system 
ranges from 0-6 with 0 (no coughing), 1 (mild coughing after encouraged move), 2 (mild coughing in rest), 3 
(moderate coughing after encouraged move), 4 (moderate coughing in rest), 5 (severe coughing after encouraged 
move), 6 (severe coughing in rest) and daily averages are calculated per group. This approach gives a detailed 
image on the course of the respiratory disease over time. However, it is more suitable for pigs in small groups, 
i.e. under experimental circumstances as the pigs need to be individually identified and are allowed to have one 
score per day (the highest score). Automatic recordings of coughing events have been developed, not only to 
obtain a coughing score, which can be useful in larger farms, but also to identify the pens in a stable where the 
coughing index is higher. Identifying the pens with (the highest) coughing might be useful to limit antimicrobial 
use, as not all pigs from all pens need to be treated, (Exadaktylos et al., 2008; Silva et al., 2008). An example of 
this is the Pig Cough Monitor (PCM), which performs a continuous (24 hours per day, seven days a week), 
automated measurement of porcine respiratory health through sound analysis. The microphone is mounted at a 
height of two meters in the centre of a pig compartment. The software is based on an algorithm to recognise 
cough sounds from other non-coughs, i.e. environmental sounds, screams of the pigs,…. The advantage of the 
automated systems compared to the discrete cough counts, is that a continuous measurement of coughing in the 
pig compartments can be performed and an identification of the pens with coughing pigs is possible as well, 
however this requires multiple microphones (Hemeryck et al., 2015; Silva et al., 2008). The disadvantage is that 
the device needs to withstand the harsh conditions in the pig stable without interfering with the sound 
acquisition itself: i.e. unstable power supplies, high temperatures and humidity, acid compounds in the air, 
internet connection problems, accelerated corrosion due to ammonia concentrations, rats biting cables, etc. 
(Hemeryck et al., 2015). 
1.5.2. Macroscopic lung lesions 
The severity or extent of macroscopic Mycoplasma-like lesions or the characteristic cranioventral pulmonary 
consolidation can be determined by visualisation and palpation of the lung in a two or three-dimensional 
approach (Garcia-Morante et al., 2016). The two-dimensional approach determines the estimated proportion of 
lung surface affected  by Mycoplasma-like lesions and is used in the scoring systems of Goodwin et al. (1969), 
Hannan et al. (1982), Madec and Kobisch (1982), Straw et al. (1986) and Sibila et al. (2014). Goodwin et al. 
(1969), Hannan et al. (1982) and Madec and Kobisch (1982) express the severity of the lesions by means of a 
points system instead of percentage (Sibila et al., 2014; Straw et al., 1986) to indicate the affected lung fields. The 
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more precise three-dimensional approach determines the proportion of affected lung area and multiplies this by 
the relative weight each lobe represents in the total lung weight and expresses the severity of the lesion as the 
weight percentage of affected tissue. However, the relative weight for each lobe can differ between methods. 
Following scoring systems use the three-dimensional scoring approach: Morrison et al. (1985), Christensen et al. 
(1999) and the reference system of the European Pharmacopoeia (Garcia-Morante et al., 2016; Christensen et al., 
1999; Morrison et al., 1985; Pharmacopoeia, 2013). A complete overview of the most used scoring systems to 
determine the severity of Mycoplasma-like lesions, is given by Garcia-Morante et al. (2016). The same authors 
concluded that all frequently used scoring systems to determine macroscopic lung lesions in M. hyopneumoniae 
infected pigs were very compatible, except for one method based on image analysis. This could be explained by 
the fact that the latter method only quantified the extent of the lesions from images of the dorsal surface of the 
lung and lesions of the accessory lobe were not considered in the image analysis. If both surfaces of the lung 
would have been included in the image analysis, the correlations with the other methods might have been 
improved (Garcia-Morante et al., 2016). By this objective scoring system, a dorsal picture of a lung is taken and 
analysed by means of an online free software tool. The ventral side of the lung is pictured only when the lesion is 
present on that side. The area affected by lesions and total area of the dorsal side of the lung are delineated in 
each picture in order to calculate the percentage of affected lung by the following formula: (right lung affected 
area + left lung affected area)/total lung area*100 (Sibila et al., 2014). Other methods based on image analysis 
have been developed (Ross et al., 1984; Asai et al., 1993 and Murphy et al., 1993), however the method of Sibila 
et al. (2014) might be preferred above these other methods, as it is the most recent method developed and 
because of the availability of the free software tool.  
1.5.3. Microscopic lung lesions 
The severity of broncho-interstitial pneumonia is often scored according to the degree of peribronchiolar and 
perivascular lymphohystiocytic infiltration, nodule formation and presence of exudate in the airways using light 
microscopy on hematoxylin and eosin stained formalin-fixed, paraffin-embedded tissue sections. Different 
scoring systems have been developed with small adaptations between the scoring systems. The scoring system of 
Livingston (1972) classifies the histological lesions as follows: - : indicates negative or no lesions; + indicates one 
or more lymphoid nodules involving the muscularis mucosae of bronchi and bronchioles; ++ indicates lymphoid 
nodules affecting the muscularis mucosae of bronchi and bronchioles and the presence of inflammatory cells in 
the septal wall, bronchi, and alveolar lumen; +++ indicates perivascular and peribronchiolar hyperplasia of the 
lymphoid tissue with inflammatory cells in the alveolar septa and neutrophils in the bronchial and alveolar 
lumens; and  ++++ indicates massive perivascular and peribronchiolar lymphoid hyperplasia in extended areas 
of the lung parenchyma. The scoring system of Morris et al. (1995), ranges from 1-5 with 1) limited infiltration of 
macrophages and lymphocytes around bronchioles, with airways and alveolar spaces free of cellular exudates; 
score 2) light to moderate infiltrates with mild diffuse cellular exudates into airways; score 3, score 4 and score 5, 
respectively mild (score 3), moderate (score 4) and severe (score 5) lesions characteristic of broncho-interstitial 
pneumonia, centered around bronchioles but extending to the interstitium, with lymphofollicular infiltration and 
mixed inflammatory cell exudates. Scores 1 and 2 are considered not to be related with a M. hyopneumoniae 
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infection, while scores 3 to 5 are presumptive of a M. hyopneumoniae infection. The scoring system of Calsamiglia 
et al. (2000) is an adaptation of both scoring systems of Livingston et al. (1972) and Morris et al. (1995), and in 
the scoring system of Opriessnig et al. (2004) the lung sections are scored for presence and severity of type 2 
pneumocyte hypertrophy and hyperplasia, alveolar septal infiltration with inflammatory cells, peribronchial 
lymphoid hyperplasia, amount of alveolar exudate, and amount of inflammation in the lamina propria of bronchi 
and bronchioles ranging from 0 to 6 (0, normal; 1, mild multifocal; 2, mild diffuse; 3, moderate multifocal; 4, 
moderate diffuse; 5, severe multifocal; 6, severe diffuse). The downside to these above mentioned scoring 
systems is that they are semi-quantitative and subjective. 
The severity of pneumonia can also be measured objectively with image analysis. Using this method, a digital 
microscopic image is taken from a hematoxylin and eosin stained, formalin-fixed, paraffin-embedded lung tissue 
section. The percentage of air in this lung section is subsequently measured by means of automated image 
analysis software, which calculates the percentage of air in each lung field. The obtained percentage is inversely 
proportional to the lymphohistiocytic infiltration in the lung tissue, the amount of atelectasis, and the 
intrabronchiolar and bronchial exudate, intra-alveolar exudate and/or oedema and proliferation of type II 
pneumocytes (Del Pozo Sacristán, 2014), and therefore a good objective way to measure the severity of 
pneumonia. The obtained results in challenged infected pigs with a M. hyopneumoniae isolate obtained from pigs 
experiencing a clinical course of EP were 39.3, 41.6, 48.5 and 47.3 % for four different isolates. In the pigs in the 
negative control group a percentage of 52.2 was detected (Vicca et al., 2003). 
1.5.4. Number of Mycoplasma hyopneumoniae organisms in the respiratory tract 
The number of organisms in the respiratory tract of the pig may also reflect the severity of the disease (Vranckx 
et al., 2012a). The number of organisms colonizing the lungs of the pig probably depends on the accumulation 
of infection doses, the capacity of the strain itself to multiply in the lung and time after infection (Thacker and 
Minion, 2012). Detection of antigen of M. hyopneumoniae can be performed by immunohistochemistry or 
immunofluorescence. Kobish et al. (1978) developed a scoring system ranging from 0 to 3 with 0: no 
immunofluorescense (IF), 1: limited IF, 2: moderate IF and 3: intense IF (Del Pozo Sacristán, 2014; Kobisch et 
al., 1978; Vicca et al., 2003). The limitation of this technique is that it is time-consuming, laborious, the amount 
of M. hyopneumoniae antigen is determined in a semi-quantitative way and subjective (Del Pozo Sacristán, 2014). A 
more accurate assay that allows the detection of the pathogen and the quantification of M. hyopneumoniae is 
quantitative real-time Polymerase Chain Reaction (qPCR) (Dubosson et al., 2004; Marois et al., 2010; Strait et al., 
2008a; Strait et al., 2008b). The number of M. hyopneumoniae-organisms also depends on the sampling site in the 
respiratory tract. In pigs pre-mortal tracheobronchial swabbing or bronchoalveolar lavage is more sensitive 
compared to oropharyngeal brushing and nasal swabbing (Fablet et al., 2010). This is consistent with the fact that 
trachea and bronchi are the multiplication sites of M. hyopneumoniae (Blanchard et al., 1992). Laryngeal swabs 
(swabbing the internal walls of the laryngeal cartilages) of 8-week old pigs after experimental M. hyopneumoniae 
infection was demonstrated to be a reliable sampling technique from five days post-inoculation as well: it showed 
the highest sensitivity compared to nasal swabs and bronchoalveolar fluids, while oral fluids had the lowest 
sensitivity of all these samples (Pieters et al., 2017). Lung tissue or flushing at the main bronchus/bronchi is 
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suitable, but is only possible post mortem and variable results are reported for detection of M. hyopneumoniae 
DNA in lung tissue (Sibila et al., 2009).  
1.6. Factors influencing the severity of the disease 
1.6.1. Virulence and pathogenicity of Mycoplasma hyopneumoniae strains 
In some farms, control measures, such as improving management practices, antimicrobial therapy and 
implementing vaccination against M. hyopneumoniae do not result in the expected level of effect against M. 
hyopneumoniae infections, whereas in other farms, these measures are sufficiently effective. Vicca et al. (2002) 
found that in farms with clinical problems of M. hyopneumoniae but with good management and housing 
conditions, compared to farms with subclinical problems and poor management and housing, the pigs in the first 
category of farms had higher seroprevalences against M. hyopneumoniae and that they were infected earlier on 
during the production cycle. They concluded that apart from housing and management, additional factors such 
as differences among M. hyopneumoniae isolates may determine the outcome of the disease. Indeed, M. 
hyopneumoniae isolates from different swine herds, may have a high variation in virulence, with highly virulent 
strains being able to induce more and more quickly severe pneumonia lesions in a larger proportion of pigs than 
low virulent strains (Meyns et al., 2007; Vicca et al., 2003; Villarreal et al., 2011). The higher virulence of these 
strains is attributed to the capacity to adhere or better adhere to the cilia of the respiratory tract, a higher ability 
to multiply in the lungs and to induce a more severe inflammation (Meyns et al., 2007; Tajima and Yagihashi, 
1982; Young et al., 2000). Little is known about specific virulence factors or factors attributable to these 
differences observed in M. hyopneumoniae isolates, and why the most closely related porcine Mycoplasma species, 
Mycoplasma flocculare (M. flocculare) is a commensal of the pig and does not cause disease (Siqueira et al., 2013). 
Nevertheless, the whole genome of four M. hyopneumoniae strains has been sequenced completely and should 
theoretically facilitate this process of identifying possible virulence factors or factors related to pathogenicity (Liu 
et al., 2011; Minion et al., 2004; Vasconcelos et al., 2005) by intensively comparing the genome, transcriptome, 
proteome, metabolome and secretome of these strains (Ferrarini et al., 2016; Liu et al., 2013; Maes et al., 2017; 
Paes et al., 2017; Pinto et al., 2009; Siqueira et al., 2014; Siqueira et al., 2013). Vicca et al. (2003) could correlate 
the presence of a 5000 bp fragment with M. hyopneumoniae virulence in a small number of isolates, using RAPD 
analysis, however more isolates need to be investigated and a specific function could not be attributed to this 
fragment. Some evidence is available that the cell envelop of M. hyopneumoniae plays a role in the virulence (Meyns 
et al., 2007). A thinner capsule enveloping the Mycoplasma cells induced by in vitro passage, demonstrated by 
Tajima and Yagahashi, (1982) by ruthenium red staining was associated with a decreased pathogenicity. 
Differences in the composition of glycoproteins and fatty acids of the cell membrane were detected when 
avirulent M. hyopneumoniae strains were compared with virulent strains. Virulent strains were able to induce higher 
cytoplasmic calcium concentrations in neutrophils, compared to non-virulent strains, suggesting altering of the 
neutrophil signal transduction mechanisms by virulent M. hyopneumoniae strains (Chen et al., 1992). This was 
confirmed by Park et al. (2002), who found that pathogenic strains of M. hyopneumoniae were capable of increasing 
intracellular calcium concentrations in porcine ciliated epithelial cells, while this was not observed in non-
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pathogenic M. hyopneumoniae strains and M. flocculare strains. They concluded that this intracellular increase of 
calcium may serve as a signal for inducing loss of cilia.  
Passaging of the M. hyopneumoniae strain in vitro or in vivo may alter its virulence quickly: DeBey and Ross (1994) 
showed that after 20 to 40 in vitro passages compared to only 1 or 2 passage(s), M. hyopneumoniae strain 232 had a 
lower capacity to induce ciliar damage. However, when the same strain was passaged in gnotobiotic pigs in vivo, 
the strain was reversed to virulence (DeBey and Ross, 1994; Hannan et al., 1984). Another example of this 
passaging effect is the J-strain, used to date in many commercially available M. hyopneumoniae vaccines. Upon 
isolation the strain was virulent causing mild pneumonia in sows, but after continued in vitro passaging, the J-
strain lost its capacity to adhere, and also its capacity to cause disease in pigs (Mebus and Underdahl, 1977; 
Thomas et al., 2003; Zielinski and Ross, 1993). A different expression level of genes, like those encoding 
adhesins can have an impact on virulence, as Pinto et al. (2009) compared the expression of proteins of two 
different virulent strains (strain 7448 and 7422) and the J-strain. They concluded that in the virulent strains an 
overexpression of 64 proteins was observed, including an overexpression of the P97 adhesin, while this was not 
the case in the non-virulent J-strain. The same author found a 23 kb region similar as a previously described 
Integrative Conjugal Element of Mycoplasma fermentans (ICEF) in the genetic material of virulent strains 7448 and 
232 of M. hyopneumoniae, that was absent in J-strain (Pinto et al., 2007). This element is generally recognized to be 
involved in virulence and coding sequences related to ICEF were detected in Mycoplasma bovis and Mycoplasma 
agalactiae. However, the function in M. hyopneumoniae remains unclear (Maes et al., 2017; Pinto et al., 2007). This 
element was also found in the virulent strain 168, but not in its attenuated variant (Liu et al., 2013). The fact that 
these putative ICEH’s were observed in three virulent M. hyopneumoniae strains, but not in a non-virulent strain, 
might imply that potentially mobile genetic elements involved in lateral gene transfer are implicated in virulence 
of M. hyopneumoniae, and this might be a tool to obtain genome variability (Maes et al., 2017; Pinto et al., 2009; 
Pinto et al., 2007). Siqueira et al. (2013) compared the genome organisation of M. flocculare and M. hyopneumoniae, 
and found that although the similarity between these species is high, the genes encoding proteins involved in 
host-cell adhesion differ in genomic structure and organisation: some genes encoding adhesins of the P97 family 
are absent in M. flocculare, contain sequence differences or lack domains which are important for adhesion. 
However, they were not able to find specific virulence determinant factors that could explain the difference in 
virulence between both investigated species (Siqueira et al., 2013). Paes et al. (2017) compared the secretomes of 
M. hyopneumoniae and the commensal M. flocculare. They found that a higher number of proteins were secreted by 
the virulent M. hyopneumoniae (62) compared to M. flocculare (26). Overall, 15 virulence-related proteins were found 
in M. hyopneumoniae and only four in M. flocculare, of which two proteins were shared with M. hyopneumoniae. Taken 
together, more research is needed to find clear-cut factors that enable us to make the differentiation between 
virulent and non-virulent M. hyopneumoniae-strains or to find markers which determines why M. hyopneumoniae is a 
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1.6.2. Diversity of Mycoplasma hyopneumoniae strains 
Mycoplasma spp. are the smallest known self-replicating organisms (Artiushin and Minion, 1996). It is believed 
that they attained their small genomes through degenerative evolution from a Gram-positive ancestor, losing a 
lot of important metabolic pathways such as those involved in phospholipid, amino acid and purine and 
pyrimidine synthesis and obtaining a reduced number of tRNAs (Maniloff, 2002; Muto and Ushida, 2002). This 
has made the organism highly susceptible to environmental conditions, but also dependent on the host for 
growth and survival (Strait et al., 2008a). Mycoplasma hyopneumoniae has a genome size of 892 kilobase pairs and 
because of the reduced genome the organism needs to rely on diversity to cope with the adverse environment of 
the host (Madsen et al., 2007; Minion et al., 2004).  
Antigenic variability in M. hyopneumoniae has been demonstrated (Assunção et al., 2005; Calus et al., 2007; Wise 
and Kim, 1987; Zhang et al., 1995). All members of the P97/P102 paralogue family are cleaved to a greater or 
lesser extent and this depends on the isolate (Burnett et al., 2006; Djordjevic et al., 2004). The presence of 
different adhesion related proteins with multiple binding sites is believed to prevent the elimination of the 
organism from the host in the presence of an adhesion-specific immune response, resulting in chronic infections 
(Hsu and Minion, 1998). Calus et al., (2007) found that the protein variability of 56 M. hyopneumoniae isolates from 
six different countries and 37 different herds was high. A protein variability of 25% was found between the 
investigated field isolates and when comparing the field isolates to the J-strain a protein variability of 30% was 
observed. However, they could not find differences between isolates originating from the same herds. Assuncao 
et al. (2005) on the other hand found that the protein patterns of 18 M. hyopneumoniae field isolates (Gran-
Canaria) were very homogenous and Scarman et al. (1997) found that the protein profiles from five out of six 
isolates of different geographical regions (Australia, UK, USA and Canada) were very homogenous as well.  
Genetic diversity of M. hyopneumoniae was demonstrated by Frey et al. (1992) and further confirmed by Arthiusin 
and Minion (1996), Kokotovic et al. (1999), Djordevic et al. (2004), Mayor et al. (2007; 2008), Madsen et al. 
(2007) Stakenborg et al. (2005; 2006), Tamiozzo et al. (2011), Nathues et al. (2011), Vrankx et al. (2011; 2012c), 
Charlebois et al. (2014), Dos Santos et al. (2015), Burgher Pulgarón et al. (2015), Tamiozzo et al. (2015), Pantoja 
et al. (2016) and Takeuti et al. (2017). Several methods have been used to type M. hyopneumoniae, including Pulsed-
Field Gel Electrophoresis (PGFE) (Stakenborg et al., 2005), Amplified Fragment Length Polymorphism (AFLP), 
RAPD or also called arbitrarily primed PCR (Artiushin and Minion, 1996; Stakenborg et al., 2006), microarray 
technology (Madsen et al., 2007), PCR-Random fragment length polymorphism (PCR-RFLP) (Stakenborg et al., 
2006), sequencing of a single locus (polyserine repeat motif of P146) (Mayor et al., 2007), Multiple-Locus 
Sequence Typing (MLST) (Mayor et al., 2008) and Multiple-Locus of variable number of tandem repeats 
(MLVA) (Burgher Pulgarón et al., 2015; Charlebois et al., 2014; Dos Santos et al., 2015; Nathues et al., 2011; 
Pantoja et al., 2016; Takeuti et al., 2017; Tamiozzo et al., 2015; Vranckx et al., 2011; Vranckx et al., 2012c). An 
overview of different molecular typing methods is shown by Vranckx et al. (2012b). Next-generation sequencing 
can be added to these techniques. Vranckx et al. (2011) and Nathues et al. (2011) were the first to investigate the 
use of MLVA for typing M. hyopneumoniae strains. This technique amplifies specific regions in the genome of M. 
hyopneumoniae. Typically, regions prone to slipped strand mispairing or homological recombination events are 
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chosen, because these events cause these regions to be highly variable in different M. hyopneumoniae strains. Such 
regions containing a repeat sequence in the genome of M. hyopneumoniae are called variable number of tandem 
repeats (VNTRs) (Torres-Cruz and van der Woude, 2003). These VNTRs are without exceptions translationally 
in frame, and code for variable number of amino acid repeats (VNTARs). These VNTARs code for putative 
structural, physicochemical and antigenic variations in the corresponding proteins, with potential implications 
regarding the pathogenicity of M. hyopneumoniae (de Castro et al., 2006). For instance, many regions in the genome 
of M. hyopneumoniae related to adherence in the host contain VNTRs. Recombination events and slipped strand 
mispairing of these VNTRs, will possibly lead to expression of a different sized protein and might have 
implications in the adhesion function of the pathogen (Torres-Cruz and van der Woude, 2003; Vranckx et al., 
2012b). The more divergent two strains are, the more VNTR regions in these strains will contain a different 
number of repeats. The length of these regions can subsequently be determined with gel or capillary 
electrophoresis after amplification of the VNTRs with PCR (Vranckx et al., 2012b). Vrankx et al. (2011) 
concluded that this technique is relatively inexpensive compared to other typing methods, has a high 
discriminatory power, is quick and reliable, can be used on bronchoalveolar lavage fluid (BALF) samples and 
tracheobronchial swabs, and is able to differentiate M. hyopneumoniae strains, without prior cultivation of the 
pathogen. This was confirmed by other authors (Charlebois et al., 2014; Dos Santos et al., 2015; Nathues et al., 
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It is clear from the table that no consistency is present in reporting M. hyopneumoniae –diversity data, and that 
different authors use different terminology to report M. hyopneumoniae diversity. From the table it can be 
concluded as well that a high genetic diversity is seen in M. hyopneumoniae in specific countries/regions and that 
different pigs can harbour different strains of M. hyopneumoniae. However, comparing data from different studies 
is not straightforward. There may be differences in reporting the data, amplifying a different number of VNTR’s, 
using different sample types, selecting different types of herds, laboratory differences (running specifications of 
the gel or capillary gel electrophoresis) and differences in interpretation of the electropherograms. One must 
therefore be very careful in comparing results between different studies and extrapolation of results obtained in 
one region/country to the situation in another region/country. Only limited research has been conducted in 
investigating strain diversity in different production rounds within the same herds. The impact of strain 
variability on lung lesions or the severity of the disease is still not well defined (Maes et al., 2017). Although some 
studies point in the direction that co-infection with more than one strain might result in more severe lung lesions 
(Villarreal et al., 2009; Vranckx et al., 2011), other studies did not find such a relationship and investigation on a 
larger scale with more samples and following up consecutive batches is needed (Charlebois et al., 2014; Maes et 
al., 2017). The fact that the pathogenesis of M. hyopneumoniae is not fully elucidated and no virulence markers 
have been found, complicates investigating the impact of a particular strain on the severity of lung lesions and 
clinical signs. The finding that several M. hyopneumoniae strains are co-existing in one individual pig complicates 
this even further (Dos Santos et al., 2015; Maes et al., 2017; Nathues et al., 2011; Vranckx et al., 2011). 
Field isolate variability of M. hyopneumoniae can impede the proper diagnostics of the pathogen. Genetic 
differences may express proteins on the cell surface of M. hyopneumoniae to a different extent. Five different M. 
hyopneumoniae isolates (232, OOMP1502, OOMP1301, 95MP1505, 95MP1509), were used to challenge infect 
seven pigs each and sera of the pigs were tested with three M. hyopneumoniae specific ELISAs: the Tween 20 
ELISA, the HerdChek® M. hyopneumoniae ELISA (IDEXX Laboratories, Westbrook, ME), both indirect assays 
detecting numerous antigens associated with the cell membrane of M. hyopneumoniae and the IDEIA™ M. 
hyopneumoniae EIA KIT (Oxoid, Ely, Cambridgeshire, UK, formerly DAKO™ M. hyopneumoniae ELISA), a 
competitive-inhibition ELISA designed to detect a conserved epitope of the Mycoplasma hyopneumoniae 74KDa 
protein. All pigs except one were positive with the Oxoid™ ELISA 28 days post challenge and fewer positives 
were detected with the IDEXX and Tween 20 ELISA. In case of the OOMP1502 up to four (IDEXX) or five 
(Tween 20) negative test results were obtained, when the same pigs tested positive with the Oxoid™ ELISA. A 
possible explanation might be that antibodies produced by certain isolates might less effectively bind to the 
antigens used in the IDEXX and Tween 20 ELISA or that for certain isolates less antibodies are produced by the 
pig (Strait et al., 2008a). In case of detection of M. hyopneumoniae DNA of different strains, the same conclusion 
was made by Strait et al. (2008b): submitting 36 M. hyopneumoniae isolates to a panel of published M. 
hyopneumoniae-specific PCR assays resulted in five assays not detecting every M. hyopneumoniae isolate of the 
collection. These five assays targeted the following three genes: a putative ABC transporter (GenBank accession 
no. U02537) (Dubosson et al., 2004; Verdin et al., 2000); a repeated element (REP; GenBank accession no. 
AF004388) (Dubosson et al., 2004; Stärk et al., 1998); a target that spanned the hypothetical genes mhp023 and 
mhp024 (GenBank accession no. AE017332; base pairs 27057 to 28020) (Kurth et al., 2002). 
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1.6.3. Husbandry characteristics 
Improving management practices is primordial in the control of M. hyopneumoniae infections and should be 
addressed first before implementing other measures (Maes et al., 2008). Herd size is a commonly known factor 
to influence the risk for introduction of respiratory agents in a farm (Stärk, 2000). This was demonstrated by 
Aalund et al. (1976), who found a gradual increase for the risk on respiratory disease with increasing number of 
pigs produced. On the other hand, owners of larger herds are more likely to adopt management and housing 
practices which may supersede this increased risk, compared to owners of smaller herds (Gardner et al., 2002). 
Frequently purchasing pigs is a risk factor significantly associated with a higher prevalence of pneumonia (Meyns 
et al., 2011).  
Farrow-to-finish farms who purchase gilts have a higher percentage of pigs seropositive for M. hyopneumoniae 
(Maes et al., 2000). An unstable parity distribution is likely unfavourable as gilts or low parity sows have low 
antibody titers and excrete more Mycoplasma organisms than older sows (Fano et al., 2006; Maes et al., 1996). 
Multiple source purchase policy is positively associated with respiratory disease (Hurnik et al., 1994) and 
purchasing a lot of animals at one occasion has been described as a risk as well, as the higher the number of pigs 
purchased, the higher the probability of buying in one infected animal (Rosendal and Mitchell, 1983). Purchasing 
of pigs is inherently connected to the herd type: fattening farms are obliged to buy their pigs, and the chance for 
a multi-source purchase policy is likely higher compared to breeding farms (Stärk, 2000).  
Continuous pig flow is disadvantageous to reduce respiratory disease compared to production systems where all 
pigs are moved in batches (all-in/all-out). All-in/all-out production is probably the main management factor in 
controlling EP, and is considered even more important than herd size (Clark et al., 1991; Flesjå and Solberg, 
1981; Maes et al., 2008; Stärk, 2000). This production system allows the farmer to clean, disinfect and implement 
a downtime period between groups of pigs (Maes et al., 2008). 
Decreasing stocking density in different production stages has been shown to have a positive impact on 
respiratory disease (Byrt et al., 1985). Flesja et al. (1982) showed that > 12 pigs per pen (an indicator of stocking 
density), can have a negative influence on respiratory disease. Overcrowding makes the pig more susceptible to 
disease by causing stress and improving the circumstances to transmit pathogens, which in case of M. 
hyopneumoniae enhances the chance to transmit the pathogen via nose to nose contact (Maes et al., 2008; Thacker 
and Minion, 2012). Lindquist (1974) found that respiratory diseases are more prevalent in farms with ≥ 500 pigs 
in one section, <3 m3 air space and <0.7m2 area per pig.  
Prevention of M. hyopneumoniae spread within herds or facilities can be done by maintaining basic hygienic 
principles for rearing pigs (Amass and Clark, 1999) and limiting factors that may destabilize herd immunity, such 
as parasite control and avoidance of infections with other respiratory agents (Maes et al., 2008). Separate 
equipment, personnel, feed, water, and transport vehicles should be provided for each production stage (Hege et 
al., 2002; Román et al., 2006; Stankovic et al., 2010). Rodent and insect control should be implemented, albeit the 
importance of such measures for the control of M. hyponeumoniae is not clear (Maes et al., 2008). Indirect 
transmission of M. hyopneumoniae through fomites has been suggested as transmission route by Goodwin (1985), 
however when standard biosecurity measures are considered by farm personnel weekly in contact with infected 
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pigs, M. hyopneumoniae was not transmitted to naïve pigs during a 20 week period (Batista et al., 2004; Goodwin, 
1985). In fact, a one-night downtime period of approximately 14 hours prevents the spread of M. hyopneumoniae, 
next to Porcine Reproductive and Respiratory Syndrome virus (PRRSv) by personnel and fomites (Pitkin et al., 
2011). 
Infectious aerosols, containing microorganisms such as M. hyopneumoniae, and generated by coughing, sneezing 
and simple exhalation, may be a source of infection to neighbouring farms as Goodwin et al. (1985) and Zhuang 
et al. (2002) found that the risk of a herd becoming infected is inversely related to the vicinity to other farms. 
The pig density in the area (Rose and Madec, 2002; Zhuang et al., 2002), close proximity of finishing farms 
(Hege et al., 2002) and the presence of M. hyopneumoniae infected farms (Goodwin, 1985; Hege et al., 2002; Stärk 
et al., 1992) are factors closely associated with the risk of a herd becoming infected with M. hyopneumoniae. Hege 
et al. (2002) found that parking sites for pig transport in an area of ≤ 200 m from the farm is a potential source 
of introduction of respiratory pathogens in the farm. It has been shown that airborne transport of M. 
hyopneumoniae is possible through a distance of 9 km (Dee et al., 2009; Otake et al., 2010), although other authors 
state that to theoretically avoid airborne transmission, the minimum distance should be at least three km 
(Zhuang et al., 2002).  
From point of view of reducing transmission of M. hyopneumoniae, it is preferred to wean the piglets between one 
and three weeks of age (Maes et al., 2008) although weaning before the age of 21 days in pigs is not allowed in 
the EU (European Council, 2008). 
Sows infected in the 200 days prior to farrowing are likely to transmit M. hyopneumoniae to their offspring. Gilts 
are most likely to be infected within the 200 days prior to farrowing. The number of pigs infected at weaning 
depends on the number of sows shedding M. hyopneumoniae at farrowing and this in turn determines the disease 
load from M. hyopneumoniae in growing pigs (Lowe, 2012). Therefore, an adequate gilt acclimation program 
should focus on reduction of M. hyopneumoniae shedding at first farrowing (Garza-Moreno et al., 2016). In Europe 
and North-America, vaccination of replacement gilts is the main tool for gilt acclimation, however, there is a 
trend in the US nowadays of deliberately exposing the gilts to the pathogen (Garza-Moreno et al., 2018). It was 
already demonstrated that the absence of gilt acclimation by providing the replacement stock access to other 
living animals was addressed being a risk factor for M. hyopneumoniae disease severity in fattening pigs (Garza-
Moreno et al., 2016; Nathues et al., 2016). Additionally, with the knowledge that gilts even after adaptation and 
after their first progeny are crucial in the spread of M. hyopneumoniae in the herd, in larger production systems they 
are housed separately from the herd until they reach second gestation. By that time, these second parity sows 
have acquired the desired immunity level in order not to destabilize the herd anymore (Hoy et al., 1986; Joo, 
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1.6.4. Housing conditions with emphasis on indoor climate  
1.6.4.1. Particulates 
A fattener pig breathes about 40 kg of air per day, compared to consuming 2.7 kg of feed and drinking 4 kg of 
water (Gonyou et al., 2006). Over the last decades, pig husbandry has become more intensive, leading to higher 
concentrations of airborne particulates (Pedersen et al., 2000). Not only particulates are of major concern to 
evaluate air quality, but gasses (see further) may not be neglected, both as an animal and human health hazard 
(Gonyou et al., 2006). 
The term PM can be defined as a complex mixture of suspended particles with different biological, chemical and 
physical properties. In this mixture, particles of different shape, size, density and chemical composition can be 
found (Cambra-López, 2010). The term PM is mainly used in the context of air quality and is in this definition 
referred to as fine liquid or solid particles suspended in a gaseous medium (Ulens, 2015). In atmospheric science 
the latter is mostly referred to as aerosol (Cambra-López, 2010). The behaviour of particles in the atmosphere or 
respiratory tract is described by the scientific term aerodynamic equivalent diameter (AED). This term groups 
three of the particle properties described above in one single parameter: shape, size and density. It is defined as 
the diameter of a spherical particle with a density of 1 g/cm3 with the same settling velocity under gravity as the 
particle in question (Cambra-López, 2010; Kulkarni et al., 2011; Ulens, 2015). In this thesis, only the size-
selective classification of PM, PM10, PM2.5, PM1 is used, although the different fractions of PM can be defined in 
multiple ways (Ulens, 2015). PM10, PM2.5 and PM1 can therefore be defined as particles that pass through a size-
selective inlet with a 50% cut-off at respectively 10 µm, 2.5 µm and 1 µm AED (U.S. EPA, 2004; Ulens, 2015). 
PM can as well be grouped based on its origin or source. Primary PM originates from mechanical processes and 
is emitted directly into the atmosphere (Ulens, 2015). Primary PM can also contain bacteria or parts of bacteria 
(Banhazi et al., 2004; Curtis, 1972; Hinz, 2002), fungal spores (Harry, 1978; Noble et al., 1963), moulds and their 
specific mycotoxins and viruses such as rotavirus and PRRSv. The organic matter in larger particles is able to 
protect micro-organisms against adverse physical and chemical factors, such as exposure to changes in humidity, 
sunlight, oxygen etc. (Butera et al., 1991; Harry, 1978). Secondary, PM on the other hand, originates from 
chemical reactions between gasses (ammonia, nitrogen oxide,…) and particles in the atmosphere (Ulens, 2015). 
Toxic gasses are able to attach to the porous surface of particulate matter (Harry, 1978; Hinz, 2002). For instance 
ammonia can be carried on PM for an extended period of time (Kaasik and Maasikmets, 2013). Odours can be 
adsorbed to particulates as well (Takai and Pedersen, 2002). For PM to become and stay airborne the attraction 
between the particle and the surrounding air molecules has to be larger than the force of gravity on the particle 
(Collins and Algers, 1986). 
A. Characteristics of particulates 
The naked human eye can only see particles larger than 50 µm in a ray of sunlight. Therefore, the air in a pig 
facility can be loaded with more (smaller) particles than thought at first sight. The ability of a particle to be 
deposited in the respiratory tract depends on its size (Collins and Algers, 1986). Following particle size ranges are 
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often distinguished: inhalable or total dust or also referred to as all particles of all sizes suspended in the air or 
expressed in size all particles smaller than 50-100 µm, (Gonyou et al., 2006), thoracal dust or fine dust (particles 
smaller than 10 µm) will reach the higher respiratory airways, and respirable dust (particles smaller than 4 µm, in 
the past often defined up to 5µm), will reach the respiratory part of the lung (Hinz, 2002; Jacobson et al., 2003; 
Takai et al., 1998). Particulate matter originating from housed livestock, also referred to as bio-aerosols, contain 
more particulates with biological activity and/or origin compared with urban and industrial PM (Cambra-López 
et al., 2010). The smaller the size of the particulates, the deeper they can penetrate into the lungs and the more 
harmful they are (Aarnink and Ellen, 2007). Particles with a size larger than approximately 5 µm will be trapped 
by the mucociliary system (Collins and Algers, 1986). On the other hand, Harry (1978) indicated that although 
smaller infected particles can be transported directly to their target area i.e. the trachea, bronchi or lungs (diseases 
of the upper respiratory tract), the larger particles could be more infective as they are more likely to carry a larger 
amount of microorganisms. 
Particulate matter in animal production can originate from different sources. Viable or non-viable 
microorganisms such as fungi, viruses, bacteria or parts of their cell wall (Banhazi et al., 2004; Curtis, 1972; Hinz, 
2002), feed and building materials in the facilities inside animal facilities (Hinz, 2002; Lemay et al., 2002), skin 
cells, hair from the animal species housed in the stable, dried manure, urine, grain mites, spores, pollen, soil, 
mineral additives in pig feed and insect parts may be added to the list of sources contributing to PM formation 
(Hinz, 2002; Kim et al., 2008). Only a small portion of PM encountered in the facility will enter via the incoming 
ventilation air (Mostafa and Buescher, 2011). Of bacteria detected in the air of a swine facility, Gram-positive 
organisms such as Staphylococcus spp., Micrococcus spp., Aerococcus spp., Enterococcus durans, Streptococcus suis, Bacillus 
spp. and Corynebacterium spp. can be detected. Of the Gram-negative bacteria Enterobacter agglomerans, Acinetobacter 
calcoaceticus, Pasteurella spp. and Vibrio spp. were detected (Gonyou et al., 2006). Following fungi have been 
detected in swine building indoor environments: Aspergillus versicolor was the most frequent species found in air 
(21%), followed by Scopulariopsis brevicaulis (17%) and Penicillium sp. (14%). Other genera were as well isolated: 
Cladosporium sp., Fusarium sp., Mucor sp., Trichoderma sp., Phoma sp., Alternaria sp., Chrysosporium sp., Scytalidium sp., 
Pithomyces sp., Acremonium sp., Chrysonilia sp, Hormographiella sp., Ochroconis sp., Beauveria sp., Botrytis sp., Stachybotrys 
sp., Epicoccum sp., Lictheimia sp., Staphilotrichum sp., Ulocladium sp., Stemphilium sp. and Rhizopus sp. (Viegas et al., 
2013). In a review article regarding mycotoxins as indoor air contaminants, it is stated that exposure to five 
important agricultural mycotoxins deoxynivalenol, fumonisins, aflatoxins and zearalenone under normal 
circumstances is very unlikely. Allergic responses (asthma, allergic rhinitis, hypersensitivity pneumonitis) are the 
most common problems associated with inhalation exposure to fungi, the extent of the effect depending on the 
health status of the exposed person or animal (Jarvis and Miller, 2005). Antibiotics, used in the feed, can also be 
detected in PM. Up to five different antibiotics (oxytetracycline, chlortetracycline, sulfamethazine, tylosin and 
chloramphenicol) were detected in sedimentation PM samples from fattening pigs collected from 1981 to 2000 
(Hamscher et al., 2003). Dried manure can also be a source of antibiotics detected in PM. Tetracyclines and 
sulphonamides are poorly metabolized in pigs, thus significant amounts of the parent drug can therefore be 
excreted (Hamscher et al., 2003; Winckler and Grafe, 2001). There might be a risk to develop antibiotic 
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resistance upon inhaling PM contaminated with antibiotics as this may represent a permanent exposure to sub-
therapeutic concentrations (Hamscher et al., 2003). 
B. Particulate matter measuring methods 
Particulate matter concentrations may be measured with different methods. Most commonly used equipment is a 
tapered element oscillating microbalance, a beta attenuation monitor, a gravimetric sampler and an optical 
particle counter (Ulens, 205). The latter device was used in this thesis because of the demonstrated equivalence 
according to EN 13205 for this particular spectrometer (Grimm 1.109 spectrometer), which describes a 
European standardized procedure to assess the performance of PM sampling with different sampling techniques 
in a workplace environment and the equivalence of this device with the Reference Sampler for measuring PM10 
and PM2.5 in ambient air (EN 12341, 1999; EN 14907, 2005; Van Ransbeeck et al., 2013b). Optical particle 
counters individually detect particles in aerosol by the principle of light scattering by the particles inside the 
optical measuring cell of the device (Van Ransbeeck et al., 2012). The intensity of light scattering correlates with 
a certain particle size (Van Ransbeeck et al., 2013a). Based on the intensity of the detected signal, the signal is 
subsequently classified into size channels (Ulens, 2015). Conversion of the counts to PM mass density is 
performed and by means of the software of the devices used, PM10, PM2.5 and PM1 mass fractions are calculated 
(Van Ransbeeck et al., 2013a). More information regarding different measuring equipment can be consulted in 
Ulens (2015) and Van Ransbeeck et al. (2013b). 
C. Concentration and size distribution of particulates in pig farm 
In a study of Takai et al. (1998) the mean inhalable and respirable PM concentrations were 2.19 and 0.23 mg/m3, 
respectively. In general terms, the total PM mass concentration in swine confinement buildings in various 
sections of the barn and over the year will stay between 2.0 and 3.0 mg/m3 (Lemay et al., 2002). The 
recommended maximal concentration of PM estimated on the basis of dose-response correlation to swine health 
or human health problems is 2.4 mg/m3 (Donham, 1991). 
D. Impact of particulates on pig health 
The impact of PM on the respiratory tract can be described as mechanical, chemical, infectious, 
immunosuppressive, allergic and toxic (Hartung, 2002). Thus it may compromise health and performance of 
livestock in different ways: as a carrier of pathogenic and non-pathogenic micro-organisms, as an allergic or 
immunosuppressive agent, as a physical irritant of the respiratory tract and as a carrier of toxic chemicals and 
odors (Baekbo, 1990; Carpenter and Moulsley, 1986; Donham, 1991; Hartung and Schulz, 2011; Hinz, 2002). 
Endotoxin is probably the most relevant parameter identified with respirable particulates and associated with 
lung function impairment (Millner, 2009). Endotoxins are lipopolysaccharide complexes originating from the 
outer membrane of Gram-negative bacteria (Cambra-López et al., 2010). They are released into the environment 
during bacterial cell growth and after cell death (Spaan et al., 2006) by handling of the bedding material or animal 
feed (Zucker et al., 2000). The highest amount of endotoxin in the air is detected in weaner houses and during 
the day, probably due to the diurnal rhythm in animal activities (Seedorf et al., 1998). It originates mostly from 
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Gram-negative, obligate anaerobic bacteria, and in minority from Escherichia coli present in faeces or manure or 
from bacteria of the species Enterobacter agglomerans (epiphytic organism on a variety of plants) (Zucker et al., 
2000). Under normal circumstances the pigs’ respiratory tract is not free of infection, or even lesion, but it is 
usually free of disease. Environmental factors, like PM can tip the balance between host and respiratory invaders 
in favour of the invaders (Donham, 1991). Particulates can have an inhibitory effect on the mucosal clearance 
system. Endotoxins in particulates originating from bacteria or the particulates themselves, can act as a chemical 
component causing inflammation. The inflammation process can damage the nasal turbinates which can 
diminish the removal of particulates (Pearson and Sharples, 1995). The airway epithelial cells, alveolar 
macrophages and neutrophils are over activated, which can lead to a loss of protective effect of alveolar 
macrophages and other lung defence mechanisms (Jolie et al., 1999). As M. hyopneumoniae is known to act on the 
mucosal clearance system as well, by disrupting the cilia on the epithelial surface, particulates (and ammonia, see 
further) and the bacterium may work in a synergistic way (Thacker, 2006). Inhalation of infectious aerosol by 
susceptible animals is a route of transmission in a number of viral and bacterial diseases. For instance M. 
hyopneumoniae was detected in the air by means of a nested PCR assay (Stärk, 1999) and acute and chronic 
exposure of pigs to aerial pollutants has been implicated in the aetiology of multifactorial respiratory diseases 
(Wathes et al., 2004). Particulates combined with ammonia take part in the pathogenesis of progressive atrophic 
rhinitis (Hamilton et al., 1999; Robertson et al., 1990) and the incidence and severity of specific respiratory 
diseases, such as EP in the weaned pig are higher when combined with chronic exposure to aerial pollutants 
(Demmers et al., 2003; Wathes et al., 2004). It has been demonstrated as well that even non-pathogenic 
organisms, when inhaled in a very high concentration can be harmful for the health of the pig (Carpenter and 
Moulsley, 1986). Pigs exposed to aerial pollutants may have a reduced performance (Demmers et al., 2003). 
Some authors have doubts about the deleterious effect of PM on pig health and performance (Done, 1991; Takai 
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E. Impact of particulates on human health in swine farmers 
From human health perspective dust exposure in pig farming is important because of the large number of 
workers needed and the increasing number of working hours inside enclosed buildings in pig production. 
Symptoms most commonly noticed are chronic bronchitis (cough and phlegm), asthma-like symptoms such as 
wheezing and shortness of breath during work, with evidence of mild airways obstruction (Iversen et al., 2000). 
A clear dose-response relationship with the number of working hours inside swine facilities and respiratory 
symptoms has been demonstrated (Radon et al., 2000). 
F. Influencing factors on the concentration of PM in pig stables 
F.1. Type of farm and animal characteristics  
The concentration of PM in pig stables depends on the species, age of the animals, stocking density, feeding and 
littering strategies, climate conditions and behaviour of the animals (Hinz, 2002). Winkel et al. (2015) measured 
indoor concentrations PM10 and PM2.5 in poultry houses, pig facilities and dairy farms. Inside concentrations 
were highest in poultry houses, followed by pig facilities and the lowest concentrations for each of these 
fractions measured were detected in dairy houses. The PM-concentration increases with the age of the pigs, and 
consequently is lower in post-weaning facilities than in finishing units (Pedersen et al., 2000). Close to the time of 
weaning, PM-concentration is also much higher than before farrowing (Kim et al., 2005). In farrowing units 
faeces take a larger part in the constitution of PM-formation, compared to feed (Donham, 1991), while for 
weaner pigs the PM seemed to originate mainly from feed and skin particles (Aarnink and Ellen, 2007). In 
growing-finishing pigs a similar contribution of feed, faeces and skin particles was found (Aarnink and van der 
Hoek, 2004). The amount of PM is influenced by the activity of the animals (Dawson, 1990). Animal activity 
causes local disturbance of settled PM (Carpenter, 1986). The overall particulate levels will generally be higher 
during the day than overnight because of more animal activity during the day (Kim et al., 2005; Pedersen et al., 
2000). The number of sows in a farm - as an indicator of farm size - is positively correlated to respirable particle 
concentration during summer according to Banhazi et al. (2004; 2008). A linear relationship exists between the 
total weight of the pigs in a room and the PM-concentration: this concentration more than doubled during a 16-
week finishing period. Therefore the animal mass present in the building will be a major factor influencing the 
PM-concentration (Pedersen et al., 2000). 
F.2. Housing 
Animals kept in total confinement are more exposed to PM compared to animals kept in open byre types or 
buildings with space boarding or another large permanent opening. The type of floor, presence of bedding 
material/litter, size of the air space, and to a much lesser extent the building materials of the pig facility are all 
able to influence the constitution of PM (Banhazi et al., 2008; Dawson, 1990). In pig facilities with slatted floors, 
PM levels are much lower compared to the ones with solid floors: the area for PM to settle is much lower and 
this minimizes resuspension of PM from animal activities (Dawson, 1990; Jacobson et al., 2003). Presence of 
bedding and agitation significantly increases the amount of PM in the air space of the pig. Inhalable particle 
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concentrations increase with the size of the air space (building) in all-in/all-out production systems and decrease 
in continuous flow systems (Banhazi et al., 2008). 
F.3. Feed 
The composition of PM and its particle size distribution largely depends upon the type of feed and feeding 
method. The addition of fat or oil to the feed has been shown to reduce both aerial and settled dust levels: 
adding 1 or 2% of fat, reduces the PM  with 10 or 20%, respectively (Dawson, 1990). According to Honey and 
McQuitty (1979), the feeding activity is the main cause of airborne dust in swine houses. Restricted feeding twice 
a day is recommended instead of feeding ad libitum to decrease the PM content in the pigs’ air space. This is 
related to the fact that when restricted feeding is applied, the activity of the pigs is more synchronized (Aarnink 
and Ellen, 2007). Using a pig feeder should be preferred above feeding the pigs on the floor (Dawson, 1990). 
Supplying liquid feed lowers the PM-concentration compared to dry feed. Providing pelleted feed to nursery pigs 
instead of a meal diet, significantly increased PM10, PM2.5 and PM1 (Ulens et al., 2015). However, the quality of 
the pelleted feed probably plays an important role in PM production as well: PM-formation is determined by 
how easily the pellets disintegrate during transport (Aarnink and Ellen, 2007) and coated pellets lead to lower 
PM-formation than non-coated pellets (Aarnink and Ellen, 2007; Dawson, 1990). Some ingredients cause higher 
PM-production than others: barley, for instance, causes more PM-formation than corn (Aarnink and Ellen, 
2007). The feed distribution mechanisms and spilling feed can increase the PM-levels in a swine facility (Hartung, 
1986; Jacobson et al., 2003). Feed delivered by a screwing system causes 150% more dust than feed delivered by 
hand in the trough. In automatic feeding systems, a substantial amount of particulates can become airborne, 
when feed drops into the feeder or trough (Aarnink and Ellen, 2007). 
F.4. Season and climatological influence 
Season or climate, intrinsically associated with ventilation rates, will affect PM concentrations inside a swine 
facility (Cambra-López, 2010). Banhazi et al. (2008) measured significantly higher inhalable particle 
concentrations in swine buildings during winter than during summer. Higher ventilation rates during summer 
will diminish PM concentrations, lower ventilation rates in winter will result in higher PM concentrations 
(Cambra-López, 2010). Aerial level of lung-deposal BCFP is higher during cold weather (Curtis et al., 1975; 
Jacobson et al., 2003). 
E.5. Thermal environment 
Temperature is positively correlated with respirable particle concentration in all-in/all-out buildings and in 
weaner, deep-bedded shelter and grower/finisher buildings, but was negatively correlated with particle 
concentrations in the farrowing unit and other sow rooms (Banhazi et al., 2008). Kim et al. (2005) found a 
positive correlation between the indoor temperature and total particulates. Lower temperatures on the other 
hand may also stimulate animal activity, which in turn increases the PM content of the facility because the settled 
particulates on surfaces and floors are resuspended in the air (Collins and Algers, 1986; Kim et al., 2005). The 
effect of temperature on PM concentration is therefore not easily explained.  
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F.6. Humidity 
When humidity inside a facility is high, the moist content of the settled dust, litter and faeces will be high and 
may prevent to some degree the amount of airborne particles generated (Collins and Algers, 1986; Pedersen et 
al., 2000). In fact, to reduce airborne particulates, the optimal absolute humidity should be as high as possible, 
without creating condense and animal discomfort. Smaller particulates clump together by the high humidity. 
Hence the settling velocity of such a particle will be increased (Harry, 1978). When the relative humidity exceeds 
80%, the infection pressure rises and a higher prevalence of several diseases will be noticed. Relative humidity 
below 60%, particularly at low temperatures, results in an increased PM content in the air (Harry, 1978). Kim et 
al. (2005) found that the trend of correlation between indoor relative humidity and environmental risk factors 
(total dust, total airborne bacteria, NH3, H2S, odour index level) was generally negative.  
E.7. Husbandry activity 
Feeding and handling the pigs, as well as bedding promote the generation of particulates (Dawson, 1990). 
Therefore it is better to reduce the visits by stockmen. Passages between the pens are preferred to reduce stock 
disturbance (Harry, 1978) .  
F.8. Hygiene 
Cleaning has a positive effect on the amount of settled particulates on smooth surfaces. Residues may persist on 
difficult accessible areas (i.e. roof beam, wall structures, ventilators) (Harry, 1978). Interestingly, Banhazi et al. 
(2004) found that in deep-bedded shelters the effect of pen soiling had a beneficial effect. It was hypothesized 
that soiling would increase humidity inside the building (see above) and that the smaller range particles can be 
trapped in the adhesive layer of dirt. However, in conventional weaner and grower/finisher buildings with 
(partially) slatted floors, pen soiling was associated with a higher respirable particle concentration. For cleaning 
the facilities, hosing and pressure washing are preferred above scraping, but pressure washing seemed only 
marginally better than hosing (Cargill et al., 2002). The use of disinfectants will have a positive effect as well, 
especially on cracked old floors, however as many disinfectants are inactivated by organic material, thorough 
cleaning should be the first step. On the other hand Ulens et al. (2014) showed that an additional wet cleaning 
and disinfection step after broom-swiping and vacuum cleaning the pens did not result in consistently lower 
indoor concentrations of PM (next to NH3, CO2, CH4, N2O). They indicated that a thorough dry-cleaning step 
might be sufficient and the wet step in the protocol might not be necessary to reduce the aerial pollutants any 
further. 
G. Particulate mitigation strategies inside the facilities 
Techniques addressing PM formation inside the swine facility are also called source-oriented mitigation 
techniques. This can be achieved by prevention of PM formation or diminishing the concentration inside the 
swine facility. This is in contrast with end-of pipe techniques which try to lower the pollutants in the outgoing 
air, reducing pollutant emission, but do not tackle the formation inside the facilities (Ulens, 2015). More 
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information on end-of pipe techniques is provided by Ulens (2015). Most source-oriented mitigation strategies 
were already described under the paragraph influencing factors on the concentration of PM in pig stables, such 
as type of feed and delivery method, hygiene in the pens, the use of bedding materials. Additionally, spraying oil 
or water has been shown to reduce indoor PM concentrations (Aarnink and Ellen, 2007). According to Takai 
and Pedersen (1999) the droplets should be >150 µm for the reduction to be effective and to avoid that smaller 
droplets might be inhaled by the pigs and pig workers. Applying an oil film on the pigs is also a possibility 
(Osman et al., 1999). An increased ventilation rate during short periods of time might dilute and thus reduce 
total PM concentrations. This effect however, only lasts for a short amount of time (Robertson, 1989). Filtration 
of the inside air (internal circulation dry filters, electrostatic precipitation, ionisations systems) is able to lower 
inside PM concentrations. However, due to the large volume housing systems and the high costs of the devices, 
this method is impractical in swine buildings (Ulens, 2015). 
1.6.4.2. Indoor gasses 
Ammonia (NH3), hydrogen sulphide (H2S), carbon dioxide (CO2) and methane (CH4) are the main pollution 
gasses in animal houses. They are produced by decomposition of animal waste and the metabolism of the animal 
(Heber et al., 1997; Muehling, 1970; Ni, 1998; Ni et al., 2008). Gasses such as NH3 and H2S can be adsorbed on 
particulates. Their porous structure allows slow and continuous gas release from the particulates over a longer 
period and enables the toxic gas to reach the deeper part of the lungs, when particulates with adsorbed gas are 
inhaled (Donham et al., 1977; Takai and Pedersen, 2002). 
Ammonia is mostly originating from drying of manure and urine on solid floor surfaces. It is formed through 
enzymatic hydrolysis of urea by the enzyme urease in faeces and produced by various microorganisms leading to 
the formation of carbonic acid and ammonia which is in equilibrium with NH3 depending on temperature and 
pH of the faeces (Ni, 1999; Wenger, 1999; Zeeman, 1999). Volatilisation occurs under the form of NH3 and 
depends on its concentration in the manure, pH, temperature, surface area and air velocity at the manure surface 
(Ni, 1999). A lesser portion of NH3 in pig facilities originates from storage of liquid manure in the manure pit 
(Wenger, 1999). Ammonia can be measured by different techniques: aqueous acid trap, gas detection tubes, 
Fourier Transform-Infrared Spectroscopy (FTIR), chemiluminescence, infrared photoacoustic system, laser 
absorption spectroscopy…Most of these techniques for continuous measuring are costly (Ulens, 2015). The 
technique used in this thesis is the infrared photoacoustic system (Innova photoactoustic gas monitor 1314). Air 
is drawn into the analysis cell of the measurement system by means of an air pump. Infrared light is reflected off 
a mirror passing a mechanical chopper, causing the light to pulsate. Next, the light beam passes through one of 
the optical filters in the filter wheel inside the device. The wavelength of the incoming beam can be modulated 
by these installed filters. At a certain wavelength, specific for each gas, the infrared light will cause excitation of 
the gas molecules, which causes an increase in temperature. By chopping the light beam, the temperature will 
increase and decrease, causing an equivalent increase and decrease in pressure of the monitored gas in the 
hermetically closed photoacoustic cell. These pressure pulses (an acoustic signal) are detected by microphones in 
the cell. The acoustic signal is proportional to the concentration of the measured gas (Innova 1314I technical 
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data sheet). For further reading on this subject, Ulens (2015) may be consulted. Ammonia levels of 5 to 10 ppm 
are typically encountered in well-ventilated swine confinement buildings with slatted floors. The ammonia 
concentration tends to be slightly higher in buildings with solid floors (Jacobson et al., 2003). Acute exposure to 
NH3 can cause damage to the epithelial lining of the less resistant bronchioli, prolonged exposure to 
concentrations above 400 ppm may destroy mucous membranes by dissolving keratin, fat and cholesterol 
(Stombaug et al., 1969). For the comfort of the farmer and staff it is recommended that the NH3 levels are kept 
below 25 ppm, but pigs will already avoid NH3 levels of 10 ppm. The maximum long-term NH3 exposure for 
swine should be less than 20 ppm as both pathological (Hamilton et al., 1996) and immunological data suggest 
that NH3 influences the inflammatory response (Urbain et al., 1994). Ammonia levels of 50 to 75 ppm reduced 
the ability of young pigs to clear bacteria form the lungs (Gonyou et al., 2006). Very high levels of NH3 , (≥2.500 
ppm) may be fatal (Jacobson et al., 2003). In 2004 a ministerial decree was passed, requiring all pig and poultry 
producers in Flanders when renovating, expanding or building new animal facilities to use officially approved 
low ammonia-emission housing systems (M.B. 19 maart 2004; Ulens et al., 2014). Although these housing 
systems are mostly built at a higher cost compared to conventional housing systems, Ulens et al. (2014) 
demonstrated that such a low-ammonia-emission system did not result in a reduction of indoor pollutant 
concentrations, except for CH4 compared to a conventional housing system for finisher pigs with fully slatted 
floors. Ammonia can also play a role in the development of turbinate atrophy in pigs affected with 
dermonecrotic (DNT) producing Pasteurella multocida (P. multocida) (Hamilton et al., 1999). It facilitates 
colonization of DNT P. multocida in the upper respiratory tract and thus increases the severity of the clinical 
disease progressive atrophic rhinitis (Hamilton et al., 1998). It may also influence the growth rate of pigs 
(Drummond et al., 1980). A significant effect was observed of 50, 100 and 150 ppm NH3 in four week old pigs 
for an exposure period of four weeks. The pigs in the respective treatment groups gained respectively 12, 30 and 
29% less body weight compared to the control group (0 ppm NH3) (Drummond et al., 1980). No impact of 
different NH3 concentrations and PM concentrations (50 ppm and 10 mg/m3 or 300 mg/m3) was demonstrated 
on nasal turbinates, trachea and lungs (Curtis et al., 1975). In Donham et al. (1991) a significant correlation in the 
finishing unit was found between NH3 (23.6 ppm) and pleurisy lesions (Donham, 1991). In a study of Hamilton 
et al., (1999) the turbinate atrophy due to DNT P. multocida was highest  in the pigs in the environmental 
exposure chambers with NH3 (50 ppm) and ovalbumin particulates (20 mg/m3) compared to all other 
combinations of treatments (ovalbumin PM, NH3, DNT P. multocida) (Hamilton et al., 1999). From these data it 
can be concluded that studies investigating the systematic long term impact of PM and NH3 simultaneously on 
(respiratory) pig health or production parameters are not available. In humans, NH3 can act as a local irritant of 
the mucous membranes and the respiratory tract (Cole et al., 2000). Clinical signs observed are sneezing, 
coughing and salivation (Donham, 2000). Source-oriented mitigation strategies for NH3 can be implemented at 
the level of the feed provided to the pigs, for instance, lowering the protein in the diet, acidifying the diet and 
adding more fibre (Aarnink et al., 2008; Kim et al., 2004; Ulens, 2015). Segregation of urine and faeces 
preventing the contact between urea in urine and the enzyme urease can be applied, for instance with V-shaped 
pit floors and scrapers. Reducing the emmiting surface of the manure pit and the use of partially slatted floors 
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can also be applied to diminish NH3 formation inside the pig facility. More information on NH3 mitigation 
strategies is provided in an excellent overview by Ulens (2015). 
Hydrogen sulphide is formed by bacterial sulphate reduction and the decomposition of sulphur-containing 
organic compounds in manure under anaerobic conditions (Jacobson et al., 2003; Wenger, 1999) and has the 
distinctive odour of rotten eggs (Holland et al., 2002; Wenger, 1999). Hydrogen sulphide is heavier than air and 
can accumulate in manure pits, holding tanks, and other low areas in a facility (Holland et al., 2002). It is 
considered the most dangerous gas in animal facilities and at the level of manure storage as it is responsible for 
many deaths both in human and livestock due to insufficient ventilation and when agitation of manure during 
storgage emptying occurs (Ni et al., 2010). At high concentrations hydrogen sulfide is an eye and respiratory tract 
irritant in humans (Cole et al., 2000). Usually the concentration in closed swine facilities (<10 ppm) is lower than 
the concentration of other gases like ammonia and carbon dioxide (Holland et al., 2002; Jacobson et al., 2003). 
From 250 ppm onwards, pigs can experience distress (O'Donoghue, 1961). Hydrogen sulphide can irritate the 
mucous membranes of the eye and respiratory tract and in the deeper airways it can result in pulmonary oedema 
(Curtis, 1983). Concentrations of H2S between 500 and 1000 ppm or higher, which may occur when manure pits 
are agitated, can cause death or intermittent spasms, cyanosis, unconsciousness and convulsions in both human 
and pigs (Donham et al., 2000; Ensley and Osweiler, 2012; Holland et al., 2002; Lillie, 1972; O'Donoghue, 1961; 
Stombaug et al., 1969).  
Carbon dioxide is produced by the animals and to a lesser extent originates from the manure (Ni et al., 1999; 
Philippe and Nicks, 2015). Measuring CO2 concentrations can be used to evaluate the ventilation efficiency. 
Indoor air CO2 concentrations were between 350 and 4350 ppm in mechanically ventilated pig houses 
(Anderson et al., 1987; Jacobson et al., 1996) and between 1430 and 3050 ppm in naturally ventilated pig houses 
(Jacobson et al., 1996; Van't Klooster and Heitlager, 1994). The production of respiratory CO2 corresponds to 
2.23, 3.68, 0.88 and 1.70 kg CO2 head_1 day_1 for gestating sows, lactating sows, weaned piglets and fattening 
pigs, respectively (CIGR, 2002). The maximum allowed concentration for animals is 3000 ppm (CIGR, 1992). 
After 6 to 8 h failing of the ventilation system, asphyxiation of animals inside the room may occur by 
displacement of oxygen by CO2  (Donham et al., 1982; Ensley and Osweiler, 2012). Not much attention is paid 
to CO2 when evaluating the air quality in relation to respiratory health of the pig, however one report found that 
sneezing, coughing or pneumonia is higher in pigs experiencing CO2 concentrations of 2000-9000 ppm 
compared to 1000-3000 ppm (Busse, 1993; Ni et al., 2000). 
Methane originates from the anaerobic degradation of organic matter performed by bacteria in the digestive tract 
of the pigs and in the manure (Philippe and Nicks, 2015). Less information of the impact of this gas on pig 
health is available, as it is considered to be a significant contributor to greenhouse gas formation and not as 
important as compromiser of pig health (Ni et al., 1999). Not much information of the impact of CH4 in terms 
of impact on animal health is available. It is reported that concentrations of 50 000 ppm are hazardous for the 
animal (Muehling, 1970; Ni et al., 1999), but rather as explosion danger, as this concentration is the lower 
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A summary on the recommendations on maximum gas concentrations is given in table 3.  
Table 3: Recommendations on maximum gas concentrations in pig stables 






Adapted from Ni, 1998 (Ni, 1998): *Intermittently, when dunging out, NH3: ammonia, H2S: hydrogen sulphide, CO2: carbon dioxide, CH4: methane, NA: 
not available 
1.6.4.3. Ventilation, air velocity and relative humidity 
Ventilation has a direct impact on aerosol levels and has been found to be associated with respiratory disease 
levels (Stärk, 2000). An air exchange of >60 m3 per hour per pig has a protective effect on pneumonia (Flesjå et 
al., 1982). Special attention should be paid to temperature set points, fan staging, air inlet, curtain settings, sensor 
placement, heating capacity, preventing draughts and building maintenance when evaluating housing systems in 
order to reduce respiratory disease (Gonyou et al., 2006; Heinonen, 2001; Maes et al., 2008; Mul and Vermeer, 
2010). Improving ventilation strategies (forced vs. natural), will decrease the prevalence of M. hyopneumoniae-
infections (Fraile et al., 2010). Air velocity is inherently connected to the thermal comfort of the pig. The air 
velocity at the pig level should be maximum 0.2 m/s (see further) (D. Maes, personal communication). A limited 
number of studies determine the influence of cold air draughts on the immune response in pigs. Sheepens et al. 
(1994) concluded that climatic stress disturbs the homeostasis of the pigs’ immune system and increases the 
activity level of the pigs, which increases the particulates levels and the risk of transmitting respiratory agents via 
aerosols. Pathogens are best controlled under the circumstances of 60-80% relative humidity (Gonyou et al., 
2006). Alterations of the air humidity have adversely affect the viability of microorganisms. Bacterial cells tend to 
die as they dry, but once dry, they can remain viable for long periods, if kept in a dry state. Survival of bacterial 
cells is lowest at midrange relative humidity. This is also true for Mycoplasma species. The effect of the relative 
humidity on the survival of airborne viruses varies with the type of microorganism (Harry, 1978). It was 
observed that a large variation in indoor humidity was also significantly associated with the prevalence of 
pneumonia, but the mechanism for this association is not clear (Done, 1991). 
1.6.4.4. Thermal environment 
Temperature can be considered as a factor of climatic stress. Quantitative data between the association of 
temperature with respiratory health is limited in pigs (Stärk, 2000). Cold temperatures have an inhibitory capacity 
to clear bacteria from the lungs, probably due to a decreased mucociliary clearance induced by cold temperatures, 
but this effect becomes less important as the pigs become older (Curtis et al., 1976; Giesbrecht, 1995). The 
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outside environmental condition strongly influences the inside conditions in fattening units, as in most fattening 
units no additional heating is provided (Stärk, 2000). The lower the outside temperature, the higher the 
probability of pigs being seropositive for M. hyopneumoniae (Segalés et al., 2012). Conversely, high outdoor 
temperatures are associated with increased pneumonia as well (Done, 1991). Not only the temperature itself is 
important, but temperature fluctuations also need to be avoided (Gonyou et al., 2006). Fattening pigs can 
tolerate temperature fluctuations of 5-10 °C within 24 hours at an air velocity of 0.15 m/s (D. Maes, personal 
communication). A 12°C or more variation in temperature within 24 hours increases the incidence of pneumonia 
(Done, 1991). It was shown that fluctuating temperatures (from 4°C to 30 °C) enhanced the progress and 
severity of Aujeszky’s disease in pigs (Narita et al., 1992) and the immune response of pigs challenged with A. 
pleuropneumoniae was significantly influenced by temperature, together with draughts (Kreukniet et al., 1990; 
Noyes et al., 1986). 
Goodwin (1985) found a tendency for EP to start especially in autumn and winter and this was confirmed by 
Jorsal and Thomson (1988). On the other hand, Stärk et al. (1992) found that onset of clinical disease started in 
November-March, under European conditions. Segalés et al. (2012) described that animals born in autumn 
(when higher rainfall occurred), entering the finishing units in winter (when lower temperatures were recorded in 
that study) and reaching the slaughter age in spring, had higher probabilities to be infected with M. hyponeumoniae 
and to be seropositive to M. hyopneumoniae. Their explanation was that in Spain the winters are cold and wet and 
in summer the climate is hot and dry, favoring M. hyopneumoniae survival in their winters (humid, low temperature 
and lower amount of UV). Logically, this cannot be generalized to other countries/regions with different climate 
conditions. Zhuang et al (2002) concluded that rainfall and especially temperature were negatively associated with 
the seasonal variation in occurrence of M. hypopneumoniae-infections. This was confirmed by Vangroenweghe et 
al. (2016) who found a negative association of rainfall in the week preceding sampling of three to five week old 
pigs with the probability of these pigs testing positive for M. hyopneumoniae on tracheobronchial swabs.  
1.6.5. Influence of other infectious agents and mycotoxins 
Single infection with M. hyopneumoniae, although uncommon under commercial circumstances, is considered to 
result in mild clinical signs (Sibila et al., 2009). In uncomplicated cases, the pigs can be (subclinically) infected 
with no evidence of coughing and pulmonary lesions (Fano et al., 2005). In the case of secondary bacterial 
infection, clinical signs will be more pronounced such as fever, laboured breathing, prostration and reduced 
appetite. This causes an increased feed conversion ratio, lower daily growth and uneven growth (Del Pozo 
Sacristán, 2014). Next to bacterial agents, also viral pathogens can play a role in the development of respiratory 
disease in pigs. Combined with many non-infectious factors discussed before, this complex is referred to as 
Porcine Respiratory Disease Complex (PRDC). Primary pathogens in this complex, next to M. hyopneumoniae are 
PRRSv, Porcine Circovirus type 2 (PCV2), swine influenza virus (SIV), Actinobacillus pleuropneumoniae (A. 
pleuropneumoniae), Bordetella bronchiseptica (B. bronchiseptica) and Aujeszky’s disease virus in countries not free of the 
pathogen. Other secondary pathogens are: Trueperella pyogenes, Streptococcus suis (S. suis), P. multocida , M. hyorhinis, H. 
parasuis, Actinobacillus suis, Porcine Respiratory Coronavirus, Torque teno sus virus, Porcine Cytomegalovirus and 
Paramyxovirus (Opriessnig et al., 2011). In most cases the interaction of M. hyopneumoniae and other pathogens 
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potentiates the effect. An overview of interactions in polymicrobial respiratory diseases is given by Opriessnig et 
al. (2011). 
Mycotoxins are secondary fungal metabolites which can contaminate many types of food crops (Vandenbroucke, 
2012). Fusarium mycotoxins are the largest group of mycotoxins, which includes more than 140 known 
metabolites of fungi (Sobrova et al., 2010). Fusarium species are the most prevalent mycotoxin producing fungi in 
Europe. This may be due to the moderate climate conditions in Europe, as they require somewhat lower 
temperatures for growth and mycotoxin production than, for instance Aspergillus species (Placinta et al., 1999). 
Trichothecenes, zearalenone, fumonisin and moniliformin are the mycotoxins produced by Fusarium fungi which 
are most important in terms of contamination of feed crops intended for food-producing animals (Sobrova et al., 
2010; Vandenbroucke, 2012). The trichothecenes causing most concern are T-2 toxin, which is the most acute 
toxic trichothecene, HT-2 toxin, nivalenol and deoxynivalenol (DON) (Eriksen and Pettersson, 2004). 
Deoxynivalenol is the predominant mycotoxin of the trichothecenes group and is mainly produced by F. 
graminearum and F. culmorum (Antonissen et al., 2014b; McMullen et al., 1997). Deoxynivalenol is also known as 
vomitoxin, due to the strong emetic effects after consumption by influencing the dopaminergic receptors in the 
brain (Sobrova et al., 2010) and is typically found in wheat, corn, barley and rye (Broeckaert et al., 2015). In 
twelve European countries, mycotoxin testing on 11,022 food samples resulted in DON being the most 
prevalent mycotoxin with a result of 57 percent of all samples being positive for this mycotoxin (European Food 
Safety Authority, 2013). In another three-year survey of Rodrigues and Naehrer (2012) 59% of 5,819 animal feed 
samples tested positive for the presence of DON and the average contamination level was 1,104 µg/kg, whereas 
the maximum observed level was 49,307 µg/kg. As described by Monbaliu et al. (2010), 67 of 82 feed matrices 
(sow feed, wheat and maize) were contaminated with mycotoxins, of which 52 were contaminated with DON. 
Swine are very sensitive to the effects of DON, mainly because of differences in metabolism of this mycotoxin 
compared to other animal species (Bracarense et al., 2012; Wu et al., 2010) and the high cereal content of their 
diets (Pierron et al., 2016). The maximum recommended level set by the European Commission for DON in 
products intended for pig feeding is 0.9 mg/kg which is the lowest value compared to other species (table 4) 
(Commission recommendation of 17 August, 2006).  
Van Asselt et al. (2012) demonstrated that acetylated forms of DON, 3-acetyldeoxynivalenol (3-ADON) and 15-
acetyldeoxynivalenol (15-ADON), are more prevalent than DON itself. Their effect was unrecognised, therefore 
not much attention was paid to these metabolites in mycotoxin feed analyses, until Broeckaert et al (2015) 
demonstrated that the pig is able to hydrolyse 100% of the acetyl-derivates 3-ADON and 15-ADON ingested per 
os to DON.  
Eriksen and Pettersson (2004) stated that changes in biochemical parameters (such as plasma nutrients and 
plasma enzymes) are possible, but this effect is partly caused by the reduced feed intake and is not a direct effect 
of the toxin. Effects of moderate to high levels of DON are well known and include decreased feed intake, feed 
refusal, decrease in weight gain, effects on intestinal health, dysfunction in spleen and liver, lower oocyte and 
slower embryo development, alteration and delay of the immune response (cellular and humoral) and increased 
disease susceptibility (Antonissen et al., 2014a; D'Mello et al., 1999; Dersjant-Li et al., 2003; Forsyth et al., 1977; 
Gerez et al., 2015; Goyarts and Dänicke, 2006; Swamy et al., 2003; Tiemann and Dänicke, 2007). Very high doses 
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of DON, even though these concentrations are not likely to be encountered in animal feed, result in abdominal 
distress, malaise, diarrhoea, emesis and even shock or death, (Antonissen et al., 2014a; Bracarense et al., 2012; 
Cheat et al., 2015). In literature, however it is not mentioned from which concentration onwards these symptoms 
are observed. It can be expected that the effects of mycotoxin on intestinal health and immune responses, may 
also influence the susceptibility to infections with pathogens (Antonissen et al., 2015; Antonissen et al., 2014a). 
In fact, DON has a known impact on the pathogenesis of several bacterial or viral diseases. Pig ileal loop tissues 
exposed to a DON-concentration of 1 µg/ml, were significantly more invaded by Salmonella Typhimurium and 
showed subsequently increased inflammatory responses compared to control loops (Vandenbroucke et al., 2011). 
Furthermore, DON in a concentration of 0.025 µg/ml, was able to induce an enhanced uptake of Salmonella 
Typhimurium in porcine macrophages, indicating the capacity of DON to alter the susceptibility of the pig to 
Salmonella Typhimurium infections by modulating the innate immune system. The impact of Fusarium mycotoxins 
on respiratory infections with bacterial or viral agents in the pig is summarized in table 5. 
 
Table 4: The maximum recommended level on the presence of deoxynivalenol and fumonisin B1+B2 in 
products intended for animal feeding, as determined by the European Commission (Adapted from 
Recommendation of 17 August 2006 (Commission recommendation of 17 August, 2006) 
Mycotoxin Products intended for animal feed Maximum 




Feed materials (*)  
— Cereals and cereal products (**) with the exception of maize by-
products  
 — Maize by-products 
Complementary and complete feedingstuffs with the exception of: 
— complementary and complete feedingstuffs for pigs 
— complementary and complete feedingstuffs for calves (< 4 








Fumonisin B1 + B2 Feed materials (*)  
— maize and maize products(***)  
Complementary and complete feedingstuffs for:  
— pigs, horses (Equidae), rabbits and pet animals   
— fish  
 — poultry, calves (< 4 months), lambs and kids 








(*) that the use of cereals and cereal product and their use in a daily ration should not lead to the animal being exposed to a higher level of these 
mycotoxins than the corresponding levels of exposure where only the complete feedingstuffs are used in a daily ration. 
(**) The term ‘Cereals and cereal products’ includes feed materials referred to in part B of the Annex to Council Directive 96/25/EC of 29 April 1996 but 
also other feed materials derived from cereals in particular cereal forages and roughages. 
 (***) The term ‘Maize and maize products’ includes not only the feed materials derived from maize listed under heading 1 ‘Cereal grains, their products 
and by-products’ of the non-exclusive list of main feed materials referred to in the Annex, part B of Directive 96/25/EC but also other feed materials 
derived from maize in particular maize forages and roughages. 
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Vaccination against M. hyopneumoniae is applied worldwide: as many as 70% of pig herds are vaccinating against 
M. hyopneumoniae (Maes et al., 2008; Martelli et al., 2014). Vaccination against M. hyopneumoniae does not protect  
the pigs from being colonized, nor offers a complete protection against clinical signs and appearance of lung 
lesions (Mateusen et al., 2001; Mateusen et al., 2002; Meyns et al., 2004). Vaccination against M. hyopneumoniae has 
been proven to reduce clinical signs, pneumonia lesions and economic losses associated with the infection, such 
as improving daily weight gain (2-8%), feed conversion ratio (2-5%), time to reach slaughter weight and 
occasionally a lower mortality and an improved carcass quality (Jensen et al., 2002; Maes et al., 1998; Maes et al., 
1999; Muirhead and Alexander, 1997; Ross, 1999). Additionally, the use of vaccination may reduce the number 
of M. hyopneumoniae organisms in the respiratory tract and may decrease the infection level in a herd (Meyns et al., 
2006; Thacker et al., 1998). These beneficial effects should be expected several months after initiating a M. 
hyopneumoniae vaccination program and should always be accompanied, if not initiated with other control 
measures (Haesebrouck et al., 2004; Maes et al., 2008). The mechanism of protection against M. hyopneumoniae 
through vaccination is still unclear (Desrosiers, 2001). Vaccination against M. hyopneumoniae induces local, 
mucosal, humoral and cellular immunity. It has been suggested that mucosal antibodies, modification of the 
inflammatory response and cell-mediated immune responses are important vaccination-responsive factors in 
controlling the disease (Thacker et al., 2000a).  
Criteria to vaccinate against M. hyopneumoniae have been suggested by Muirhead and Alexander (1997): presence 
of M. hyopneumoniae in the herd, primary or secondary respiratory infections, variable or poor growth associated 
with respiratory disease in the herd, weaning to slaughter mortalities >4%, the necessity to apply in-feed 
medication and the cost of vaccination ≤ cost of mortality and in-feed medication. Currently, the prudent use of 
antimicrobials to combat resistance might as well be one of the decisions to vaccinate against M. hyopneumoniae. 
All commercially available vaccines are bacterins, and therefore mainly consist of killed M. hyopneumoniae bacteria. 
Many commercially available M. hyopneumoniae vaccines are constituted of the same strain, the J-strain but are 
formulated with a different adjuvant. The water based adjuvants, like aluminium salts are relatively mild and 
stimulate the immune system to a lesser extent. They are used for a prime-boost regime. Compared to the water 
based adjuvants, the oil-based adjuvants, show a prolonged release of the antigen and stimulation of the immune 
response, mimicking the two-dose prime-boost regime vaccines, but are administered only once (Del Pozo 
Sacristán, 2014; Yuki and Kiyono, 2003). The type of adjuvant is important since it steers the induced immune 
response towards a certain direction and therefore may influence the level of protection. An overview of the 
commercially available vaccines against M. hyopneumoniae is given by Maes et al. (2017).  
Deciding which vaccination strategy should be implemented needs to be based on the type of herd, production 
system, and the infection pattern in the herd (Haesebrouck et al., 2004). In general, the main strategy of M. 
hyopneumoniae-vaccination is directed towards vaccinating the piglets before or at weaning, while sow vaccination 
is rarely practiced (Bargen, 2004; Del Pozo Sacristán, 2014; Sibila et al., 2008). 
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Vaccination of gilts before entering the sow herd, may be advised to avoid destabilisation of the herd immunity. 
Especially when gilts are purchased from M. hyopneumoniae-free farms, it is strongly advised to vaccinate these 
gilts (Bargen, 2004).  
Sow vaccination is based on the strategy to passively immunize their offspring via colostral antibodies and to 
decrease (though not prevent) vertical transmission via nose-to nose contact from sow to piglet (Ruiz et al., 
2003; Sibila et al., 2008; Thacker et al., 2000a). It was demonstrated that sow vaccination did not have an impact 
on colonisation of M. hyopneumoniae in the piglets, but the severity of pneumonia in those piglets was reduced 
(Sibila et al., 2008). The effect from vaccinating the gilts and sows against M. hyopneumoniae on the efficacy of 
piglet vaccination against M. hyopneumoniae remains debated. The effect on the efficacy of vaccination in the 
piglets of this interference is unclear as post-vaccination serum antibody levels have limited utility in determining 
the degree of protection afforded by vaccination (Haesebrouck et al., 2004). Regardless, vaccination against M. 
hyopneumoniae in Europe is performed in the presence of maternal antibodies, with good results (Maes et al., 2008; 
Martelli et al., 2006). Other authors report interference with building up an active immunity when vaccinating 
piglets in face of maternal antibody titers in the piglets (Jayappa et al., 2001). Bandrick et al. (2014) found that 
piglets with M. hyopneumoniae specific maternally derived immunity indeed failed to show a rise in vaccine induced 
M. hyopneumoniae antibody levels, but did show primary (antigen-specific lymphoproliferation) and secondary 
(delayed type hypersensitivity) M. hyopneumoniae-specific cell-mediated immunity responses following vaccination. 
Vaccination of suckling piglets (early vaccination, < 4 weeks of age) is frequently applied (Del Pozo Sacristán, 
2014), as in this case, active immunity is established before the piglets are exposed to the pathogen (Del Pozo 
Sacristán, 2014; Maes et al., 2008). This vaccination strategy is frequently applied in single-site herds.  
Late vaccination (between 4 and 10 weeks of age) may be applied in herds where the infection occurs during the 
finishing period, mostly in multi-site systems (Haesebrouck et al., 2004; Maes et al., 2008), in herds with strict all-
in/all-out production, or when segregated early weaning is practised. It is not recommended in herds with 
continuous pig flow and in herds where the pigs are infected early in life (Haesebrouck et al., 2004). Vaccinating 
nursery piglets has the advantage that the possible interference with maternal immunity is lower. However, 
nursery pigs might already be infected with M. hyopneumoniae and other pathogens such as PRRSv and PCV2, 
which might interfere with building up a proper immune response and might therefore not be the perfect 
moment for vaccination (Campbell et al., 2013; Maes et al., 2008; Pié et al., 2004).  
Single-dose vaccines applied at 3 weeks of age or older confer similar effects as double vaccination (Baccaro et 
al., 2006; Haesebrouck et al., 2004). Single-dose vaccines reduce labour, cause less stress for the pigs and can 
easily be implemented in routine management practices in the farm (Del Pozo Sacristán et al., 2014). In some 
cases, double-dose vaccination for M. hyopneumoniae are still advised: multi-source/age purchase policy, 
continuous flow of the pigs instead of AI/AO policy, during critical periods (pigs placed in the fattening units in 
fall because of added environmental stress) and large herds with unstable PRRSv or swine influenza virus 
situation (Yeske, 2001). 
Although it is clear that vaccinating against M. hyopneumoniae has beneficial effects in most herds, these effects can 
vary between herds (Maes et al., 2008). Mycoplasma hyopneumoniae vaccine efficacy can be reduced by incorrect 
injection technique and improper storage of the vaccine. Also infection with other pathogens, such as Ascaris 
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suum (Steenhard et al., 2009) or PRRSv (Thacker et al., 2000b) during or shortly after vaccination has shown to 
decrease the response of vaccinating against M. hyopneumoniae. Another factor to consider is the antigenic 
difference between vaccine strain and circulating field strains (Maes et al., 2008). 
Intramuscular injection is the main route of administration of M. hyopneumoniae vaccination. Intradermal 
vaccination against M. hyopneumoniae can be an asset, as specialised antigen presenting cells are necessary to obtain 
a good cellular immune response and more of these specialised cells are present in the skin compared to the 
muscle (Bos and Kapsenberg, 1986; Fu et al., 1997; Iwasaki et al., 1997; Martelli et al., 2009). In addition, no 
needles are used but the vaccine is administered intradermal via pressure. This may reduce the risk for iatrogenic 
infections and the higher dispersion of the antigen at the site of injection reduces injection site reactions (Del 
Pozo Sacristán, 2014). Intradermal vaccination is already being applied for M. hyopneumoniae with good results 
(Ferrari et al., 2011; Jones et al., 2005; Martelli et al., 2009; Martelli et al., 2014; Tassis et al., 2012). Beffort et al. 
(2017) compared the safety and efficacy of intradermal versus intramuscular vaccination against M. hyopneumoniae 
and  observed less injection site reactions and a superior reduction of prevalence and severity of lung lesions in 
the intradermal vaccinated group. Other administration routes like aerosol vaccination (Murphy et al., 1993), oral 
vaccination (Lin et al., 2003; Ogawa et al., 2009), intranasal vaccination (Shimoji et al., 2003) and intraperitoneal 
vaccination (Sheldrake et al., 1991) have been investigated, with variable results. These administration routes are 
currently not used in practice. 
Combination vaccines contain antigens from different pathogens in the same vaccine formulation. The current 
objectives in modern pig husbandry necessitate maximising vaccine benefits and minimising cost, labour for the 
farmer and stress for the pig (Drexler et al., 2010). Studies that evaluate the effect of different combination 
vaccines are available: Drexler et al. (2010), Bourry et al. (2015) and Jiménez and Lopéz (2007) studied the effect 
of combining M. hyopneumoniae and PRRSv vaccination, Witvliet et al. (2015); Park et al. (2016), Jeong et al., 
(2016) and Hayes and Saltzman (2009) investigated the combined effect of M. hyopneumoniae and PCV2 
vaccination, while Delisle and Rigaut (2007) investigated the combined effect of PRRSv, M. hyopneumoniae and A. 
pleuropneumoniae vaccination. These authors showed that the above mentioned vaccines may be combined without 
compromising the efficacy and safety. However, the instructions in the product leaflet should be followed strictly 
and only vaccines that are registered and therefore thoroughly tested should be used in combination vaccines. 
There is a need to produce more effective and lower cost vaccines against EP. Questions regarding the efficacy 
of the existing vaccines remain, and cultivating M. hyopneumoniae to produce bacterins is expensive (Kobish and 
Friis, 1996; Simionatto et al., 2013). In addition, the slow growth rate and fastidious nutrient requirements make 
it very challenging to reach sufficient biomass for antigen production (Kamminga et al., 2017). Several studies 
have used recombinant DNA technology approaches to find new vaccine candidates and to investigate their 
suitability (Marchioro et al., 2014; Marchioro et al., 2012; Simionatto et al., 2013). An overview of experimental 
vaccines is provided by Simionatto et al. (2013) and Maes et al. (2017). The availability of complete genome 
sequences gave a boost to the reverse vaccinology approach. This approach starts from genome sequencing 
results and subsequently predicts antigens by ‘in silico’ analysis as promising candidates for vaccines (Rappuoli, 
2001). The combination of recombinant DNA technology and ‘in silico’ analysis of whole genome sequences has 
the advantage that the pathogen is being excluded from the vaccine production process (Liljeqvist and Stahl, 
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1999; Movahedi and Hampson, 2008). The disadvantage is that it is difficult to correlate these antigens with 
protection and that the reverse vaccinology approach for antigens like glycolipids and lipopolysaccharides, which 
are important components of vaccines, cannot be employed (Rappuoli, 2001; Serruto and Rappuoli, 2006). 
Further research is being carried out to develop more effective vaccine candidates against M. hyopneumoniae. 
1.6.7. Antimicrobial medication 
Antimicrobials can help controlling EP, but are not able to eliminate the organism from the respiratory tract, nor 
heal existing lesions. For the success of the therapy, it is important to know the secondary pathogens present in 
the lower respiratory tract and their antimicrobial susceptibility profile (Thacker and Minion, 2012). Lack of this 
knowledge might be one of the reasons why treatment of EP is not always successful (Desrosiers, 2001; Ross, 
1999). 
Antimicrobials applied as individual treatments (parenteral administration) are favoured in the acute phase of 
respiratory disease when pigs have a reduced appetite or refuse to drink (Henry and Apley, 1999; Pijpers et al., 
1990). Group treatments via in-feed or in-water medication are less labour intensive and cause less stress 
compared to parenteral treatment (Del Pozo Sacristán, 2014). Antimicrobials can be used in a therapeutic, 
metaphylactic or prophylactic way. Therapeutic treatment involves episodic use of therapeutic doses of 
antimicrobial agents for management of specified infectious diseases in clinically ill animals (Paulson et al., 2015). 
Metaphylactic use is defined as treating the whole group when some pigs are clinically diseased and others 
subclinically infected. Prophylactic or preventive use is medicating a group of pigs during high-risk periods to 
prevent them from a possible clinical outbreak (Murphy et al., 2017; Vicca et al., 2005).  
All Mycoplasma species are resistant against beta-lactam antimicrobials (such as penicillin, ampicillin, amoxicillin 
and cephalosporins), because they lack a cell wall, which is the target of these antimicrobials. Classes of 
antimicrobials working against M. hyopneumoniae are tetracyclines, macrolides, lincosamides, pleuromutilins, 
amphenicols, aminoglycosides, aminocyclitols and fluoroquinolones (Holst et al., 2015). An excellent overview of 
the mode of action and the spectrum of activity of these antimicrobials against M. hyopneumoniae is provided by 
Del Pozo Sacristán et al. (2014). Because of the importance of fluoroquinolones in human medicine, the use of 
these antimicrobials should be avoided (Desrosiers, 2001; WHO, 2012), unless susceptibility tests show that M. 
hyopneumoniae is resistant to other antimicrobials, except fluoroquinolones. In practice susceptibility testing is not 
feasible, as M. hyopneumoniae is difficult to culture, hence antimicrobial sensitivity tests for M. hyopneumoniae are not 
performed routinely (Friis, 1975; Thacker and Minion, 2012). Acquired resistance against tetracyclines, 
macrolides, lincosamides and fluoroquinolones has been documented (Hannan et al., 1997; Inamoto et al., 1994; 
Vicca et al., 2007; Vicca et al., 2004). 
A decade ago, the choice between implementing vaccination or administration of antimicrobials was debated: 
antimicrobials are flexible in use, several (respiratory) pathogens are addressed, if in-feed or in-water medication 
is used, they are less labour intensive to be applied compared to vaccinating and they have an immediate effect, 
while the effect of vaccination will be noticeable after some months (Del Pozo Sacristán, 2014; Haesebrouck et 
al., 2004; Maes et al., 2008). Mateusen et al. (2001) showed that the use of tilmicosin compared to implementing 
vaccination against M. hyopneumoniae conferred similar beneficial effects. Combination vaccines, nowadays can be 
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applied for up to two agents (viral and bacterial agents). Antibiotic use increases the risk for residues in the 
carcass at slaughter and select for antimicrobial resistance in commensal, pathogenic and/or zoonotic bacteria in 
the animal (Maes et al., 2008). 
Prudent use of antimicrobials to combat antimicrobial resistance is a priority for the European Commission. At 
the EU level, the monitoring and reporting of antimicrobial resistance in bacteria associated with the main 
livestock animal species (cattle, pigs, poultry) and derived food is regulated by Commission Implementing 
Decision 2013/652/EU (Murphy et al., 2017). Different countries have implemented national programs to 
monitor and reduce the use of antimicrobials in livestock (Callens et al., 2012). In fact, AMCRA (Antimicrobial 
Consumption and Resistance in Animals) advises no first choice antimicrobials for the treatment of EP, but 
suggests that preventive measures should be implemented, preventive treatments are strongly discouraged 
(AMCRA, 2018). On the other hand, even in herds vaccinating against M. hyopneumoniae, clinical disease can 
remain (Mateusen et al., 2002) and the use of antimicrobials may therefore be necessary to control respiratory 
disease (Callens et al., 2012; Del Pozo Sacristán, 2014; Maes et al., 2008; Mateu and Martin, 2001; McEwen and 
Fedorka-Cray, 2002; Schwarz et al., 2001; Timmerman et al., 2006). Additionally, eradication programs for M. 
hyopneumoniae based on partial sanitation often require the use of antimicrobials. Eradication programs based on 
total sanitation, where all animals from the farm are sold or culled and the farm is populated with M. 
hyopneumoniae-free pigs, does not include the use of antimicrobial agents (Holst et al., 2015; Maes et al., 2008; 
Zimmerman et al., 1989). A recent overview of current eradication protocols, including the protocols with or 
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AIMS OF THE STUDY 
M. hyopneumoniae is the primary pathogen of enzootic pneumonia, and one of the most important pathogens 
involved in the porcine respiratory disease complex. Infections with M. hyopneumoniae negatively impact growth 
and feed efficiency, increase antimicrobial use and facilitate infections with other respiratory pathogens.  
The outcome of M. hyopneumoniae infections is quite variable, ranging from subclinical infection to severe clinical 
disease leading to tremendous economic losses for the pig sector. It has been shown that many different factors 
such as the virulence of M. hyopneumoniae strain, environmental and management factors and vaccination 
strategies may influence the severity of infection. However, the impact of many factors such as the diversity of 
M. hyopneumoniae strains, the concentration of air pollutants in the stable, and the presence of mycotoxins in the 
feed is still not yet fully understood. In addition, the currently available vaccines are mostly based on the J-strain 
which was isolated in the second half of the previous century. These vaccines are widely used and are cost-
efficient in many herds. Although they provide partial protection against clinical disease and lung lesions, they do 
not prevent infection. 
 
The general aim of this thesis was to investigate factors that influence the outcome and the severity of M. 
hyopneumoniae infections in order to achieve a better control of the disease. 
The specific objectives were: 
1. To determine the diversity of M. hyopneumoniae in Flemish pig farms and to investigate its impact on lung 
lesions at slaughter  
2. To investigate the impact of particulate matter and ammonia levels in the stable on pneumonia and pleurisy 
lesions 
3. To assess the impact of deoxynivalenol and acetyl-derivates in the feed on an experimental M. hyopneumoniae 
infection  
4. To investigate the effect of vaccination with a commercial vaccine on an experimental M. hyopneumoniae 
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CHAPTER 3: FIELD AND EXPERIMENTAL STUDIES Ch. 3.1 
Abstract 
The importance of diversity of Mycoplasma hyopneumoniae (M. hyopneumoniae) strains is not yet fully known. This 
study investigated the genetic diversity of M. hyopneumoniae strains in ten pig herds, and assessed associations 
between the presence of different strains of M. hyopneumoniae and lung lesions at slaughter. Within each herd, 
three batches of slaughter pigs were investigated. At slaughter, from each batch, 20 post mortem 
bronchoalveolar lavage fluid samples were collected for multiple locus variable-number tandem repeat analysis 
(MLVA), and lung lesions (Mycoplasma-like lesions, fissures) were recorded. Multivariable analyses including 
potential risk factors for respiratory disease were performed to assess associations between the number of 
different strains per batch (three categories: one strain, two-six strains, ≥ seven strains), and the lung lesions as 
outcome variables. In total, 135 different M. hyopneumoniae strains were found. The mean (min.-max.) number of 
different strains per batch were 7 (1-13). Batches with two-six strains or more than six strains had more severe 
Mycoplasma-like lesions (P= 0.064 and P= 0.012, respectively), a higher prevalence of pneumonia (odds ratio 
(OR): 1.30, P=0.33 and OR: 2.08, P=0.012, respectively), and fissures (OR= 1.35, P=0.094 and OR= 1.70, 
P=0.007, respectively) compared to batches with only one strain. In conclusion, many different M. hyopneumoniae 
strains were found, and batches of slaughter pigs with different M. hyopneumoniae strains had a higher prevalence 
and severity of Mycoplasma-like lung lesions at slaughter, implying that reducing the number of different strains 
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Introduction 
Mycoplasma hyopneumoniae (M. hyopneumoniae) is the causative agent of enzootic pneumonia, and infections occur in 
all countries with an intensive pig production (Thacker, 2004). Infections with M. hyopneumoniae cause 
tremendous economic losses, either directly or indirectly, by increasing the susceptibility of infected animals to 
other respiratory pathogens (Thacker, 2006). 
Mycoplasmas have small genomes (580 to 1,300 kb) (Hutchison and Montague, 2002; Minion et al., 2004), and 
genetic diversity might be one solution to adapt to the adverse environment of the host (Madsen et al., 2007; 
Vranckx et al., 2012). Many regions in the genome of M. hyopneumoniae related to adherence in the host contain 
variable number of tandem repeats (VNTRs). These regions are prone to recombination events and slipped 
strand mispairing, which can possibly lead to expression of a different sized protein (Torres-Cruz and van der 
Woude, 2003). Multiple locus variable number of tandem repeat analysis (MLVA) has been used successfully to 
genetically characterize M. hyopneumoniae isolates (Charlebois et al., 2014; Dos Santos et al., 2015; Nathues et al., 
2011; Vranckx et al., 2011; Vranckx et al., 2012). This technique has a high discriminatory power, and can be 
applied directly to clinical samples without the necessity to grow the bacterium, which is very fastidious in the 
case of M. hyopneumoniae (Vranckx et al., 2011). 
Previous studies have shown that there is a high diversity of M. hyopneumoniae field isolates, especially between 
strains from different herds (Charlebois et al., 2014). Other studies including a limited number of herds not 
practising vaccination against M. hyopneumoniae, showed that in some herds, only one strain was detected, whereas 
different strains were found in other herds, even in the same pig (Vranckx et al., 2011; Vranckx et al., 2012). The 
importance of genetic diversity of M. hyopneumoniae strains however is not fully known. A possible link between 
the presence of multiple simultaneous or subsequent infections with different M. hyopneumoniae strains and the 
presence and severity of lung lesions has been suggested (Charlebois et al., 2014; Villarreal et al., 2009; Vranckx 
et al., 2011), but no systematic study has been conducted to answer this question. If the presence of different M. 
hyopneumoniae strains is associated with more clinical disease and/or lung lesions, then measures decreasing the 
diversity of strains may be helpful to control respiratory problems in pig herds. 
The aim of this study was to investigate the presence of different M. hyopneumoniae strains in consecutive batches 
of slaughter pigs from different herds, to type the strains using MLVA and to investigate associations between 
the occurrence of multiple strains of M. hyopneumoniae and the prevalence and severity of lung lesions. 
Materials and methods 
Study population 
A list of herds (n=56) complying with following criteria: closed herd or closed production system, herd with at 
least 100 breeding sows and vaccination of piglets against M. hyopneumoniae was provided by one of the largest 
slaughter houses in Belgium (Covalis). The list of these farms was randomised (Excel 2010, Microsoft Corp., 
Redmond, WA) and the farmers were contacted in order of appearance on the randomized list until ten herds 
willing to participate to the study were obtained. Descriptive data of the ten study herds are presented in table 1. 
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Ch. 1 Ch. 3.1 CHAPTER 3: FIELD AND EXPERIMENTAL STUDIES 
Different potential risk factors for respiratory disease were collected from these herds during a herd visit by the 
first author. During the visit, a questionnaire was completed, the stables were visited and the fattening pigs 
inspected. The potential risk factors in the questionnaire were based on previous studies (Villarreal, 2010) and 
pertained to biosecurity, management, housing and vaccination status (table 2). 
Table 2: Potential risk factors for respiratory disease that were collected from the ten herds 
Continuous variables  
Times per year farmer is purchasing gilts ‘X’ times per year that the farmer purchased gilts 
Number of herds surrounding the herd in a perimeter 
of < 5 km 
calculated with Lambert coordinates and the Pythagoras 
Theorem   
Number of sows present on the herd Measure for the size of the herd 
Production system for the sows  0: no week system, 1, 2, 3, 4 - week system 
Coughing score given by the farmer (0-10) fatteners 
Categorical variables  
Purchase of gilts 1 = yes, 0 = no 
Purchase of gilts always from the same supplier 1 = yes, 0= no  
Quarantine period for gilts 1 = yes, 0 = no 
Herd located close to a highway (< 5 km) 1 = yes, 0 = no 
Herd located near a slaughter house (<5 km) 1 = yes, 0 = no 
Distance herd to the public road (< 100 or ˃ 100 m) 1 ( < 100 m), 2 ( ˃ 100 m) 
Sow breed  0: Topigs, 1: LW+ELR+FLR, ELR+FLR, Danbred+hypor, 
Danbred, RA-SE, Hypor 
Dynamic or stable groups for pregnant sows Stable (0) or dynamic (1) group sows 
AIAO farrowing unit 1 = yes, 0 = no 
AIAO nursery unit 1 = yes, 0 = no 
AIAO fattening unit 1 = yes, 0 = no 
Stocking density nursery 1 < 0.30 m2/pig; 2 > or = 0.30 m2/pig 
Cross fostering during first week of life piglets  0 = no, 1 < 10%, 2 = ˃ 10% 
Cross fostering after first week of life piglets  0 = no, 1<10%, 2=˃10% 
Stocking density fattening unit 1 = >0.70 m2/pig , 2 = 0.70- 0.65 m2/pig, 3 < 0.65 m2/pig 
Cleaning and disinfection farrowing unit 1 = yes, 0 = no 
Cleaning and disinfection nursery 1 = yes, 0 = no 
Cleaning and disinfection fattening unit 1 = yes, 0 = no, 2 = only cleaned not disinfected 
Stand empty period farrowing unit  1 = yes, 2 = not always 0= no 
Stand empty period nursery unit 1 = yes, 2 = not always, 0 = no 
Stand empty period fattening unit 1 = yes, 2 = not always, 0 = no 
Gilts vaccinated against M.hyopneumoniae 1 = yes, 0 = no 
Clinical signs of M. hyopneumoniae in grower-finishers 1 = yes, 0 = no  
LW+ELR+FLR: large white, English landrace, French landrace 
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Sampling at the slaughterhouse and lung lesion scoring 
Three different batches of fattening pigs per herd were evaluated at the slaughterhouse during a time span of one 
to three months. All visits were performed from November 2012 until April 2013. From each batch, 20 
randomly selected blood samples were collected at exsanguination, and from 20 other randomly selected pigs, 
the lungs were collected. For practical reasons, only the left half of the lung was taken. The blood samples and 
lungs were transported to the laboratory of Bacteriology of the Faculty of Veterinary Medicine, Ghent University 
immediately after the slaughterhouse visit.  
Additionally, as many lungs as possible of each batch (min. 50) were evaluated for lung lesions. The lungs that 
were sampled were not included in the lung lesion scoring. The lungs were scored for presence of pneumonia 
and severity of Mycoplasma-like lesions using the method described by Morrison et al. (1985). Mycoplasma-like 
lesions were defined as macroscopic greyish to purplish consolidated pneumonia areas, generally located on the 
cranio-ventral parts of the lung lobes. The lungs were also evaluated for the presence of fissures and pleurisy. 
Fissures were defined as areas of collapsed alveoli adjoining alveolar emphysema (recovery lesions) (Kobish et 
al., 1993), while pleurisy was defined as fibrotic adherences between the parietal and visceral membranes of the 
pleural cavity (Chapter 3.2). No approval of the ethical committee of Ghent University was necessary, as the pigs 
were destined for slaughter. 
Nested Polymerase Chain Reaction (nPCR) 
Upon arrival in the laboratory, the lung halves were flushed with 20 ml phosphate buffered saline (PBS, 8 g/L 
NaCl, 0.34 g/L KH2PO4, 1.21 g/L K2HPO4, pH 7.3). The recovered fluid was centrifuged at 2000 g during 30 
minutes to obtain the remaining pellet by carefully removing the supernatant. The pellet was resuspended in 1 ml 
of PBS and 200 µl of the resuspension was used to perform the DNA extraction using the DNeasy blood and 
tissue kit (QIAGEN, Belgium) according to the instructions in the protocol manual. Mycoplasma hyopneumoniae -
DNA was detected with a two steps nested polymerase chain reaction (nPCR) (Stärk et al., 1998). The nPCR 
products were analyzed by gel electrophoresis on a 1.5% agarose gel in Tris-Borate-EDTA (TBE)-buffer and 
stained with GelRed™ (Biotium. Inc., CA. USA) with visualization under UV illumination.  
Multiple Locus Variable Number Tandem Repeat Analysis (MLVA) 
All nPCR positive samples were submitted to a multiplex PCR as previously described (Vranckx et al., 2011). 
Briefly, loci h1, h5 repeat 2, p97 repeat 1 and p146 repeat 3 were amplified in a multiplex reaction with a 
mastercycler epgradient S (Eppendorf, Hamburg, Germany) in a final volume of 20 µl containing 1X PCR buffer 
(20 mM Tris-HCl (pH 8.4), 50 mM KCl), 3 mM MgCl2, 0.2 mM deoxynucleotide triphosphate, 0.75 U of 
Platinum® Taq DNA Polymerase (Invitrogen, Merelbeke, Belgium), 0.1 μM of each primer and finally 2 µl of 
template DNA. Ten cycles (30” 94°C; 30” 63°C; 1’15” 69°C) in which the annealing temperature was 
incrementally decreased with 1°C per cycle were performed. Next, forty cycles (30” 94°C; 30” 53°C; 1’15” 69°C) 
and a final extension step of five minutes at 69°C followed.  
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The PCR-products were diluted 1:10 with high performance liquid chromatography filtered water (HPLC-H2O). 
Amplicons were kept at 4 °C for a maximum of 48 hours. A volume of 165 µl Hi-Di formamide (one run, 16 
samples) (Applied Biosystems, Halle, Belgium) or a multitude of 165 µl for multiple runs was pipetted in an 1.5 
ml Eppendorf tube (Eppendorf Belgium N.V.- S.A, Rotselaar, Belgium) and 1.5 µl of 600 LIZ standard (Applied 
Biosystems, Halle, Belgium) was added. Ten µl of this mixture was added to one µl of sample (PCR-product).  
Samples were denatured at 95°C for 5 min, cooled on ice and electrophoresis was applied on the ABI 3130xl 
genetic analyzer (Applied Biosystems) for 16 samples at 15kV during 14000 seconds at 65°C or for more than 16 
samples on the ABI 3730xl (Applied Biosystems) at 15kV during 14000 seconds at 70°C.  
The resulting electropherogram files were imported into BioNumerics version 7.5 (Applied Maths, Sint-Martens-
Latem, Belgium). After normalization, the VNTR numbers were calculated automatically from the detected 
peaks. A minimal spanning tree was constructed with the Prims’ algorithm using the multistate categorical 
coefficient. Only samples for which all four loci were detected, were included in the tree. A weight factor was 
assigned to each locus according to its’ allelic variation in the obtained dataset with the highest weight assigned 
to the locus with the lowest variation. Following weights were assigned to each locus: 2, 3, 3 and 6 to p146, h1, 
h5, and p97, respectively. A strain was defined as a unique MLVA-type, e.g. if the combination of repeat numbers 
was unique. Clonal complexes were defined when strains differed in no more than one locus, with the exception 
of the most stable locus p97. The Hunter-Gaston discriminatory index was calculated for the complete dataset, 
as well as for each herd (Hunter and Gaston, 1988). 
Serology 
The sera of the blood samples (20 per batch) were tested for presence of antibodies against M. hyopneumoniae 
using a blocking ELISA (IDEIA™ Mycoplasma hyopneumoniae EIA kit, Oxoid Limited, Hampshire, UK). Sera with 
optical density (OD) <50% of the average value of the OD-buffercontrol were considered to be positive (ELISA 
M. hyopneumoniae positive samples). All values above or equal to 65% of the average value of the OD-
buffercontrol were classified as negative. All doubtful samples equal to 50% and less than 65% of the average 
value of the OD-buffercontrol were considered to be negative as well.  
Eight of the 20 samples from each batch were also tested for presence of antibodies against porcine reproductive 
and respiratory syndrome virus (PRRSv) (HerdCheck PRRS X3, IDEXX, Liebefeld-Bern, Switzerland) and 
subtypes H1N1, H1N2 and H3N2 SIV (standard haemagglutination-inhibition test). 
Statistical analyses 
Different statistical models were used to assess the associations between the number of strains on the one hand 
and the presence and severity of lung lesions on the other hand. The number of different strains found in each 
batch of pigs was categorized as follows: category 1 (CAT 1): one M. hyopneumoniae strain per batch, category 2 
(CAT 2): two to six different strains per batch, and category 3 (CAT 3): ≥ seven different strains per batch. The 
category one strain per batch was used as reference; the classification in category 2 and 3 was made to obtain the 
same number of strains in these categories.  
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The number of strains per batch was considered as explanatory variable in the models. As lung lesions may not 
only be caused by infection with M. hyopneumoniae and/or determined by the number of strains, the effect of the 
different potential risk factors for respiratory disease (table 2) was also taken into account in the models. A 
forward selection procedure was used during the model building, and risk factors with a P-value >0.15 were 
removed. Remaining risk factors (with P-value <0.15) were tested for collinearity. Correlations were assessed 
using Pearson’s (continuous variables) or Spearman rank (categorical variables) correlation, and in case two 
variables were highly correlated (r >0.6), the most significant factor was retained. In the final model, only risk 
factors with a P-value < 0.05 were retained. Confounding factors were identified when the regression coefficient 
(β) of another risk factor deviated more than 25% or 0.1 when β < 0.4 when removing the factor from the 
model. Such factors were excluded, but mentioned below each model. In total, four separate multivariable 
models were tested. The outcome variables for the different models were: severity of Mycoplasma-like lesions, 
likelihood of pneumonia lesions, fissures and pleurisy. Ln-transformation of the severity of the Mycoplasma-like 
lesions was performed to normalize the data. In all models, herd and lung were included as a random effect and 
batch was included as fixed effect.  
A linear mixed regression model (MLwiN 2.26 (Rasbash et al., 2012)) was used to assess the influence of 
category of number of strains on the severity of the Mycoplasma-like lesions in each batch. The assumptions of 
normality and homogeneity of variance of the final model were tested by examining normal probability plots of 
residuals and plots of residuals versus predicted values. No patterns indicating heteroscedasticity were present. 
The multilevel linear regression model may be represented mathematically as: Yij = β0 + β1category 2ij + 
β2category 3ij+ batch2ij + batch3ij + εij, where Yij is the continuous outcome variable (severity of Mycoplasma-like 
lesions), βs are the model coefficients, category is the fixed effect of the category of different number of strains, 
batch is the fixed effect of batch 1 to 3, herd is the random effect of herd i (i = 1 to 10), j refers to the jth lung in 
the ith herd and εij is the random error term, assumed to be normally distributed with mean 0 and variance σ2.  
Logistic mixed regression models using 1st order marginal quasi-likelihood algorithms were used to assess the 
influence of strain category on the likelihood of pneumonia, fissures and pleurisy (MLwiN 2.26 - Centre for 
Multilevel Modeling, Bristol, UK (Rasbash et al., 2012)). The fit of the models was evaluated by inspection of the 
lung standardized residuals plotted against the normal scores and the lung level predicted values. The Hosmer 
Lemeshow goodness-of-fit measure was calculated for the explanatory variable models using SAS 9.3 (PROC 
LOGISTIC, SAS Institute Inc., NC, USA). The results were represented as odds ratio (OR) with the 95% 
confidence interval calculated around these odds ratios. The multilevel logistic regression model may be 
represented mathematically as: g(Yij) = β0 + β1category 2ij + β2category 3ij+ batch2ij + batch3ij + εij, where (g) 
refers to the logit link function, Yij is the probability of the outcome variable on the logit scale (likelihood of 
pneumonia, fissures and pleurisy), βs are the model coefficients, category is the fixed effect of category of 
number of strains, batch is the fixed effect of batch 1 to 3, herd is the random effect of herd i (i = 1 to 10), j 
refers to the jth lung in the ith herd and εij is the random error term, assumed to be normally distributed with 
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Results 
Descriptive results of the nPCR, MLVA, lung lesions and serology 
Nested PCR 
From the 600 bronchoalveolar fluid samples, 495 (82.5%) tested positive using nPCR for M. hyopneumoniae. The 
average percentage of positive samples in each category (table 3) per batch were: CAT 1: 42.5%, CAT 2: 79.6% 
and CAT 3: 91.1%. In all batches of each herd, nPCR positive samples were detected. The descriptive nPCR 
results for each herd and for each batch per herd separately are shown in table 4. 
Table 3: Descriptive results in the three category groups: prevalence of nPCR positive results, average 
number of different strains, severity of Mycoplasma-like lesions±SD, prevalence pneumonia, fissures 
and pleurisy expressed in percentages 
 Category  
 1 2 3 Overall 
nPCR results 42.5 79.6 91.1 82.5 
Average number of different strains 1 4 9 7 
Severity of Mycoplasma-like lesions±SD 0.78±2.4 3.97±10.7 5.54±12.7 4.59±11.7 
Prevalence of pneumonia 11.8 23.2 29.7 25.9 
Prevalence of fissures 29.2 41.4 42.3 41.3 
Prevalence of pleurisy 10.2 21.2 29.1 24.6 
Category: 1=batches with only one strain detected, 2= batches with 2-6 different strain and 3= batches with ≥ 7 strains detected 
SD: standard deviation, n= number 
nPCR results: nested polymerase chain reaction: percentage of positive animals for M. hyopneumoniae-DNA detected in the bronchoalveolar  lavage fluid 
Severity of  Mycoplasma-like lesions: minimum 0% and maximum 100% of the lung surface affected with pneumonia 
 
Multiple locus variable number tandem repeat analysis (MLVA) 
Samples that were positive using nPCR were submitted to MLVA. In the entire dataset, 135 different M. 
hyopneumoniae strains were found (Figure 1). The Hunter-Gaston discriminatory index for the complete dataset 
and for each herd separately is presented in table 5. The average number of different strains per batch was 7 (min 
1; max 13). The total number of strains and the number of different strains per batch are presented in table 4. 
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Figure 1. Minimal spanning tree of all samples with a full MLVA profile in this study. Samples in one 
colour belong to the same herd (A –J) and samples in a different shade of colour (1-3) belong to one of the three 
batches of each herd. Each circle represents a strain, the size of the circle is proportional with the number of 
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Table 5: The Hunter-Gaston discriminatory index was calculated for the complete dataset, for 
each VNTR, as well as for each of the 10 herds (A, B, C, D, E, F, G, H, I and J). 
 Hunter-Gaston Discriminatory index 













































     
h1, h2, p146, p97: four VNTRs in the genome of M. hyopneumoniae of which the length of the amplified fragments were measured 
Total: the Hunter-Gaston DI calculated for the entire dataset 
 
The most prominent strain was strain 2, with 24 detections in the whole data set of all herds. This strain was 
detected in herds C, I and J. Strain 113 was the second most prominent strain and was found in herd A and D 
for a total of 20 times. Strain 135 was only detected 5 times in the dataset, however in herd D, H and I. Hundred 
and ten strains out of 135 were only detected 5 times or less and 60 out of 135 strains were only detected once. 
Strain 2, 42, 45, 59, 61, 77, 78, 109 and 117 were found in each of the three sampling periods in herds C, F, F, E, 
E, H, H and A respectively. In herds B, D, G, I, J no strains were found circulating throughout all three sampling 
periods. In all herds, strains were identified that were detected in at least two out of three sampling periods, 
except for herd B. Most returning strains per batch were found in two consecutive sampling points. Five strains 
were found in the first and the third sampling point only: strain 2, 19, 21, 99 and 113 in respectively herd I, E, E, 
G and A. In a lot of lungs (102), two and a few lungs (6) three different strains were detected (table 4). In herds 
B and J, no samples with two different strains were obtained. In two lungs of herd F, three different strains were 
found. In herds A, C, E, and G, always in the second batch, one sample with detection of three strains was 
found. In herds B, D, H, I and J no samples with three strains were detected.  
Lung lesions 
In total, 3820 lungs were evaluated at the slaughter line. The average (min.-max.) number of lungs scored per 
herd and per batch were 382 (200-494) and 127 (54-186), respectively. The average severity of Mycoplasma-like 
lesions in CAT 1, 2 and 3 were 0.78±2.4%, 3.97±10.7 and 5.54±12.7. The average prevalence of pneumonia was 
11.8, 23.2 and 29.7% in CAT 1, CAT 2 and CAT 3, respectively. The average prevalence of fissures was 29.2, 
41.4 and 42.3% in CAT 1, CAT 2 and CAT 3, respectively. The average prevalence of pleurisy in CAT 1, CAT 2 
and CAT 3 was 10.2, 21.2 and 29.1%, respectively (table 3). The severity scores of Mycoplasma-like lesions, and 
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Serology 
The serological results for M. hyopneumoniae, PRRSv and H1N1, H1N2, H3N2 SIV of each herd and each batch 
per herd are shown in table 7.  
Association between diversity of M. hyopneumoniae strains and lung lesions 
The results of the final multivariable models are shown in table 8. The severity of Mycoplasma-like lesions and the 
prevalence of pneumonia were higher in batches of CAT 2 than in batches of CAT 1 and significantly higher in 
batches of CAT 3 than in batches of CAT 1 (P= 0.064 for CAT 2 to CAT  and P= 0.012 for CAT 3 to CAT 1 
and OR: 1.30; P=0.33 for CAT 2 to CAT 1 and OR: 2.08; P=0.012 for CAT 3 to CAT 1, respectively for the 
severity of Mycoplasma-like lesions and the prevalence of pneumonia). 
In batches of CAT 2 and 3, there was a higher prevalence of fissures than in batches of CAT 1: CAT 2 to CAT 
1: OR= 1,35; P=0.094 and CAT 3 to CAT 1: OR= 1.70; P=0.007).  
Batches belonging to CAT 2 and 3 showed a lower prevalence of pleurisy (overall P<0.001, CAT 2- CAT 1: 
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Table 8a: Results of the four final multivariable models, with severity of Mycoplasma-like lesions, prevalence of pneumonia, fissures 
and pleurisy as outcome variables. For severity of Mycoplasma-like lesions, a linear model was used. For the other outcome variables, a 
logistic model was used. For category (CAT), CAT 1 was the reference, for Batch, Batch 1 was the reference. 
Severity of Mycoplasma-like lesions β SE OR CImin CImax P 
Intercept -2.85 0.18 - - - 
 
CAT 
     
0.027 
 CAT 2  0.35 0.19 - - - 0.064 
 CAT 3  0.51 0.20 - - - 0.012 
Batch 
     
< 0.001 
 Batch 2  0.16 0.07 - - - 0.027 
 Batch 3  0.38 0.07 - - - 0.0021 
Distance to public roadA 
     
0.0015 
 <100 m  
  >100 m 0.24 0.08 - - - 0.0015 
Stand empty farrowing unitB 
     
< 0.001 
 no  
 yes -0.31 0.08 - - - < 0.001 
 not always 0.03 0.09 - - - 0.70 
 
Likelihood of pneumonia β SE OR CImin CImax P 
Intercept -2.24 0.34 0.11 0.05 0.21 
 
CAT 
     
< 0.001 
 CAT 2 0.26 0.27 1.30 0.77 2.19 0.33 
 CAT 3 0.73 0.29 2.08 1.18 3.68 0.012 
Batch 
     
< 0.001 
 Batch 2  -0.45 0.11 0.64 0.52 0.78 < 0.001 
 Batch 3  0.42 0.10 1.53 1.25 1.86 < 0.001 
Number of herds surrounding the trial herd in a perimeter < 
5 km 0.01 0.00 1.01 1.01 1.01 
 
< 0.001 
Vaccination gilts M. hyopneumoniaeB      < 0.001 
 no       
 yes -0.99 0.23 0.37 0.24 0.58 < 0.001 
 
Likelihood of fissures β SE OR CImin CImax P 
Intercept -0.94 0.20 0.39 0.26 0.58 
 
CAT 
     
0.008 
 CAT 2 0.30 0.18 1.35 0.95 1.93 0.094 
 CAT 3 0.53 0.20 1.70 1.15 2.50 0.007 
Batch 
     
< 0.001 
 Batch 2  0.29 0.09 1.34 1.12 1.59 0.001 
 Batch 3  0.74 0.09 2.09 1.75 2.48 < 0.001 
Distance to public roadA      0.009 
 <100 m       
 ˃100 m 0.26 0.10 1.30 1.07 1.58 0.009 
Stand empty farrowing unitB      < 0.001 
 yes -0.40 0.10 0.67 0.55 0.82 < 0.001 
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Table 8b: Results of the four final multivariable models, with severity of Mycoplasma-like lesions, prevalence of pneumonia, fissures 
and pleurisy as outcome variables. For severity of Mycoplasma-like lesions, a linear model was used. For the other outcome variables, a 
logistic model was used. For category (CAT), CAT 1 was the reference, for Batch, Batch 1 was the reference. 
Likelihood of pleurisy β SE OR CImin CImax P 
Intercept 0.25 0.72 1.29 0.32 5.25   
CAT           < 0.001  
      CAT 2 -1.06 0.27 0.35 0.21 0.59 < 0.001 
      CAT 3 -1.07 0.30 0.34 0.19 0.62 < 0.001 
Batch           0.002  
      Batch 2  0.35 0.10 1.41 1.16 1.72 < 0.001 
      Batch 3  0.25 0.11 1.29 1.04 1.59 0.021 
Cross fostering piglets during first week of lifeB      0.002 
 no       
 <10% -0.32 0.71 0.73 0.18 2.91 0.67 
 ˃10% -1.96 0.77 0.14 0.03 0.64 0.040 
clinical signs M. hyopneumoniae with intensity mixing CF confounded 
 
OR: odds ratio, CI: confidence interval, SE: standard error, P: p-value, Batch 1, 2, 3: referring to respectively the first, second and third sampling point in 
each herd, CAT (category) 1 (one M. hyopneumoniae strain per batch per herd), CAT 2: category 2 (two to six strains per batch per herd), CAT 3: category 3 
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Discussion 
The present study revealed that, using MLVA, many different M. hyopneumoniae strains are present in slaughter 
pigs from different pig herds and batches within a herd. The results also showed that prevalence and severity of 
pneumonia lesions at slaughter were significantly higher in batches where more different M. hyopneumoniae strains 
were found. 
The ten selected study herds can be considered as representative for other pig herds, as the housing, feeding and 
management practices are quite similar to most Belgian and West-European herds. Also the prevalence of lung 
lesions (pneumonia 26%, fissures 41%, and pleurisy 25%) was similar to the results of previous studies (Meyns et 
al., 2011). The fact that three different batches of pigs were investigated within a herd, allowed to account for 
possible variations over time within a herd. 
The minimal spanning tree (MST) visualizes the phylogenetic relationship of the analysed strains. In comparison 
with previous work (Vranckx et al., 2012), the MST in the present study had a wide distribution, confirming the 
high diversity of the M. hyopneumoniae strains. A weighing factor was assigned to each locus according to its 
abundancy in the dataset. This allowed to take into account the importance of variation of less abundant loci. To 
the author’s knowledge this is the first time this approach is used for analysing the diversity of an organism. The 
Hunter-Gaston discriminatory index (98.4 when all four VNTRs are combined), confirmed that MLVA is a 
suitable and discriminatory technique to investigate genetic differences in M. hyopneumoniae (Vranckx et al., 2011). 
The high variation in strains is also illustrated by the large number of different strains found at batch and even at 
animal level: in 102 pigs, two different strains were found, and in six pigs, three different strains were present. In 
theory more than three strains at animal level can be present and detected if multiple peaks in the 
electropherograms of each VNTR can be distinguished. In practice the MLVA-technique, has some limitations: 
the detection limit is 100 organisms/μl in bronchoalveolar lavage fluid and multiple strains can be detected if the 
differences in concentration are less than tenfold. Therefore, it cannot be excluded that only the dominant 
strains in the herd were detected (Vranckx et al., 2011). Although it is known from previous studies that pigs may 
be infected with more than one strain (Nathues et al., 2011; Vranckx et al., 2011; Vranckx et al., 2012), the results 
of the present study in vaccinated herds document a higher diversity of M. hyopneumoniae strains than shown by 
previous authors (Calus, 2010; Mayor et al., 2007; Nathues, 2011; Vranckx et al., 2012). The results also suggest 
that a high M. hyopneumoniae diversity might occur despite vaccination of piglets against M. hyopneumoniae. Some of 
the measures that might influence introduction of new strains in the farm might be purchasing and quarantine 
policy, swine density in the area, pig transport, all-in/all-out management and animal flow. It is not known 
whether contamination of the sampled pigs’ lungs had occurred through the scalding water. Marois et al. (2008) 
showed that although M. hyopneumoniae was detected in the scalding water, the lungs of SPF pigs remained 
negative by nested PCR. 
The prevalence and severity of pneumonia lesions at slaughter were significantly higher in batches where more 
different M. hyopneumoniae strains were found, illustrating for the first time the importance of strain diversity at 
batch level. The severity of Mycoplasma-like lesions, the prevalence of pneumonia and the prevalence of fissures 
was significantly higher in batches of CAT 3 compared to CAT 1, and numeric differences were obtained when 
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batches of CAT 2 were compared to CAT 1. The effect of batch was significant in all models, indicating that 
there is quite some variation between successive batches in a herd. It also indicates the importance of 
investigating more batches from each herd. 
The exact explanation why more different M. hyopneumoniae strains at batch level may lead to more pneumonia 
lesions is not known. Some strains have been shown to be more virulent than others (Vicca et al., 2003), and 
infection with a low virulent strain did not protect against subsequent infection with a high virulent strain 
(Villarreal et al., 2009). On the contrary, clinical symptoms and lesions were more severe in case of dual 
infection. It is therefore possible that also at batch level, the presence of many different M. hyopneumoniae strains 
may lead to more (severe) pneumonia lesions. Further research to explain the mechanisms is necessary. 
Charlebois et al., (2014) did not find a significant association between the number of different M. hyopneumoniae 
strains and severity of lung lesions in slaughter pigs (Charlebois et al., 2014).  
To account for infection pressure possibly influencing the lung lesion data, rather than the number of different 
strains, all models were run with nPCR results included in the model. Only in the pneumonia model, the factor 
nPCR needed to be retained, but the overall conclusions for each model, including the pneumonia model 
remained the same (data not shown). Apart from M. hyopneumoniae, also other respiratory pathogens may be 
involved in pneumonia lesions (Sibila et al., 2009). Almost all pigs tested for swine influenza and PRRS virus 
were positive, and therefore, it is unlikely that these pathogens have biased the results. As lung lesions are 
multifactorial, the effect of potential non-infectious risk factors was taken into account in the multivariable 
models (Del Pozo Sacristán, 2014; Stärk, 2000; Villarreal, 2010). This allowed to investigate the effect of strain 
diversity in batches, apart from the effect of these risk factors. As the aim of the study was mainly to assess the 
importance of strain diversity, the other significant risk factors in the final models will only be discussed briefly.  
The severity of Mycoplasma-like lesions was higher in batches from herds located further away from a public road 
(more than 100 versus less than 100 meter), and when a stand-empty period in the farrowing unit was not 
practiced. The same two variables were also significant in the model for prevalence of fissures. One would 
expect that severity of lesions and prevalence of fissures to be higher in herds located closer to the public road, 
as this has been shown to be a risk factor for infection with M. hyopneumoniae (Stärk et al., 1992). One explanation 
could be that herds located further away from the public road are smaller herds with a lower biosecurity (Amass 
and Clark, 1999). Also, all herds were located quite close to a public road in the present study. Not practicing a 
stand-empty period can be considered as one aspect of poor hygiene and biosecurity, which has been shown as a 
risk factor for respiratory disease (Stärk, 2000). 
The prevalence of pneumonia lesions was higher in case more other pig herds surrounded the herd, and when 
breeding gilts were not vaccinated against M. hyopneumoniae. Pig herd density in the region has been shown to be a 
risk factor for introduction of M. hyopneumoniae in the herd or for increased seroprevalence of M. hyopneumoniae 
(Maes et al., 2000; Villarreal, 2010). Purchasing gilts compared to no purchase was a risk factor for higher 
seroprevalence of M. hyopneumoniae in slaughter pigs (Maes et al., 2000). Younger sows are more likely to transmit 
the infection to their piglets (Fano et al., 2006) and vaccination of breeding sows may lead to a lower infection 
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Pleurisy was also measured in the study, as it is a common and economically important lesion. Experimental M. 
hyopneumoniae infection does however not lead to pleurisy lesions. Under field conditions, positive associations 
have been found between M. hyopneumoniae infection and pleurisy lesions (Meyns et al., 2011), although the 
results are not consistent (Fraile et al., 2010). In the present study, although the descriptive values showed a 
higher  prevalence of pleurisy when comparing CAT 2 and CAT 3 with CAT 1, the final models resulted in a 
higher number of different M. hyopneumoniae strains being associated with a lower prevalence of pleurisy, though 
the effect was small. A high intensity of mixing and cross-fostering pigs (>10%) compared to no cross-fostering 
of piglets was associated with a lower prevalence of pleurisy. This might be explained by the fact that cross-
fostering may lead to a better colostrum intake by the piglets, resulting in better performance and health during 
their lifetime (Declerck et al., 2016; Quesnel, 2011). 
Conclusions 
MLVA testing on bronchoalveolar lavage fluid showed a high diversity of M. hyopneumoniae strains in slaughter 
pigs from herds vaccinated against M. hyopneumoniae. Mycoplasma-like lesions were more severe and the prevalence 
of pneumonia and fissures were higher when more different M. hyopneumoniae strains were present in a group of 
pigs. These results imply that inter- and intra-herd biosecurity measures decreasing the introduction of new M. 
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Abstract 
The present study investigated the simultaneous influence of particulate matter (PM10) and ammonia (NH3) on 
performance, lung lesions and the presence of Mycoplasma hyopneumoniae (M. hyopneumoniae) in finishing pigs. A pig 
herd experiencing clinical problems of M. hyopneumoniae infections was selected. In total, 1095 finishing pigs of 
two replicates in eight compartments each were investigated during the entire finishing period (FP). Indoor PM10 
and NH3 were measured at regular intervals during the FP with two Grimm spectrometers and two Graywolf 
Particle Counters (PM10) and an Innova photoacoustic gas monitor (NH3). Average daily weight gain (ADG) and 
mortality were calculated and associated with PM10 and NH3 during the FP. Nasal swabs (10 pigs/compartment) 
were collected one week prior to slaughter to detect DNA of M. hyopneumoniae with nested PCR (nPCR). The 
prevalence and extent of pneumonia lesions, and prevalence of fissures and pleurisy were examined at slaughter 
(29 wks). The results from the nasal swabs and lung lesions were associated with PM10 and NH3 during the FP 
and the second half of the FP. 
In the univariable model, increasing PM10 concentrations resulted in a higher odds of pneumonia lesions (second 
half of the FP: OR=8.72; P=0.015), more severe pneumonia lesions (FP: P=0.04, second half of the FP: 
P=0.009),  a higher odds of pleurisy lesions (FP: OR=20.91; P<0.001 and second half of the FP: OR=40.85; 
P<0.001) and a higher number of nPCR positive nasal samples (FP: OR=328.00; P=0.01 and second half of the 
FP: OR=185.49; P=0.02). Increasing NH3 concentrations in the univariable model resulted in a higher odds of 
pleurisy lesions (FP: OR=21.54; P=0.003) and a higher number of nPCR positive nasal samples (FP: OR=70.39; 
P=0.049; second half of the FP: OR=8275.05; P=0.01). In the multivariable model an increasing PM10 
concentration resulted in a higher odds of pleurisy lesions (FP: OR=8.85; P=0.049). These findings indicate that 
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Introduction 
Mycoplasma hyopneumoniae (M. hyopneumoniae) is the causative agent of enzootic pneumonia (EP) which is a chronic 
respiratory disease in swine (Maes et al., 2008). Lung lesions in grower-finishers caused by EP are still held 
responsible for tremendous losses to the pig sector (Maes et al., 2008; Meyns et al., 2011). Mycoplasmal 
pneumonia and pleurisy lesions have a negative impact on growth and feed conversion (Meyns et al., 2011). On 
average, 17% and 34% reduction in live weight gain and 14% and 26% increase in feed conversion can be 
attributed to mycoplasmal pneumonia and pleuropneumonia, respectively (Meyns et al., 2011; Straw et al., 1989). 
Several management and environmental factors have been shown to contribute to enzootic pneumonia, such as 
low general herd health, poor disease prevention, high pen stocking density, and mixing pigs of different origin 
(Sibila et al., 2004; Stärk, 2000). Pigs are exposed to aerial pollutants, such as particulate matter (PM) and 
ammonia (NH3) (Pedersen et al., 2000). Particulate matter is a mixture of suspended materials with particle-like 
properties, with different physical, chemical and biological characteristics, which determine its behavior and the 
associated environmental and health effects.  
Similar to M. hyopneumoniae, which affects the mucosal clearance system by attaching to and disrupting the cilia on 
the epithelial surface of the respiratory tract (Thacker, 2006), PM and NH3 have an adverse effect on the mucosal 
clearance system. Particulates cause inflammation or irritation of the respiratory epithelia (Pearson and Sharples, 
1995). Ammonia depresses ciliary activity and mucus flow (Stombaugh et al., 1969). In this way, the function of 
the mucosal clearance system is impaired, thereby predisposing the respiratory tract to respiratory infections 
(Maes et al., 2008; Wilton et al., 1998). Several particle size ranges are often distinguished: total or inhalable 
particles, thoracal or fine particles and respirable particles. Total particles include all size particles (particles 
smaller than 50-100 µm). Thoracal particles are particulates ≤ 10 µm and can be inhaled into the respiratory tract 
of the pig (Aarnink and Ellen, 2007; Hinz, 2002; Jacobson et al., 2003; Takai et al., 1998). The majority of micro-
organisms are present on particles sized 5-20 µm and mainly on particles of size 10 µm (Harry, 1978). Larger 
particles of approximately 5 µm or more will affect the mucociliary system (Collins and Algers, 1986). Respirable 
particles are smaller than 4 µm and will reach the alveoli (Collins and Algers, 1986; Hinz, 2002). Particulate 
matter (PM10) can be defined as particulate matter which passes through a size-selective inlet with a 50% 
efficiency cut-off at 10 µm aerodynamic diameter (European Council, 1999). The abbreviation PM is mostly 
accompanied by an index number. This number refers to the size of the cut-off diameters of particle separators 
which separate particles from gaseous substances (Hinz, 2002). 
Ammonia is the most important health threatening gas in animal houses (Cargill et al., 2002). Carbon dioxide 
(CO2) and hydrogen sulfide (H2S) are other gasses present in swine facilities. Carbon dioxide is less harmful to 
animal health (Cargill et al., 2002; Ni et al., 2008) whereas hydrogen sulfide can cause death in swine when 
manure pits are agitated (Stombaugh et al., 1969), but usually the concentrations in the facility are low (Jacobson 
et al., 2003). Other gasses detected in swine facilities are methane (CH4) and nitrous oxide (N20), however they 
are related to global climate changes (Jacobson et al., 2003; Ni et al., 2008). Total PM in various sections of the 
facilities throughout the year stay between 2000 and 3000 µg/m3 (Lemay et al., 2002). The PM10 concentration 
measured by Van Ransbeeck et al. (2013b) in a Flemish pig finishing stable during different seasons in different 
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ages of the pigs between 2009-2010 ranged from 22 to 2288 µg/m3 (Van Ransbeeck et al., 2013b). Ammonia 
levels range from five to ten ppm in well ventilated pig buildings and tend to be higher in stables with solid 
floors compared to those with slatted floors (Jacobson et al., 2003). Indoor NH3 concentrations in finishing pig 
stables were 18.7 and 16.3 ppm on average for conventional and low emission stables respectively (Van 
Ransbeeck et al., 2013a). 
To date, research focusing on the simultaneous impact of PM and NH3 on specific respiratory diseases such as 
EP are scarce. Many studies focus on the impact of NH3 or PM on atrophic rhinitis (AR), are dated and were 
performed in confined research facilities (Curtis et al., 1975; Done et al., 2005; Drummond et al., 1980; Hamilton 
et al., 1999; Hamilton et al., 1998; Stombaugh et al., 1969; Underdahl et al., 1982; Urbain et al., 1996; Wathes et 
al., 2004). No consensus is obtained on whether (Chiba et al., 1985; Curtis et al., 1975; Donham, 1991; Jolie et al., 
1999b; Stombaugh et al., 1969) or not (Carpenter and Moulsley, 1986; Done et al., 2005; Drummond et al., 1980; 
Hamilton et al., 1999; Jansen and Feddes, 1995; Takai et al., 1995; Urbain et al., 1996; Van 't Klooster et al., 
1993) PM or NH3 affect health or production under current field conditions. Further, many studies consider 
only the impact of PM (Chiba et al., 1985; Jolie et al., 1999a; Van 't Klooster et al., 1993) or NH3 (Hamilton et al., 
1998; Stombaugh et al., 1969; Underdahl et al., 1982; Urbain et al., 1996) on respiratory parameters (Done et al., 
2005; Hamilton et al., 1999; Hamilton et al., 1998; Urbain et al., 1996) or production data (Bate et al., 1987; 
Wathes et al., 2004), but not the associations and long term environmental exposures in relation with health and 
production. Only one study exposed pigs to aerial PM (40.6mg/m3) in combination with lipopolysaccharide for 
15 weeks (5 days per week, 8 hours per day) but no influence on macroscopic lung lesions was noticed (Jolie et 
al., 1999a). 
The present study investigated the simultaneous and long term influence of PM10 and NH3 on pig performance, 
lung lesions and the presence of M. hyopneumoniae under field conditions in a pig herd with clinical problems of 
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Material and Methods 
Herd and animals 
A commercial farrow-to-finish pig herd comprising 210 JSR (John Sykes Rymer Genetics Limited) hybrid sows 
with clinical respiratory problems associated with M. hyopneumoniae (i.e. dry coughing) in grower-finishing pigs was 
selected. Artificial insemination was performed with semen of Piétrain boars and the farm operated a four week 
batch production system. The piglets were vaccinated against M. hyopneumoniae at day three and day 21 with 
Suvaxyn Mhyo® (Zoetis). At weaning age (21 days), the pigs were transferred to the nursery unit (three pens, 
one unit, door ventilation). From eleven weeks of age (±25 kg) onwards until slaughter age at 29 weeks, which 
will be referred to as finishing period (FP), the trial pigs were present in the finishing unit. This unit comprised 
eight compartments located in the same barn. A minimum of two days empty period was applied before stocking 
new pigs in the finishing unit. All compartments were equipped with an automated temperature-regulated 
ventilation (door ventilation). Pelleted feed and drinking water were provided to the pigs ad libitum. Additional 
information regarding the farm can be consulted in the supplementary data section at the end of the manuscript. 
Study design 
The trial started in August – September 2011 (replicate 1, R1), with the selection of 501 pigs (eleven weeks of 
age). The pigs originated from two consecutive groups of sows, resulting in two groups of pigs. The pigs of the 
first group were one month older than those of the second group. Within each group, the pigs were randomly 
assigned using the Excel RAND function (Excel 2010, Microsoft Corp.) to four compartments: two fully slatted 
compartments (0.65 m2/pig) and two partially slatted floor compartments (0.64 m2/pig and 0.66 m2/pig). In 
December 2011 – January 2012, a second replicate (R2), comprising 594 pigs, was investigated. Each replicate of 
the study comprised thereby eight  compartments (two groups of four compartments). The study was conducted 
after approval of the Ethical Committee for Animal Experiments of the Faculty of Veterinary Medicine, Ghent 
University (approval number: EC2011/142). 
Explanatory variables: PM10 and NH3 
Particulate matter (PM10) (µg/m3) and NH3 (ppm) inside the pig facilities were measured. A schedule of the 
different compartments can be found in the supplementary data. The PM10 measurements were performed by 
two Grimm 1.109 spectrometers (Grimm Aerosol Technik GmbH & Co. KG) (one minute sampling interval) 
and two Graywolf Particle Counters-Handheld 3016IAQ (GrayWolf Sensing Solutions) (15 minute sampling 
interval) during the FP. The data were obtained semi-continuously by rotation of the devices twice per week per 
compartment and hourly averages were calculated. Bi-weekly side-by-side measurements in a random chosen 
compartment were performed for 30 minutes to ensure the equivalence of the four PM monitors. When 
differences exceeding 10%, the results of the aberrant monitor were corrected based on the side-by-side 
measurements (Ulens et al., 2014). Both devices were calibrated by the manufacturer.  
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Indoor concentrations of NH3 (ppm) were measured in all eight compartments sequentially during FP with an 
Innova photoacoustic gas monitor 1314 (Innova AirTech Instruments) as described by Ulens et al. (2014). One 
hour was needed to measure all compartments sequentially. Calibration was done by the Dutch Metrology 
Institute VSL according to ISO/IEC 17025. 
Sampling of both PM10 and NH3 was performed in the central pen of the four compartments at 0.8 m height and 
according to the rotation scheme for PM10 and in each compartment for NH3. The average PM10 (avPM10) and 
average NH3 (avNH3) concentrations were calculated for each compartment in each replicate from eleven weeks 
until either the day of sampling/weighing (28 weeks) of the pigs or day of slaughter (29 weeks), further referred 
as FP. The same calculations were considered from halfway the FP (19 weeks) onwards until the day of 
sampling/weighing (28 weeks) or day of slaughter (29 weeks), further referred as the second half of the FP for 
each replicate. 
Outcome variables 
The average daily weight gain (ADG: g/pig/day) and mortality were measured. The pigs were weighed 
individually at eleven and 28 weeks to determine the ADG (Del Pozo Sacristán et al., 2014). Dead pigs were 
included in the calculation of the ADG by registering the end weight and date of mortality during the FP. 
The lungs were individually examined at slaughter (29 weeks of age) in a blinded manner. First, the presence of 
suppurative bronchopneumonia, further referred to as pneumonia was recorded (prevalence of pneumonia), 
defined as macroscopical greyish to purplish consolidated areas. These lesions are generally located on the 
cranio-ventral parts of the lung lobes, and are demarcated from normal tissue by a sharp line following the 
interlobular septa (Van Alstine, 2012). Subsequently, the total area of lung tissue affected by pneumonia lesions 
(further referred to by extent of pneumonia lesions) representing the severity of these lesions was calculated 
(Morrison et al., 1985). Finally, the lungs were checked for the presence or absence of fissures and pleurisy. 
Fissures were defined as areas of collapsed alveoli adjoining alveolar emphysema (recovery lesions) (Kobish et 
al., 1993), while pleurisy was defined as fibrotic adherences between the parietal and visceral membranes of the 
pleural cavity (Del Pozo Sacristán et al., 2014). 
To determine the presence of M. hyopneumoniae, ten pigs per compartment were randomly selected at the start of 
the trial. From these animals, nasal swabs (sterile aluminum applicator rayon tipped, COPAN) were collected at 
28 weeks. The DNA-extractions for M. hyopneumoniae and the two steps polymerase chain reactions were 
performed as previously described (Stärk, 1999). 
Data and statistical analyses 
Prior to statistical analysis, the PM10 and NH3 data were explored and checked for irrelevant values. These could 
occur because of instrument failure, repositioning of the equipment, or entering the compartment by farmer or 
researchers. These outlier data were discarded. A logarithmic transformation of the explanatory variables avPM10 
and avNH3 was performed in order to normalize the data, further referred to as PM10 and NH3. The PM10 and 
NH3 concentrations were associated with the production parameters (ADG and mortality) during FP, and with 
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the respiratory health parameters (prevalence of pneumonia and extent of pneumonia lesions, prevalence of 
fissures, pleurisy and nPCR results) during the FP and the second half of the FP. 
PM10 and NH3 were the explanatory variables in the statistical analyses. Seven parameters were considered as 
outcome variables, namely: ADG, mortality, likelihood and extent of pneumonia lesions, likelihood of fissures 
and pleurisy and likelihood of nPCR positivity. Associations were considered significant when P < 0.05. 
Linear mixed regression models [MLwiN 2.26 (Rasbash et al., 2012)] were used to assess the influence of PM10 
and NH3 on ADG and extent of pneumonia lesions, respectively. First, the influence of PM10 and NH3 was 
tested in four models in a univariable way. The assumptions of normality and homogeneity of variance of the 
final model were tested by examining normal probability plots of residuals and plots of residuals versus predicted 
values. No patterns indicating heteroscedasticity were present. 
The multilevel linear statistical model may be represented mathematically as:  
Yij = β0 + β1log10NH3 + β2log10PM10 + β3Replicate + µcompartment(j) + εij, where Yij is the continuous outcome 
variable (ADG or extent of pneumonia lesions), βs are the model coefficients, log10NH3 is the log-transformed 
NH3 concentration, log10 PM10 is the log-transformed PM10 concentration, replicate is the finishing period in 
which the pigs participated in the study, and started for replicate 1 in August - September 2011 and for replicate 
2 in December 2011 - January 2012, µcompartment(j) is the random effect of the compartment i (i = 1 to 8), j refers to 
the jth pig in the ith compartment and εij is the random error term, assumed to be normally distributed with 
mean 0 and variance σ2. The influence of PM10 and NH3 on mortality, the likelihood of the different lung lesions 
and nPCR-positivity, were analyzed by means of logistic mixed regression model using 1st order marginal quasi-
likelihood algorithms (MLwiN 2.26 - Centre for Multilevel Modeling, Bristol, UK (Rasbash et al., 2012). First, 
PM10 and NH3 were tested in a univariable way. The fit of the models was evaluated by inspection of the pig 
standardized residuals plotted against the normal scores and the pig level predicted values. The Hosmer 
Lemeshow goodness-of-fit measure was calculated for the explanatory variable models using SAS 9.3 (PROC 
LOGISTIC, SAS Institute Inc., NC, USA). The results were represented as odds ratio (OR) with the 95% 
confidence interval calculated around these odds ratios.  
The multilevel logistic statistical model may be represented mathematically as:  
(g)Yij = β0 + β1log10NH3 + β2log10PM10 + β3Replicate + µcompartment(j) + εij, where (g) refers to the logit link 
function, Yij is the probability of the outcome variable on the logit scale (lung lesions and nPCR results), βs are 
the model coefficients, logNH3 is the log-transformed NH3 concentration, log10PM10 is the log-transformed 
PM10 concentration, replicate is the finishing period in which the pigs participated in the study, and started for 
replicate 1 in August - September 2011 and for replicate 2 in December 2011- January 2012, µcompartment(j) is the 
random effect of the compartment i (i = 1 to 8), j refers to the jth pig in the ith compartment and εij is the 
random error term, assumed to be normally distributed with mean 0 and variance σ2. In total, 20 separate 
univariable models were tested i.e. four predictor variables (PM10, NH3, PM10 during the second half of the FP 
and NH3 during the second half of the FP) and five different outcome variables. In case both PM10 and NH3 
were significantly associated with the specific outcome variables, they were simultaneously included in a 
multivariable model (Table 5). In all models, replicate was included as predictor variable to account for seasonal 
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influence and compartment was included as random effect to correct for clustering of pigs within a 
compartment.  
Results 
Average values of the explanatory variables and outcome variables in each replicate of the study are shown in 
Tables 1 and 2, and 3, respectively. Results of the univariable and multivariable models are shown in Table 4 and 
5, respectively. Neither PM10 FP nor NH3 FP were significantly associated with ADG and mortality (Table 4). 
The PM10 second half of the FP concentration was positively and significantly associated with the likelihood of 
pneumonia (OR=8.72; P=0.015) (Table 4). 
A positive significant association was found between PM10 and the extent of pneumonia lesions (FP; P=0.04 and 
second half of the FP; P<0.009) (Table 4). 
A significant positive association was found between PM10 FP and NH3 FP with the odds of prevalence of 
pleurisy (OR=20.91; P<0.001 and OR=21.54; P=0.003) (Table 4). In the multivariable model, a trend of a 
positive association between NH3 FP and the likelihood of pleurisy was observed, while PM10 FP remained 
significantly associated with the likelihood of pleurisy (OR=8.85; P=0.049) (table 5). Increasing PM10 (second 
half of the FP) increased (OR=40.85; P<0.001) the likelihood of pleurisy (Table 4). 
A significant positive association was found between PM10 FP (OR=328.00; P=0.01) and NH3 FP (OR=70.37; 
P=0.049) and the likelihood of nPCR-positivity (Table 4). However, in the multivariable model, only a trend of a 
positive association between both PM10 and NH3 and the likelihood of nPCR-positivity remained (Table 5). 
Similar results were observed for the association between the likelihood of nPCR-positivity and the PM10 and 
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Table 4: Results of univariable models between both the log10-transformed average PM10 and log10-
transformed average NH3 calculated over the entire finishing period (11-28/29 weeks) and/or over the second 
half of the finishing period (19 – 28/29 weeks) on the different outcome variables: average daily weight gain 
(ADG), the likelihood of mortality, extent of pneumonia lesions, the likelihood of pneumonia lesions, fissures 






β0 β1 SE OR CI P-value 
ADG PM10 FP 0.98 -0.08 0.04 - - 0.08 
 NH3 FP 0.82 -0.07 0.04 - - 0.08 
Likelihood of 
Mortality 
PM10 FP 4.44 -2.23 1.92 0.11 0.00-4.62 0.245 
NH3 FP 0.52 -2.26 1.98 0.10 0.00-5.10 0.255 
Likelihood of 
pneumonia 
PM10 FP -3.30 1.03 0.87 2.80 0.51-15.43 0.236 
NH3 FP -1.32 0.94 1.06 2.56 0.32-20.26 0.372 
PM10 2ndFP -7.50 2.17 0.89 8.72 1.52-49.92 0.015* 




PM10 FP -0.26 0.10 0.05 - - 0.04* 
NH3 FP -0.07 0.11 0.06 - - 0.08 
PM10 2ndFP -0.39 0.14 0.05 - - 0.009* 
NH3 2nd FP -0.06 0.091 0.09 - - 0.299 
Likelihood of 
fissures 
PM10 FP 0.99 -0.53 0.91 0.59 0.10-3.50 0.562 
NH3 FP -0.04 -0.48 1.10 0.62 0.07-5.37 0.665 
PM10 2ndFP 1.26 -0.57 0.94 0.57 0.09-3.57 0.544 
NH32nd FP 0.86 -1.04 1.53 0.35 0.02-7.02 0.495 
Likelihood of 
pleurisy 
PM10 FP -9.78 3.04 0.89 20.91 3.65-119.63 < 0.001* 
NH3FP -4.40 3.07 1.05 21.54 2.75-168.68 0.003* 
PM10 2ndFP -12.80 3.71 0.94 40.85 6.47-257.86 < 0.001* 





PM10 FP -19.89 5.79 2.34 328.00 3.34-32189.64 0.01* 
NH3 FP -6.56 4.25 2.16 70.39 1.02-4882.83 0.049* 
PM10 2ndFP -18.66 5.22 2.31 185.49 1.99-17265.75 0.02* 
NH3 2ndFP -14.14 9.02 3.51 8275.05 8.60-7966852.07 0.01* 
Each row per outcome variable represents one univariable model 
ADG: average daily weight gain 
PM10/NH3 FP: log10-transformed average value of PM10 or NH3 calculated over the entire finishing period: 11-29 weeks of age 
PM10/NH3 2nd FP: log10-transformed average value of PM10 or NH3 calculated over the second half of the finishing period: 19-29 weeks 
β0: Intercept of the linear/logistic regression equitation 
β1: regression coefficient of the linear/logistic regression equitation 
SE: standard error 
OR: odds ratio = exponent (β1) 
CI: confidence interval 
P-values with an asterisk (*) are significant (P<0.05) 
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Table 5: Multivariable associations of the explanatory variable log10 transformed average PM10 and log10 
transformed average NH3 calculated over the entire finishing period (11-28/29 weeks) or/and over the second 
half of the finishing period (19 – 28/29 weeks)  associated with the outcome variable likelihood of pleurisy and 





β0 β1 SE OR CI P-value 
Likelihood 
of pleurisy 
PM10 FP -9.29 2.18 1.11 8.85 1.00-77.91 0.049* 
NH3 FP 1.56 1.33 4.76 0.35-64.51 0.239 
nPCR PM10 FP -19.230 5.01 2.95 149.46 0.46-48484.53 0.09 
 NH3 FP 1.44 2.58 4.20 0.03-656.50 0.58 
nPCR PM10 2ndFP -21.440 3.18 2.77 24.14 0.11-5503.83 0.25 
 NH3 2ndFP 6.52 3.90 680.62 0.32-1426764.71 0.09 
Each row per outcome variable represents one multivariable model 
PM10/NH3 FP: log10-transformed average value of PM10 or NH3 calculated over the entire finishing period: 11-29 weeks of age 
PM10/NH3 2ndFP: log10-transformed average value of PM10 or NH3 calculated over the second half of the finishing period: 19-29 weeks 
β0: Intercept of the logistic regression equitation 
β1: regression coefficient of the logistic regression equitation 
SE: standard error 
OR: odds ratio = exp (β1) 
CI: confidence interval 
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Discussion 
The present study investigated the influence of PM10 and NH3 on performance, lung lesions and the occurrence 
of M. hyopneumoniae in grower-finishing pigs with clinical problems of EP. The remaining finding of the 
multivariable models was that the PM10 concentration significantly increased the odds of pleurisy (FP). Other 
statistically significant findings for both PM10 and NH3 (nPCR FP and second half of the FP) in the multivariable 
models were reduced to non-significance. Particulate matter 10 appeared to have a greater impact than NH3 on 
the respiratory parameters in the univariable models prevalence of pneumonia and pleurisy (second half of the 
FP) and extent of pneumonia (FP and second half FP).  
As the study was conducted in one commercial herd with clinical problems of enzootic pneumonia in grower-
finishers, the results cannot be generalized as such to all pig herds, but only to similar farms. However, the 
housing, feeding and management practices were similar to many pig farms in Belgium and Western Europe. To 
see any effect of PM10 and NH3 on presence of lung lesions caused by M. hyopneumoniae, it was key that a farm 
with clinical problems of M. hyopneumoniae and with a sufficiently high level of PM10 and NH3 concentrations was 
selected. One of the compartments in the farm had a total unobstructed floor area of 0.64 m2/pig per pen, while 
an area of 0.65 m2/pig is required for pigs from 85 kgs until 110 kgs as stated in article 3 of council directive 
2008/120/EC (European Council, 2008). From 110 kgs onwards the floor space area per pig is required to be 
1.00 m2/pig. Likewise the average weight at the end of the finishing stage in most pens exceeded 110 kgs. In 
practice, temporary overstocking at the end of the finishing period (when the allowed stocking density shifts 
from 0.65 to 1 m² per pig i.e. at 110 kg is quite common, although it is in contrast with the European law. It is 
well known that overstocking contributes to respiratory problems (Stärk, 2000). These problems addressed 
above can be the reason why M. hyopneumoniae was still causing fairly large clinical problems in the farm, despite 
vaccination of the piglets. To reduce the transmission pressure and PM10 and NH3 concentration it would be 
recommended to comply with the stocking density as stated in the European regulation. Overstocking might be 
a potential confounder in this study, however including compartment into the model as a random effect takes 
into account the association between observations within the same compartment and thus controls for any 
potential confounding factor at compartment level.  
No recommendations in Belgian legislation for animals regarding airborne dust and NH3 are given. However, the 
maxima of the average PM10 concentrations measured in this farm were higher than the upper level of the range 
given in Van Ransbeeck et al. (2013b) (2288 µg/m3). Following threshold for NH3 regarding swine health is 
suggested based on a dose-response correlation to swine health: eleven ppm (Donham, 1990). The NH3 values in 
this farm showed higher levels than this recommended value.  
A simultaneous, long term and detailed measurement of environmental parameters, PM10 and NH3 was 
performed to relate these parameters to performance as well as to respiratory parameters. No other 
climatological data such as temperature, rainfall or wind were included in the analysis. PM10 and NH3 were 
measured during the entire year, thereby correcting for seasonal influence. Humidity and ventilation can 
influence the PM10 and NH3 levels as well. However by performing the semi-continuous (PM10) or continuous 
(NH3) measurement during an entire day and night, during four different seasons, these factors were taken into 
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account. Inter-compartment variation was taken into consideration by including replicate and compartment 
respectively into the model. The study was conducted in one farm. This has the advantage that the main 
influencing factors as management, husbandry activity, animal activity, age of the animals, feeding system and 
type of feed (Dawson, 1990; Harry, 1978; Pedersen et al., 2000) were the same for all fattening pigs included in 
the study and it is therefore not necessary to include these factors into the statistical model. Adding a control 
group with low PM10 and NH3 concentrations in the same farm would have had practical difficulties: which 
technique to use, more equipment to maintain and to check, etc. Moreover the main interest was to investigate 
associations between PM10 and NH3 on the one hand and production parameters and lung lesions on the other 
hand. From that perspective, and to make the study not unnecessary complicated, the authors opted not to add a 
control group. Between different compartments in one farm there are certain factors which can diminish the 
PM10 and/or NH3 levels: lowering the level of light and thus animal activity in the stable, not using litter and dry 
feed, reduction of the slurry pit surface (sloped pit walls), floor material (iron, metal, plastic versus concrete 
slats), a good drainage of the faeces through the floor (Dawson, 1990; Pearson and Sharples, 1995; Philippe et al., 
2011). High ventilation rates and low temperatures promote the production of particulates (Kim et al., 2005; 
Stärk, 1999). However these listed factors were not measured as this fell out of the scope of this study. Temporal 
variation of the PM10 and NH3 data was explored (data not shown). The PM10 levels were, according to the 
rotation scheme of the devices, measured with a one minute interval or 15 minute interval during day and night. 
In this way higher PM concentrations which occur during the day were taken into account as well (Takai et al., 
1998). According to Van Ransbeeck et al. (2012), the variation in location of the devices by the rotation scheme 
can be neglected compared to the importance of measurements carried out during many stages of the whole 
finishing period (Van Ransbeeck et al., 2012). 
A chronic effect of PM10 and NH3 on the outcome variables was emphasized as long term measurements (entire 
finishing period) were performed. However, also the maximum concentration might have influenced the 
outcome variables, as at one time point inhaling a high concentration of hazardous substances and micro-
organisms can have a detrimental and permanent effect on the pig’s health.  
Average daily growth in the study was rather low compared to today’s standards [725 g per pig per day recorded 
in a national technical data report (Bulens et al., 2013)]. However it should be noted that dead pigs were included 
in the calculation of the ADG. In this farm artificial insemination with Piétrain semen was performed. Piétrain-
sired progeny accumulate less fat in comparison with other sires used, however they grow more slowly (Edwards 
et al., 2006; Labroue et al., 1999). Other than the type of boar being used, the poor growth rate in this farm could 
also be due to the clinical problems with M. hyopneumoniae. It is well known that enzootic pneumonia decreases 
performance such as ADG (Thacker and Minion, 2012). No significant association of both environmental 
parameters, PM10 and NH3 with ADG could be found. This finding is in accordance with the observations of 
(Van 't Klooster, 1993), (Jansen and Feddes, 1995) and (Takai et al., 1995), although these authors only 
considered particulates and not NH3.  
The overall mortality rate during the FP was 3.84%. No significant association was observed between the PM10 
and NH3 concentration and mortality. One other study associated PM with death loss (Donham, 1991). The 
latter author found a positive and significant correlation between total and respirable PM and death loss in 
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fatteners. However no correlation with the thoracal dust fraction, which is included in the PM10 fraction 
measured in our study, was made. This can be the reason why the result of Donham et al. (1991) was not in line 
with our findings.  
The pigs were slaughtered at 29 weeks. Some pigs were not slaughtered at that time (as they did not reach 
sufficient weight yet), but two weeks later. The measurements of PM10 and NH3 and the associations with the 
outcome variables were determined from eleven weeks onwards until 29 weeks of age (and for the lung lesions 
and nPCR results as well from 19 – 29 weeks), as a lower number of pigs in the pens would have influenced the 
PM10 and NH3 concentrations and therefore the outcome of the results. A high prevalence of pneumonia lesions 
was recorded at slaughter (63.0%) and these active pneumonia lesions will appear at earliest one week and reach 
a maximum four weeks post infection and will be recovered resulting in interlobular scar retractions more or less 
twelve weeks after infection (Kobish et al., 1993; Sørensen et al., 1997). Thus a large part of these pigs with 
active pneumonia lesions at slaughter were infected maximum twelve weeks before slaughter, which is roughly 
half way the finishing period. This means that not only M. hyopneumoniae was circulating in the earlier stages of the 
finishing period which can be determined by the fissurae lesions, but also during the second half of the finishing 
stage. On the other hand the pneumonia lesions found at slaughter were not that severe (score 8.25). Del Pozo 
Sacristán et al. (2012), using the same scoring system, found similar prevalences (20.5, 13.1, 23.0) and extent of 
pneumonia lesions (15.0, 13.4 and 14.9) in three groups of slaughter pigs. Higher PM10 concentrations were 
significantly associated with the prevalence of pneumonia (second half of the FP) and with the extent of 
pneumonia lesions (FP, second half of the FP). Higher NH3 concentrations resulted in a trend of the extent of 
pneumonia lesions (FP and second half of the FP) being higher. The finding was in agreement with Jolie et al 
(1999b). They found more macroscopic lung lesions indicative for M. hyopneumoniae when the air of the 
compartment was more contaminated with PM and NH3, although no significance level was mentioned (Jolie et 
al., 1999b). If an association between PM and NH3 on the one hand and prevalence of pneumonia and extent of 
pneumonia lesions on the other hand can be assumed, it is more likely that this association will be expressed in 
the second half of the FP. The onset of the pneumonia lesions will not likely have started earlier than twelve 
weeks before slaughter house check as these pneumonia lesions heal after a period of twelve weeks (Sørensen et 
al., 1997). Based on this finding, it is clear that the indoor air quality for the finishing pig is not only important in 
the early stages of life as stated by Fablet (2009), but during the second half of the production stage as well 
(Fablet, 2009). Upon healing of pneumonia lesions (Sørensen et al., 1997), fissures develop and remain for a 
period of 12 weeks (Kobish et al., 1993; Van Alstine, 2012). An overall prevalence of 34.8% was detected at 
slaughter which indicates that the pigs had been experiencing pneumonia lesions earlier on in the FP as well, as 
already mentioned. To the author’s knowledge, no other reports describe the association between PM and NH3 
on the one hand and the prevalence of fissures on the other hand. In our study no association between these 
parameters was detected. It was found that slaughter pigs seropositive for M. hyopneumoniae had chronic pleurisy 
in 29% of the cases (Van Alstine, 2012). The overall value detected at slaughter in our study was 63.8% which is 
high in comparison with the 20.76% found in Meyns et al. (2011). Particulates and ammonia (FP) were positively 
associated with the prevalence of pleurisy lesions, with only PM10 remaining significantly associated with the 
prevalence of pleurisy in the multivariable model. Donham et al. (1991) found a significant correlation between 
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PM and NH3 and pleurisy lesions (univariably tested) in finishing pigs as well notwithstanding the differences in 
experimental design compared with our study. Particulates and NH3 can tip the balance between host and 
respiratory invaders in favor of the invaders (Donham, 1991). This study focused mainly on the influence of 
PM10 and NH3 on the presence of M. hyopneumoniae. Therefore, our interest was to associate PM10 and NH3 to 
the prevalence of M. hyopneumoniae and other diseases e.g. atrophic rhinitis were not investigated. An overall result 
of 27.7% of positive samples for M. hyopneumoniae in the nasal swabs was obtained and the overall prevalence of 
pneumonia lesions was 63.0%. The discrepancy between the results of the nPCR and the pneumonia prevalence 
can be due to several reasons. First, pneumonia lesions detected at slaughter are characteristic for M. 
hyopneumoniae infections in the farm and are frequently used to assess the severity of enzootic pneumonia in the 
farm. However, it is well known that the lesions are not pathognomonic. Secondly, other pathogens, especially 
viruses (e.g. Influenza virus) can induce similar lesions (Sibila et al., 2009). Another reason for this above 
mentioned discrepancy might be that only a subsample of the 1095 animals in the farm was investigated. It is 
also possible that due to coincidence a lower number of positive animals was detected than the animals that were 
really infected with M. hyopneumoniae, although the samples were taken at random. Nasal swabs were collected, as 
it is safer for the researchers and less stressful for the animals than taking tracheal swabs (Fablet et al., 2010; 
Thacker, 2004). However, nasal swabs are less sensitive to detect DNA of M. hyopneumoniae than tracheal swab or 
BALf. When including both PM10 and NH3 in the multivariable model, only a trend of PM10 and NH3 causing a 
higher number of nPCR positive results remained in FP and second half of the FP. To the author’s knowledge 
no previous work ever associated PM or NH3 with DNA of M. hyopneumoniae detectable in pigs. 
Conclusions 
The present study demonstrated that increasing PM10 concentrations resulted in a higher prevalence of pleurisy 
lesions under field conditions. When PM10 was considered in the univariable model, it appeared to have a greater 
impact than NH3 on the respiratory parameters, in the second half of the FP for the prevalence of pneumonia 
and pleurisy. This statement was also true for the extent of pneumonia lesions (FP and second half of the FP). 
The effect of PM10 and NH3 on other parameters (nPCR FP and second half of FP) in the multivariable model 
was reduced to non-significance. This implies that more research is necessary to draw further conclusions. A 
higher sample size can be a solution to investigate the trends found in this study into depth, however conducting 
a larger study will have practical implications in terms of feasibility of the study. These findings indicate that the 
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Supplementary data files 
Table 1: Description of the herd enrolled in the study 
Number of sows 210 
Sow breed JSR-hybrid 
Type of herd Closed herd 
Type of batch farrowing system 
for sows 
4-week 




Vaccination of gilts and sows 
against other agents 
SIV (Suvaxyn Flu®, Zoetis) 
PRRSV (Porcilis PRRS®, MSD) 
E. rhusiopathiae + Parvovirus (Parvoruvax®, Merial) 
E. coli (Neocolipor®, Merial) 
PCV-2 (Porcilis PCV2®,  MSD)  
AR (Porcilis AR-T DF®, MSD) 
Number of piglets weaned per 
sow per year 
27 
Management of suckling piglets  Day 0 (birth day): teeth clipping, umbilicus disinfection, 
ceftiofur (Naxcel®, Zoetis)  
Day 3: Fe, IM (Ferrohipra®, Laboratorius Hipra), 
surgically neutering of the males, tail docking, ceftiofur 
(Naxcel®, Zoetis)  
Vaccination piglets against 
Mycoplasma hyopneumoniae 
Day 3 + Day 21: Suvaxyn Mhyo® (Zoetis)  
Vaccination piglets against other 
agents 
Day 21: PCV-2, (Porcilis® PCV, MSD)  
Strategic medication of nursery 
piglets  
Amoxycillin and colistin (Amoxycol WSP®, 
Dopharma), in drinking water, two times five days 
administration and five amoxicillin and colistin-free 
days in between 
Strategic medication finishing 
pigs 
No 
Deworming finishing pigs Levamisole hydrochloride 80%® (Kela Laboratoria 
N.V.), in drinking water, every 2 months 
JSR: John Sykes Rymer Genetics Limited 
SIV: Swine Influenza virus 
PRRSV: Porcine Reproductive and Respiratory Syndrome Virus 
E. rhusiopathiae: Erysipelothrix rhusiopathiae  
E. coli: Escherichia coli  
PCV-2: Porcine Circovirus type 2  
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Fig. 1: Schematic overview of the pig compartments included in the study. 
Compartments are separated with a black line, the corridors are marked with a blue line. The main corridor is 
marked with two black lines. Compartments are numbered from one to eight, in a counter clockwise direction, 
starting with compartment one (left, below). Doors are marked with a blue square. The cage with the equipment 
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Abstract 
The mycotoxin deoxynivalenol (DON) is highly prevalent in cereals in moderate climates and therefore pigs are 
often exposed to a DON-contaminated diet. Pigs are highly susceptible to DON and intake of DON-
contaminated feed may lead to an altered immune response and may influence the pathogenesis of specific 
bacterial diseases. Therefore, the maximum guidance level in feed is lowest in this species and has been set at 900 
micrograms (µg)/kilogram (kg) feed by the European Commission. This study aimed to determine the effect of 
in-feed administration of a moderately high DON concentration (1,514 µg/kg) on the severity of an 
experimental Mycoplasma hyopneumoniae (M. hyopneumoniae) infection in weaned piglets. Fifty M. hyopneumoniae-free 
piglets were assigned at 30 days of age [study day (D)0] to four different groups: 1) negative control group 
(NCG; n=5), 2) DON-contaminated group (DON; n=15), 3) DON-contaminated and M. hyopneumoniae-
inoculated group (DONMHYO; n=15), 4) M. hyopneumoniae-inoculated group (MHYO; n=15). The piglets were 
fed the experimental diets ad libitum for five weeks and were monitored during this period and euthanized at day 
35 [27 days post infection (DPI)] or 36 (28 DPI). The main parameters under investigation were macroscopic 
lung lesions (MLL) at euthanasia, respiratory disease score (RDS) from day 8 until day 35, histopathologic lesions 
and log copies of M. hyopneumoniae DNA detected by qPCR, determined at the day of euthanasia.  
No significant difference was obtained for MLL at euthanasia, RDS (8-35), histopathologic lung lesions and log 
copies of M. hyopneumoniae DNA in the DONMHYO and MHYO group and consequently, no enhancement of 
the severity of the M. hypneumoniae infection could be detected in the DONMHYO compared to the MHYO 
group. 
Under present conditions, the findings imply that feed contaminated with DON (1,514 µg/kg) provided to 
weaned pigs for five weeks did not increase the severity of an experimental M. hyopneumoniae infection. Further 
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Introduction 
The mycotoxin deoxynivalenol (DON) is a fungal metabolite produced mainly by Fusarium graminearum and 
Fusarium culmorum (Bracarense et al., 2012; Whitlow et al., 2010). Fusarium species-produced mycotoxins, of which 
by toxicological viewpoint the trichothecenes DON and T-2 toxin, zearalenone and fumonisins are the most 
important (Antonissen et al., 2014a), have been reported worldwide in many cereal-based cropping systems. 
Fusarium species have traditionally been associated with temperate cereals, as these fungi require lower 
temperatures for growth and mycotoxin production (Placinta et al., 1999). Indeed, DON is one of the most 
common natural mycotoxin contaminants of wheat and other small cereal grains harvested in moderate climate 
zones (Kostelanska et al., 2011; Miller, 2008; Rasmussen et al., 2012). Extensive data on global mycotoxin 
occurrence showed that 59% of 5,819 samples of animal feed tested positive on DON presence (Antonissen et 
al., 2014a; Placinta et al., 1999; Rodrigues and Naehrer, 2012). In low doses, DON causes anorexia, decreased 
weight gain and immune stimulation (Bracarense et al., 2012). Pigs are known to be a very sensitive animal 
species to DON, mainly because of the high oral bioavailability and differences in metabolism of this mycotoxin 
compared to other species (Bracarense et al., 2012). In moderate to high doses (above 840 µg/kg feed), 
decreased feed intake or feed refusal, vomiting and immune suppression are seen (Accensi et al., 2006; 
Bracarense et al., 2012; Dersjant-Li et al., 2003). In fact, the European Union (EU) recommended maximum pig 
feed guidance level for DON is 900 µg/kg, which is the lowest one compared to other farm animal species for 
total diets and compounds of total diets. For adult ruminants and poultry a maximum of 5,000 µg/kg and 2,000 
µg/kg for calves and lambs are set as guidance levels (Commission recommendation of 17 August, 2006). On 
top of that, the pig consumes a cereal rich diet and DON is frequently detected in wheat, barley, corn and by-
products (Accensi et al., 2006; Pierron et al., 2016).  
It is known that DON can have an impact on the pathogenesis of several bacterial diseases (Antonissen et al., 
2015; Antonissen et al., 2014a; Antonissen et al., 2014b). Exposing porcine ileal loop tissue to a DON-
concentration of 1 µg/ml, potentiated the inflammatory response and significantly enhanced Salmonella 
Typhimurium invasion in and passage of the bacterium across the intestinal epithelium (Vandenbroucke et al., 
2011). Furthermore, DON (0.025 µg/ml) induced an enhanced uptake of Salmonella Typhimurium in porcine 
macrophages, indicating the capacity of DON to modulate the innate immune system, and thus to increase the 
susceptibility of the pig to Salmonella Typhimurium infections (Vandenbroucke et al., 2009). Deoxynivalenol 
might, due to the immunomodulatory effect on the host and/or the immediate impact on the pathogen, have an 
impact on the course of respiratory infectious diseases in swine. However only limited in vivo information is 
available. A three-week ingestion period of feed contaminated with high levels of 2,500 µg/kg and 3,500 µg/kg 
DON resulted in a higher viremia and lung viral load in case of a Porcine Circovirus type 2 (PCV2) infection, 
and a lower body weight gain, more lung lesions and mortality in porcine reproductive and respiratory syndrome 
virus (PRRSv)-infected pigs, respectively (Savard et al., 2014; Savard et al., 2015b). Pigs receiving fumonisin B1 in 
a concentration of 10,000 µg/kg feed, and dually infected with Bordetella bronchiseptica (B. bronchiseptica) and 
Pasteurella multocida, (P. multocida ) were at greater risk to develop pneumonia and had an increase of the extent and 
severity of the pathological changes compared to dually infected pigs that did not receive fumonisin B1 (Pósa et 
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al., 2011). Oral gavage of P. multocida-infected pigs with a crude extract of fumonisin B1 in a concentration of 500 
µg/kg body weight (BW) per day for a period of seven days resulted in the pigs coughing more, in increased 
bronchoalveolar lavage fluid total cells, macrophages and lymphocytes, and resulted in an increased occurrence 
of lung lesions compared to the pigs only infected with P. multocida (Halloy et al., 2005). Dietary exposure to 
fumonisin B1 in a concentration of 12,000 µ/kg feed increased the risk on PRRSv–associated disease (Ramos et 
al., 2010) and induced pulmonary edema which may aggravate M. hyopneumoniae infection (Pósa et al., 2013).  
Mycoplasma hyopneumoniae is causing tremendous economic losses in all intensive pig producing countries 
worldwide (Maes et al., 2017), despite many attempts to control the disease (enzootic pneumonia) through 
vaccination strategies and control measures. Consequently, there is a high prevalence of both M. hyopneumoniae 
infections and a high contamination rate of feed with mycotoxins, more specific DON, in Europe (Rodrigues 
and Naehrer, 2012). Therefore, the odds for a pig to ingest feed contaminated with DON, whilst simultaneously 
being infected with M. hyopneumoniae is high. The present study aimed to investigate the effect of in-feed 
administration of DON, 3-acetylDON and 15-acetylDON at a moderately high level of 1,540 µg/kg feed, on the 
clinical course of an experimental M. hyopneumoniae infection with two genetically different M. hyopneumoniae 
strains in weaned piglets. 
Material and methods 
Study animals and Experimental design 
The study was compliant with all relevant institutional and European standards for animal care and 
experimentation. The experiment was approved by the Ethics Committee for Animal Experiments of the Faculty 
of Veterinary Medicine and Faculty of Bioscience Engineering, Ghent University (approval number 
EC2015/112). Fifty M. hyopneumoniae-free Rattlerow-Seghers piglets (RA-SE Genetics NV, Ooigem, Belgium) 
were included in the study. The herd of origin has been free of M. hyopneumoniae and PRRSv since 2012 based on 
repeated serological testing, absence of clinical signs and pneumonia lesions, and nested polymerase chain 
reaction (nPCR) testing on tracheobronchial swabs as described in Chapter 3.4. The gilts and sows in the herd 
were vaccinated against Erysipelothrix rhusiopathiae and Parvovirus before insemination. No vaccinations were 
administered to the piglets. The piglets were weaned on average at 26 days of age and moved four days later to 
the experimental facilities of the Faculty of Veterinary Medicine, Ghent University, Belgium. The piglets were 
individually identified by means of an ear tag. The study design, the different parameters and timing are 
summarized in table 1. Upon arrival (D0) the piglets were randomly allocated to four different groups: 1) 
negative control group (NCG; n=5): sham-inoculated D8, D9 + control diet, 2) DON-contaminated group 
(DON; n=15): sham-inoculated D8, D9 and DON-diet (1,514 µg/kg), 3) DON-contaminated and M. 
hyopneumoniae-inoculated group (DONMHYO; n=15): experimentally inoculated with M. hyopneumoniae D8, D9 
and DON-diet (1,514 µg/kg), 4) M. hyopneumoniae-inoculated group (MHYO; n=15): experimentally inoculated 
with M. hyopneumoniae D8, D9 + control diet. The number of 15 animals in the treatment groups enabled to find 
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certainty and a statistical power of 80%. This difference is biologically relevant and was based on previous 
research in our research group (Vicca et al., 2003). The NCG (5 pigs) was used to verify whether the purchased 
piglets remained M. hyopneumoniae negative throughout the study. The different groups were housed in four 
different facilities equipped with absolute filtered chambers (HEPA U15) in order to avoid cross-infection of M. 
hyopneumoniae between the different groups. The pigs had free access to drinking water and were fed ad libitum.  
Table 1: Experimental design, sample collections and timing in the different experimental groups  
Study day, D  
 
Groups 
NCG (n=5) DON (n=15) DONMHYO 
(n=15) 
MHYO (n=15) 
D01  Arrival 
Weight 
Randomisation 












Sham-inoculation4 Sham-inoculation4 F7.2C5-inoculation F7.2C5-inoculation 
Weight 
Blood 









1the average age of the pigs at arrival was 26 days,2all pigs of the NCG and DON group, and five pigs of MHYO were necropsied at D35. Ten pigs of 
MHYO and all pigs of DONMHYO were necropsied at D36, 3RDS was not determined at D0 and D36 because the piglets arrived later than 8 a.m. (hour 
of performing coughing score every day) and part of the piglets were already euthanized on D36, respectively, 4sham-inoculation was performed with sterile 
Friis medium, 5highly virulent strain of M. hyopneumoniae, 6low virulent strain of M. hyopneumoniae  
NCG: negative control group, DON: deoxynivalenol contaminated group, DONMHYO: deoxynivalenol contaminated +M. hyopneumoniae-inoculated 
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Mycoplasma hyopneumoniae strains and challenge infection 
The pigs were inoculated with two different strains of M. hyopneumoniae: a highly virulent strain F7.2C and low 
virulent strain F1.12. Both strains had been differentiated and characterized at proteomic level with Sodium-
Dodecyl-Sulphate Polyacrylamide gelelectrophoresis (SDS-page) (Calus et al., 2007) and at genomic level with 
Random Amplified Polymorphic DNA (RAPD), Amplified Fragment Length Polymorphism (AFLP), PCR-
Random Fragment Length Polymorphism (PCR-RFLP) of the p146 gene, Variable Number of Tandem Repeats 
(VNTR) analysis of  p97, with Multiple-Locus of VNTR Analysis (MLVA) (Stakenborg et al., 2005; Stakenborg 
et al., 2006; Vranckx et al., 2011a) and used in previous studies (Chapter 3.4; Vicca et al., 2003a; Villarreal et al., 
2009). Previous research has shown that pigs are often infected with two or even three genetically different M. 
hyopneumoniae strains (Chapter 3.1; Vranckx et al., 2011; Vranckx et al., 2012), and in slaughter pigs infected with 
different strains, more lung lesions can be detected (Chapter 3.1). Therefore, the pigs in the present  study were 
inoculated with two genetically different M. hyopneumoniae strains, to mimic the situation in the field. All pigs were 
anesthetised via the intramuscular route with 0.22 ml/kg BW of a mixture of tiletamine, zolazepam (Zoletil 100®, 
Virbac, Louvain-la-Neuve, Belgium) and xylazine (Xyl-M® 2%, VMD, Arendonk, Belgium) and the pigs of the 
DONMHYO and MHYO groups were endotracheally inoculated with 7 ml of inoculum containing 107 colour 
changing units per ml (CCU/ml) of strain F7.2C on D8 and 7 ml of inoculum containing 107 CCU/ml of strain 
F1.12A on D9. On both inoculation days, the pigs of the NCG and DON group were endotracheally sham-
inoculated with 7 ml of sterile Friis medium. At D35 or D36 of the experiment, the pigs were euthanized using 
deep anaesthesia by intramuscularly administering 0.3 ml/kg BW of a mixture of tiletamine, zolazepam (Zoletil 
100®, Virbac, Louvain-la-Neuve, Belgium) and xylazine (Xyl-M® 2%, VMD, Arendonk, Belgium), followed by 
exsanguination. For practical reasons and to avoid M. hyopneumoniae contamination of the samples, all pigs of the 
NCG and DON group were euthanized at D35, followed by five animals of the MHYO group. All the other 
animals of the MHYO and all animals of the DONMMHYO group were necropsied on D36.  
Deoxynivalenol contaminated diet 
A commercial antibiotic-free diet for weaned piglets was purchased (Leievoeders N.V., Waregem, Belgium). 
Before purchasing the feed, a sample of the batch was tested with liquid chromatography-tandem mass 
spectrometry (LC-MS/MS) according to Monbaliu et al. (Monbaliu et al., 2010; Monbaliu et al., 2009) for the 
presence of DON, 3-Acetyldeoxynivalenol (3-ADON), zearalenone and fumonisin B1+ B2, the levels were 
below the reporting limit of 50 µg/kg, 50 µg/kg, 10 µg/kg and 50 µg/kg, respectively. The piglets of the NCG 
and MHYO groups were fed this commercial diet from D0 until D35/36. A part of the purchased feed  (1,300 
kg) was transported to the laboratory of the Department of Applied Biosciences (Faculty of Bioscience 
Engineering, Ghent University) to add the target concentration of 1,800 µg/kg feed DON. This procedure was 
followed: the reference strain Fusarium graminearum (F. graminearum)  MUCL 42841 (Mycothèque de l’Université 
catholique de Louvain) was used to produce the DON-culture. The strain was grown in liquid mineral (MIN) 
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(Gardiner et al., 2009). After 14 days of cultivation, the culture was filtered and centrifuged. The obtained 
concentration of DON was determined with LC-MS/MS by adding 150 µl of the resulting undiluted MIN 
medium to 5 g of certified blank wheat standard (Sigma Aldrich, Overijse, Belgium). In total, 7,535 mg/kg DON 
was quantified and 1,076 mg/kg acetylated DON (3-ADON +15-ADON) in the grown DON-culture. Next to 
the presence of DON, the inoculum was tested with LC-MS/MS for the presence of other F. graminearum 
trichothecenes such as nivalenol, neosolaniol, fusarenon-X, diacetoxyscirpenol, HT-2 toxin and T-2 toxin, and 
results were below the detection limit. Also no zearalenone was detected. Eight liters (l) of inoculum were 
obtained for preparation of 1,300 kg of DON-contaminated feed in a concentration aimed at twice the 
recommended maximum pig feed level of 900 µg/kg or 1,800 µg/kg DON. First, 2.67 l of the inoculum was 
mixed with 10 kg of feed to obtain a thoroughly mixed premix of the DON-contaminated feed. Subsequently, 
the premix with inoculum was added to 433.3 kg of feed in a feed mill and thoroughly mixed for at least 40 
minutes. The same procedure was repeated twice, to obtain the total amount of 1,300 kg of DON-contaminated 
feed in a concentration of 1,800 µg/kg and the feed was collected again in the original 25 kg bags of the feeding 
company. After preparation of the contaminated feed, a mixed sample originating from three DON-
contaminated feed bags was taken and was submitted for LC-MS/MS to obtain the true DON-concentration of 
the contaminated feed. The results of the LC-MS/MS of the contaminated feed were 407 ± 120 µg/kg DON, 
280 ± 100 µg/kg 3-ADON and 827 ± 300 µg/kg 15-ADON, resulting in a total DON and acetylated DON (3-
ADON +15-ADON-concentration of 1,514 µg/kg in the contaminated feed sample. This feed was used in the 
DON and DONMHYO-groups from D0 until D35/36 of the study. 
Clinical and performance parameters 
From D0 until D35/36 onwards, the piglets were observed daily at 8 a.m. for at least half an hour by the same 
researcher to assess appetite, faecal consistency and presence of dyspnea and tachypnea. A faecal consistency 
score was used to evaluate the faeces found on the pen floor before cleaning (Pedersen and Toft, 2011): 1 (firm 
and shaped), 2 (soft and shaped), both addressed as a normal faecal consistency in pigs, 3 (loose) and 4 (watery), 
with scores 3 and 4 considered as abnormal. A respiratory disease score (RDS) was recorded daily from D1 until 
D35. The score could range from 0-6 with 0 (no coughing), 1 (mild coughing after encouraged move), 2 (mild 
coughing in rest), 3 (moderate coughing after encouraged move), 4 (moderate coughing in rest), 5 (severe 
coughing after encouraged move), 6 (severe coughing in rest) (Halbur et al., 1996). The RDS was not determined 
at D0 and D36, as the pigs arrived later than 8 a.m. at the facilities and already part of the animals was 
euthanized on D35. The daily RDS values were averaged for the following periods: D1-7, D8-35/36 and D1-
35/36. All pigs were weighed (kg) at the day of arrival (D0), the first inoculation day (D8) and the day of 
euthanasia (D35/36). The average daily gain (ADG, kg/pig/day) was calculated from D0-7, D8-35/36 and D0-
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Macroscopic and histopathologic lung lesions 
The lungs were removed and macroscopic lung lesions (MLL) (D35/36) were determined according to Hannan 
et al. (1982) (Hannan et al., 1982) from each pig. Consequently, the lungs were transported to the laboratory of 
the Department of Pathology, Bacteriology and Avian Diseases, Faculty of Veterinary Medicine, Ghent 
University from the necropsy rooms from the experimental facilities in the same department and from each lung 
in each pig, samples from the right apical, cardiac and diaphragmatic lung lobes were collected. In case a lesion 
was present, a sample was collected including both healthy and affected lung tissue, at the border of the lesion. 
The samples were fixed in 10% neutral formalin and processed and embedded in paraffin for histopathological 
examination. Staining was performed with hematoxylin and eosin and the samples were scored using light 
microscopy based on the degree of peribronchiolar and perivascular lymphohistiocytic infiltration and nodule 
formation (cuffing) (Morris et al., 1995). The scoring system ranged from 1 to 5 with 1) limited infiltration of 
macrophages and lymphocytes around bronchioles, with airways and alveolar spaces free of cellular exudates; 
score 2) light to moderate infiltrates with mild diffuse cellular exudates into airways; score 3, score 4 and score 5 
(respectively mild, moderate and severe lesions characteristic of broncho-interstitial pneumonia, centered around 
bronchioles but extending to the interstitium, with lymphofollicular infiltration and mixed inflammatory cell 
exudates). Scores 1 and 2 are not considered to be related with M. hyopneumoniae infection, while scores 3 to 5 are 
presumptive of a M. hyopneumoniae infection (Del Pozo Sacristán, 2014; Morris et al., 1995). The percentage of air 
(percentage of lung area occupied by air) was examined by means of an automated image analysis system (Leica 
application suite AF Lite (Diegem, Belgium) and image J (Bethesda, Maryland, USA)) (Rasband, 1997-2016). 
This parameter is inversely proportional to the lymphohistiocytic infiltration in the lung tissue and the 
intrabronchiolar and bronchial exudate (Vicca et al., 2003b). 
Quantitative PCR for Mycoplasma hyopneumoniae 
Two weeks post inoculation (PI) (D21) of the high virulent strain F7.2C (D8), bronchoalveolar lavage (BAL) 
fluid from all pigs, while conscious was collected. The pigs were snared and the mouth was opened by means of 
a gag to allow insertion of a catheter (Portex® Dog Catheter with Female Luer Mount, Smiths Medical 
International Ltd. Kent, United Kingdom). Next, the lungs were flushed with 10 milliliters (ml) of sterile 
phosphate buffered saline (PBS) and the fluid was subsequently aspirated. Additionally, at necropsy (D35/36), 
BAL fluid was collected from all pigs. Before collection of the histopathological samples, the head bronchus of 
the left part of the lung was flushed with 10 ml of sterile PBS. The BAL fluids were stored at -70°C awaiting 
analysis. The DNA was extracted with the DNeasy Blood & Tissue kit (QIAGEN, Qiagen Benelux, B.V., 
Antwerp, Belgium) with the DNA Purification protocol for bloods or bloody fluids (spin protocol) on 200 µl of 
BAL fluid according to the manual instructions and quantitative PCR (qPCR) was performed as previously 
described to detect the number of M. hyopneumoniae organisms (Marois et al., 2010). Briefly, after DNA-
extraction, qPCR was performed with primers p102f (5’GTCAAAGTCAAAGTCAGCAAAC 3’) and p102r 
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the CFX384 real-time PCR detection system (Bio-Rad, Nazareth, Belgium). A tenfold dilution series of M. 
hyopneumoniae DNA of strain F7.2C was used to convert the threshold values to the number of M. hyopneumoniae 
organisms. Values below the dilution of 1.50x101 (1.18 log copies) were considered as negative (Marois et al., 
2010; Vranckx et al., 2011b). 
Serology 
The blood samples were stored at 4°C for a maximum of 24 hours. Subsequently the blood was centrifuged at 
2000 rpm for  30 minutes and the serum was collected. The serum was stored at -70°C until analysis. At D8, D21 
and at necropsy (D35/36), blood was collected from all pigs and tested with a blocking ELISA (IDEIA™ 
Mycoplasma hyopneumoniae EIA kit, Oxoid Limited, Hampshire, UK) for presence of antibodies against M. 
hyopneumoniae, by following the instructions in the protocol manual. Sera with optical density < 50% of the 
average value of the OD-buffer control were considered to be positive. All values above or equal to 50 % of the 
average value of the OD-buffer control were classified as negative.  
Routine bacteriological culture on bronchoalveolar lavage fluid 
For bacteriological examination, 10 microliters (µl) of BAL fluid collected at necropsy (D35/36) of each pig was 
inoculated on Columbia agar supplemented with 5% sheep blood (Oxoid, Hampshire, UK) with a Staphylococcus 
pseudintermedius streak (Villarreal et al., 2011). Plates were incubated for 48 h in a 5% CO2-enriched environment 
at 35 °C for identification of respiratory bacteria in the lungs. All macroscopically different colonies were 
identified to the species level (score value >2.000) with a Bruker Daltonic Microflex LT Biotyper Biotyper 
MALDI-TOF mass spectrometer by using the direct transfer method and α-cyano-4-hydroxycinnamic acid 
(HCCA) as matrix, according to the manufacturer’s guidelines. The spectra were obtained and analysed with the 
MBT Compass software version 3.1. (Bruker Daltonik), which included a database of 6,903 mean spectra 
projections.  
Statistical analyses 
The independent variable in the statistical analyses was ‘group’: NCG, DON, DONMHYO and MHYO-group. 
The dependent variables were RDS, weight, ADG, MLL, histopathology and percentage of air, qPCR-results, 
percentage of M. hyopneumoniae qPCR-positive samples, M. hyopneumoniae specific AB expressed in OD values and 
percentage of ELISA M. hyopneumoniae positive samples. These variables were all run in separate models with ‘pig’ 
as statistical unit and no additional factors included into the model. The normality of the data was investigated by 
means of descriptive statistics, except for the binary data (M. hyopneumoniae qPCR positive samples and ELISA M. 
hyopneumoniae positive samples). The parameters BW, ADG and percentage air analysis were normally distributed 
and a one-way analysis of variance (ANOVA) test was used. In case of the RDS, a repeated measures ANOVA 
was performed. Scheffé’s post-hoc test was used to make pair-wise comparisons. The qPCR-results and M. 
hyopneumoniae specific antibodies were not normally distributed and therefore, a non-parametric Kruskal-Wallis 
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test was used, with the Dunn-Bonferroni approach to make pair-wised comparisons, as well for MLL and 
histopathology results. In case of the normally distributed data, the mean and standard deviation (SD) were 
reported, in case of the non-parametric data, the median and the interquartile range were reported. All analyses 
for these parameters were performed with SPSS 23 for Windows (SPSS inc. Illinois, USA). Percentage of 
seropositive pigs and percentage of pigs testing positive with qPCR in each group were analyzed using binomial 
logistic regression (R version 3.3.1) (Team, 2016). The results were considered to be statistically significant when 
P<0.05.  
Results 
Clinical and performance parameters 
In none of the groups, feed refusals or vomiting were observed. No tachypnea, nor dyspnea were observed in 
any of the groups. Post-weaning diarrhoea was observed from D0 onwards until D3 in all groups, therefore all 
pigs were treated IM with Colistin sulphate (Colivet ‘S’, Prodivet, Eynatten, Belgium) from D0 onwards for 5 
days, according to the product leaflet. The post weaning diarrhoea lasted until D8, D3, D3 and D7 in NCG, 
DON, DONMHYO and MHYO respectively. In three groups some pigs with faecal consistency score 3 were 
noticed throughout the study: in NCG two pigs at D20 and D23 respectively, in DON one pig at D13 and in 
DONMHYO two pigs at D20 and D23, respectively. In MHYO, normal faecal consistency was observed 
throughout the study. Coughing was not observed in the NCG. All results of the different time periods for this 
parameter in the study are shown in table 2 (RDS 1-7, RDS 8-35 and RDS 1-35). The RDS from the first inoculation 
day onwards until euthanasia (RDS 8-35) were 0.00 ± 0.00, 0.0071 ± 0.028, 1.04 ± 0.82,, 1.14 ± 0.92 for NCG, 
DON, DONMHYO and MHYO, respectively (P<0.001). No statistically significant differences were obtained 
between all groups for D1-7. For D8-35 and D1-35 a statistically significant difference was obtained between the 
experimentally infected (DONMHYO and MHYO) and non-infected pigs (NCG and DON) (P<0.001). 
However, no statistically significant differences were obtained for DONMHYO and MHYO groups in each time 
period of the study (table 2). The daily course of RDS 1-35 for each group is shown in figure 1. 
There were no significant differences between the groups for the parameter BW and the ADG during the 
different time periods (table 2).  
Macroscopic and histopathologic lung lesions 
The MLL of the NCG, DON, DONMHYO and MHYO groups were 0.00 ± 0.00, 0.00 ± 0.00, 2.77 ± 3.22 and 
5.87 ± 7.32, respectively (P<0.001). The histopathological lung lesions were 1.70 ± 0.20, 2.00 ± 0.30, 2.40 ± 0.80 
and 2.40 ± 0.90 for the NCG, DON, DONMHYO and MHYO group, respectively (P<0.001). The percentage 
of air was 45.94 ± 6.54, 46.85 ±6.86, 49.75 ± 9.90 and 46.96 ± 8.51 for NCG, DON, DONMHYO and MHYO, 
respectively (P=0.25). There were no statistically significant differences between the DONMHYO and MHYO 
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the experimentally infected (DONMHYO and MHYO) and non-infected pigs (NCG and DON) (P<0.001), 
except for the parameter percentage of air analysis (P=0.25) (table 2).  
Quantitative PCR for Mycoplasma hyopneumoniae 
The samples of the NCG and DON group remained negative throughout the study. The qPCR results at D21 
were 0.049 ± 0.37, 0.63 ± 0.81, 3.92 ± 2.60 and 3.24 ± 1.91 (P<0.001) and at D35/36 0.80 ± 0.70, 0.29 ± 1.09, 
4.05 ± 1.38 and 4.20 ± 1.00 (P<0.001) for NCG, DON, DONMHYO and MHYO, respectively. There were no 
significant differences between the DONMHYO and MHYO group, however there were statistically significant 
differences between the experimentally infected (DONMHYO and MHYO) and non-infected pigs (NCG and 
DON) (P<0.001) for D21 and D35/36 (table 3). 
Serology 
The serological results are presented in table 3. All pigs of the NCG and DON remained serologically negative 
throughout the study. The OD-values of the serological results at D35/36 were 1.15 ± 0.27, 1.16 ± 0.18, 0.25 ± 
0.18 and 0.23 ± 0.094 for the NCG, DON, DONMHYO and MHYO, respectively. At necropsy (D35/36), all 
pigs of DONMHYO and MHYO were serologically positive.  
Routine bacteriological culture on bronchoalveolar lavage fluid 
Few colonies of Streptococcus suis were isolated from one pig of both the DONMHYO (1/15) and MHYO (1/15) 
groups. In addition, few colonies of Bordetella bronchiseptica were isolated from one pig of DON (1/15) and four 
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Table 2. Results of the clinical parameters, macroscopical and microscopical lung lesions in the 
different experimental groups: 
Respiratory disease score (RDS), bodyweight, average daily weight gain (ADG), macroscopical lung lesions 
(MLL), histopathology score of the lungs and percentage of air in the lungs for NCG, DON group, 
DONMHYO group, MHYO group.  










RDS      




 0.0071 ± 0.028
a
 1.04 ± 0.82
b






 0.0057 ± 0.025
a
 0.83 ± 0.84
b
 0.91 ± 0.94
b
 <0.001 
Weight ± SD (kg)      
D0 6.37 ± 1.09 6.39 ± 0.92 6.38 ± 1.04 6.42 ± 1.23 1.00 
D8 7.70 ± 1.13 8.04 ± 1.27 8.20 ± 1.08 8.11 ± 1.90 0.92 
D35/36 20.10 ± 2.33 19.45 ± 3.83 21.02 ± 3.18 21.75 ± 4.36 0.38 
ADG (kg/pig/day)      
D0-8 0.52 ± 0.14 0.53 ± 0.190 0.56 ± 0.15 0.67 ± 0.17 0.12 
D0-35/36 0.39 ± 0.057 0.37 ± 0.11 0.41 ± 0.075 0.43 ± 0.098 0.41 
D8-35/36 0.46 ± 0.076 0.42 ± 0.13 0.46 ± 0.094 0.49 ± 0.10 0.37 
MLL, histopathology and 
percentage of air  D35/36 




 0.00 ± 0.00
a
 2.77 ± 3.22
b






 2.00 ± 0.30
a
 2.40 ± 0.80
b
 2.40 ± 0.90
b
 <0.001 
Percentage of air (%)  45.94 ± 6.54 46.85 ±6.86 49.75 ±9.90 46.96 ± 8.51 0.25 
 
The parameters bodyweight, ADG, percentage of air analysis were analysed by means of one way analysis of variance, the parameter RDS with a repeated 
measures analysis of variance, in both cases with Scheffé post-hoc test to make pair-wised comparisons, therefore means ± SD are reported. The parameter 
MLL and histopathology were analysed with Kruskal-Wallis test and the Dunn-Bonferroni approach to make pair-wised comparison, therefore medians 
and interquartile range are reported. Different superscripts in one row are statistically different (P<0.05). 
NCG: negative control group, DON: deoxynivalenol contaminated group, DONMHYO: deoxynivalenol contaminated +M. hyopneumoniae-inoculated 
group, MHYO: M. hyopneumoniae-inoculated group, SD: standard deviation 
n: number 
D=Day of the study 
ADG: average daily gain 
RDS: respiratory disease score  
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Fig. 1: Course of average respiratory disease score (RDS) from day 1 until the day of necropsy (D 35) 
Average RDS from D1 until D35 in the negative control group (NCG), the DON-contaminated group (DON), 
DON-contaminated and M. hyopneumoniae-inoculated group (DONMHYO), and M. hyopneumoniae-inoculated 
group (MHYO). The challenge infections were performed on D8 (a highly virulent M. hyopneumoniae strain 
F7.2C) and D9 (a low virulent strain F1.12) in DONMHYO and MHYO. The NCG and DON were sham-
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Table 3: Results of Mycoplasma hyopneumoniae-DNA detection in the BALF and serology in the 
different experimental groups: 
qPCR-results (log copies of M. hyopneumoniae DNA/ml BALF), percentage of M. hyopneumoniae qPCR positive 
samples, M. hyopneumoniae specific antibodies expressed in OD-values, percentage of ELISA M. hyopneumoniae 
positive samples and routine bacteriological examination in BALF in the different groups NCG, DON group , 
DONMHYO group and MHYO group.  
Parameter Groups  
 NCG (n=5) DON (n=15) DONMHYO (n=15) MHYO (n=15) P-value 
qPCR (log copies of M. 
hyopneumoniae DNA /ml BALF) 
± SD 
     
D21 0.049 ± 0.37
a
 0.63 ± 0.81
a
 3.92 ± 2.60
b
 3.24 ± 1.91
b
 <0.001 
D35/36 0.80 ± 0.70
a
 0.29 ± 1.09
a
 4.05 ± 1.38
b
 4.20 ± 1.00
b
 <0.001 
Percentage of M. hyopneumoniae 
qPCR positive samples 
(n of positive samples/total n of 
samples tested) 
     


















M. hyopneumoniae specific AB 
expressed in OD-values ± SD 
     
D8 1.68 ± 0.23 1.83 ± 0.34 1.71 ± 0.19 1.70 ± 0.19 0.27 
D21 1.15 ± 0.22
a
 1.29 ± 0.23
a
 1.16 ± 0.36
ab
 0.94 ± 0.26
b
 0.001 
D35/36 1.15 ± 0.27
a
 1.16 ± 0.18
a
 0.25 ± 0.18
b
 0.23 ± 0.094
b
 <0.001 
Percentage of ELISA M. 
hyopneumoniae positive samples  
(n of positive samples/total n of 
samples tested) 
     
D8 (%) 0.00 (0/5) 0.00 (0/15) 0.00 (0/15) 0.00 (0/15) 1.00 
D21 (%) 0.00 (0/5) 0.00 (0/15) 0.00 (0/15) 13.33 (2/15) 0.17 









The parameter qPCR and M. hyopneumoniae specific AB were analysed with a non-parametric Kruskal-Wallis and the Dunn-Bonferroni approach to make 
pair-wised comparisons, therefore median and interquartile range are reported. The prevalence of M. hyopneumoniae qPCR positive samples and the 
prevalence of ELISA M. hyopneumoniae positive samples were analysed with binomial logistic regression. Different superscripts in one row are statistically 
different (P<0.05). 
NCG: negative control group, DON: deoxynivalenol contaminated group, DONMHYO: deoxynivalenol contaminated + M. hyopneumoniae-inoculated 
group, MHYO: M. hyopneumoniae-inoculated group 
Different superscripts in one row are statistically different (P<0.05) 
n: number 
SD: standard deviation 
D=Day of the study 
M. hyopneumoniae: Mycoplasma hyopneumoniae 
AB: antibodies 
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Discussion 
In the present study, the outcome of the main parameters (RDS, MLL, histopathological lesions and log copies 
of M. hyopneumoniae DNA in bronchoalveolar lavage fluid) was not statistically different in M. hyopneumoniae 
infected pigs that received or did not receive DON-contaminated feed. This indicates that ingestion of DON- 
and acetylated DON-contaminated feed at a concentration of 1,514 µg/kg, exceeding the maximum guidance 
level for pigs according to EU regulation, did not aggravate the severity of an experimental M. hyopneumoniae-
infection in weaned piglets.  
The challenge infection was successful as all animals in the M. hyopneumoniae inoculated groups (MHYO and 
DONMHYO group) coughed, showed lung lesions (except for one animal in the MHYO group), seroconverted 
and M. hyopneumoniae-DNA was detected in BAL fluid at necropsy. The results obtained in the M. hyopneumoniae 
challenged pigs (DONMHYO and MHYO group) differed significantly from the non-challenged pigs (DON 
group, NCG). The latter pigs remained serologically negative throughout the entire study period and no M. 
hyopneumoniae- DNA was detected in BAL fluid two weeks post-inoculation, nor at necropsy. The obtained data 
in the challenged groups were comparable with a study performed by our research group with the same challenge 
model (Chapter 3.4), demonstrating the repeatability of the model. The two M. hyopneumoniae-strains were not 
administered on the same day, as the infection model practiced at our research group uses seven ml inoculum 
containing 107 CCU of the strain/ml (Vicca et al., 2003). It is not known whether piglets of  four to five weeks 
of age (on average 26 days, D0 at arrival and inoculation at D8) are able to cope with twice the inoculum volume 
(14 ml for both strains). In addition, it is not known whether both strains will grow next to each other, or 
whether one strain will overgrow the other strain consuming most of the nutrients, when these M. hyopneumoniae 
strains are grown in the same culture flask. Consequently, it was decided to challenge the piglets on two 
consecutive days. 
In the present study, DON was aimed to be administered at two times the maximum guidance level of DON 
advised by the European commission for pigs (1,800 µg/kg feed) (Communities, 2006). This dose was selected 
as Madson et al. (Madson et al., 2014) stated that moderate (1,000-5,000 µg/kg feed) to high concentrations (> 
5,000 µg/kg feed) are associated with delayed or supressed immune responses due to leukocyte apoptosis and 
resulting in increased disease susceptibility (Madson et al., 2014; Pestka, 2008). It was demonstrated that a dose-
related decrease in daily feed intake is observed when administering DON-supplemented feed to pigs, and that 
this effect was mostly significant to the control feed in the range of 2,000 µg/kg – 4,000 µg/kg (Bergsjø et al., 
1992; Dänicke et al., 2004; Prelusky et al., 1994). Therefore, a dose below this range was chosen to be 
administered to the pigs in this study to limit feed refusals and to avoid hampering of DON possibly influencing 
the investigated parameters. The commercial, un-spiked feed was tested before the start of the study, not only 
for the presence of DON, but also for zearalenone and fumonisin B1+B2, to avoid these components having an 
effect in the feed of the control groups (MHYO group, NCG) and avoiding an additional or synergistic effect to 
the DON-toxicity in the DON-spiked groups (DON group, DONMHYO group) (Pestka, 2008). After 
preparation of the contaminated feed, a mixed feed sample from three DON-contaminated feed bags was 
submitted to LC-MS/MS to detect the DON-concentration and to ensure thorough mixing of the DON-
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inoculum in the feed. The results of the LC-MS/MS was 1,514 µg/kg of DON and acetylated forms and 
deviated only slightly from the target concentration of 1,800 µg/kg. Cytotoxicity of the produced DON in the 
study was not tested on beforehand, as the deleterious effects of DON in the pigs are known and the same 
DON inoculation method in pig feed was already successfully used in a study by Goossens et al., 2012. In the 
latter study, in the in vivo effect of DON on intestinal damage influencing the resorption of doxycycline was 
determined in pigs. 
It remains to be elucidated why no impact of DON and acetylated forms in the pigs was observed in the present 
study. One of those factors might be the degree of susceptibility of certain breeds/lines to the effects of DON 
(Eriksen and Pettersson, 2004). For instance a lower severity in porcine circovirus type 2 associated 
histopathological lesions has been shown for Piétrain compared to landrace pigs (Opriessnig et al., 2009), but so 
far no studies have assessed the impact of genetic differences in sensitivity to the effects of DON.  
No feed-refusals were observed in the pigs administered the DON-contaminated feed. The minimum emetic 
dose for orally distributed DON in pigs is 100 µg/kg (Pestka et al., 2007), yet vomiting was not observed in this 
study. The reason why this did not occur is unclear. It must be noted that the observation period of the pigs (30 
min. of RDS-scoring, 15 min. feeding and cleaning in the morning, 10 min. of observation and cleaning in the 
evening) was fairly short compared to the time the pigs spent in the facilities. However, the main researcher was 
always present after providing the feed to identify possible sick pigs, as most healthy pigs start eating immediately 
after providing the feed and Young et al., (Young et al., 1983) observed that vomiting occurs within minutes 
after ingesting the DON-contaminated feed. Pestka et al. (Pestka, 2007) stated that vomiting due to DON-
contaminated feed, is more likely if the feed is ingested at once and not via smaller portions throughout the day. 
The contaminated feed and hence the DON and DON-acetylated forms in the DONMHYO and DON pigs, 
was consumed throughout the day as the pigs were fed ad libitum and had freely access to the feed.  
The M. hyopneumoniae-infected pigs on the DON and DON-acetylated forms-supplemented feed did not have a 
higher RDS compared to the pigs only infected with M. hyopneumoniae. No other studies are available investigating 
the impact of DON on respiratory tract disease signs in M. hyopneumoniae-infected pigs. However the effect of 
fumonisin B1 in combination with M. hyopneumoniae or the effect of DON on other pathogens has been studied. 
Pósa et al., (2013) studied the effect of 20 000 µg/kg fumonisin B1 on M. hyopneumoniae-infected pigs, however 
no firm conclusions could be drawn regarding the difference in coughing between the M. hyopneumoniae-infected 
pigs with or without fumonisin B1 supplementation in the feed. Halloy et al. (2005) investigated the impact of 
fumonisin B1 administered orally (500 µg/kg BW per day, seven days) in P. multocida-infected pigs and concluded 
that these pigs coughed more compared to the pigs only infected with P. multocida.  
It is known that M. hyopneumoniae-infections can negatively influence production parameters, such as ADG 
(Thacker and Minion, 2012). Deoxynivalenol-ingestion in pigs may result in reduced feed intake, and 
subsequently decrease ADG (Eriksen and Pettersson, 2004; Friend et al., 1982; Trenholm et al., 1983). In the 
present study, DON and DON-acetylated forms did not decrease ADG in the M. hyopneumoniae inoculated 
animals. This result is in agreement with Accensi et al. (2006) (840 µg DON/kg feed), Gerez et al. (2015) (1,500 
µg DON/kg feed), and Savard et al. (2015b).The latter authors studied the impact of DON (2500 and 3,000 µg 





CHAPTER 3: FIELD AND EXPERIMENTAL STUDIES Ch. 3.3 
an effect of fumonisin B1 (20, 000 µg/kg) on ADG  in M. hyopneumoniae-infected pigs. Rotter et al. (Rotter et al., 
1994) observed an adaptation of  pigs to oral ingestion of Fusarium mycotoxins from one week onwards. In that 
study, pigs were fed a diet mixed with naturally contaminated corn (28,700 µg/kg DON, 8,600 µg/kg 15-ADON 
and1,100 µg/kg ZEA ) to obtain DON-concentrations of 750, 1,500 or 3,000 µg DON /kg feed during 28 days. 
During the first week, the exposed pigs had lower weight gains than the pigs fed a non-contaminated control 
feed. At the end of the study, however, the overall weight gains did not differ anymore between these groups. 
This adaptation might be one of the reasons why we did no see an effect of DON and acetylated forms on daily 
growth. The relative low number of pigs, followed up during a limited period of time, which is inherent in 
experimental infection studies like ours, also makes it difficult to obtain a statistical significant difference in daily 
growth (Arsenakis et al., 2016; Jensen et al., 2002; Vicca et al., 2003). No effect of DON and acetylated forms 
ingestion on the macroscopic and histopathological lung lesions was observed in the M. hyopneumoniae-infected 
group. This finding is in agreement with Pósa et al (2011) who neither saw a statistical difference in macroscopic 
lung lesions between the Bordetella bronchiseptica and Pasteurella multocida dually-infected groups with or without 
supplementation of fumonisin B1 in the feed (10,000 µg/kg) of three-day-old piglets. Savard et al. (2015) on the 
other hand, did observe an effect of DON-supplementation in the feed (3,500 µg/kg, three weeks) on 
macroscopic lung lesions in PRRSv-infected pigs (Eriksen et al., 2004). In this study, DON and acetylated forms-
ingestion did not influence the number of log copies detected in the M. hyopneumoniae-infected animals. Similarly, 
Savard et al. (Savard et al., 2015a) did not observe an effect of DON-contamination on the presence of viral 
RNA, measured with qPCR, in PRRSv-infected pigs. It is not clear why the obtained effects of dietary DON 
vary among experiments, it might be explained by different factors such as starting weight or age of the pigs, the 
contamination source of DON (natural versus artificial contamination), presence of other known or unknown 
undetected fungal metabolites or pathogens, duration of the study (adaptation), number of pigs used in the study, 
gender of the pigs, health status, nutritional balance of the pig and statistical design of the study (Dersjant-Li et 
al., 2003; Goyarts et al., 2005; Rotter et al., 1995). It is not known why DON and acetylated forms did not 
influence a M. hyopneumoniae-infection under the circumstances in this study. Deoxynivalenol has a good 
distribution in the lung of the pig (Prelusky and Trenholm, 1991). However, as M. hyopneumoniae is attached to the 
cilia of the upper respiratory tract and does not invade the parenchyma of the lung (Blanchard et al., 1992; Jaques 
et al., 1992; Maes et al., 2017), it might be that DON is not able to exert its effect on the pathogen. More 
research is needed to investigate this relationship in pigs, for instance by in vitro tests on pig tracheal explants. On 
the other hand discrepancies have been reported between in vivo (higher viremia in pigs exposed to DON in the 
feed ) and in vitro (decreased PRRSv replication in MARC-cells) effects of DON on PRRSv (Savard et al., 2015a; 
Savard et al., 2014), thus extrapolation of in vitro results to in vivo effects has to be done cautiously.  
Conclusions  
No effect was observed of DON contamination in a moderately high dose in the feed on the severity of an 
experimental M. hyopneumoniae-infection in weaned piglets. In the field, however, the impact of DON-
contaminated feed on a M. hyopneumoniae-infection might be more expressed, because mostly multi-mycotoxin 
contamination of the feed occurs (Antonissen et al. 2014; Opriessnig et al., 2009; Young et al., 1983; Pestka et al., 
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2007), the pigs can be exposed to DON-contaminated feed for a longer period than the five week exposure 
period in this study, often suboptimal housing and climate conditions may prevail and other pathogens may be 
present (Thacker et al., 2012; Friend, 1982). Further research should assess the impact of DON on M. 
hyopneumoniae infections under these multi-pathogen and multi-mycotoxins circumstances and investigating the 
impact of DON in vitro on M. hyopneumoniae in tracheal explant cells. More research could also focus on factors 
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Mycoplasma hyopneumoniae (M. hyopneumoniae) is the primary agent of enzootic pneumonia in pigs. Pigs are often 
infected with different M. hyopneumoniae strains. This study assessed the efficacy of vaccination against 
experimental infection with two genetically different M. hyopneumoniae strains in weaned piglets. At 33 days of age 
(D0), 45 M. hyopneumoniae-free piglets were randomly assigned to three different groups: 1) negative control 
group (NCG; n=5): not vaccinated, not infected, 2) positive control group (PCG; n=20): not vaccinated, 
infected, and 3) vaccination group (VG; n=20): single vaccination with an inactivated whole-cell M. hyopneumoniae 
vaccine (Hyogen®, Ceva) (D1), infected. The PCG and VG were endotracheally inoculated with 7 x 107 CCU in 
7 ml of the highly virulent M. hyopneumoniae strain F7.2C (D24) and 7 x 107 CCU in 7 ml low virulent strain 
F1.12A (D25). A respiratory disease score (RDS) was assessed from D24 until D53. At D53 (euthanasia), 
macroscopic lung lesions (MLL) were scored,  log copies of M. hyopneumoniae DNA (qPCR)  and IL-1β  and IL-6-
concentrations (ELISA) on bronchoalveolar lavage fluid were determined  
The RDS and MLL at euthanasia were respectively 0, 1.20 and 0.55 (P<0.001) and 0, 7.56 and 0.68 (P<0.001) for 
NCG, PCG and VG, respectively. The qPCR results for PCG and VG were 3.99 and 1.78 log copies (P<0.001), 
respectively, with a significant difference between PCG and VG. The IL-1β  and IL-6 results at euthanasia for 
NCG, PCG and VG were 17.61, 1283.39 and 53.04 pg/ml (P<0.001) and 148.10, 493.35 and 259.80 pg/ml 
(P=0.004), respectively with a significant difference between PCG and VG.  
Vaccination with Hyogen® in pigs was efficacious against an experimental challenge with both a low and highly 
virulent M. hyopneumoniae strain as the vaccinated pigs coughed significantly less, and showed significantly less 
lung lesions compared to the non-vaccinated challenged pigs: the vaccinated animals showed a 52.9 % lower 
RDS and 91.0 % lower MLL compared to the PCG. In the bronchoalveolar lavage fluid collected at the necropsy 
of the vaccinated pigs, a significantly lower amount of M. hyopneumoniae-DNA and a significantly lower IL-1β  
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Introduction 
Mycoplasma hyopneumoniae (M. hyopneumoniae) is the causative agent of enzootic pneumonia (Maes et al., 2008). The 
disease has a worldwide impact on intensive swine production and causes substantial losses due to reduced 
growth of the pigs, poor feed conversion ratio, higher antimicrobial use and increased susceptibility to secondary 
respiratory agents (Maes et al., 1999; Maes et al., 2008; Villarreal et al., 2011b). Previous research has shown that 
most pigs are infected with more than one M. hyopneumoniae strain (Vranckx et al., 2011; Vranckx et al., 2012a), 
and in chapter 3.1 it was showed that a higher severity and prevalence of Mycoplasma-like lung lesions was found  
in batches of slaughter pigs with detection of more than one M. hyopneumoniae strain. It is generally accepted  that 
control of M. hyopneumoniae is critical for reducing economic losses in infected swine operations (Pointon et al., 
1985). This is achieved by optimizing housing conditions, management practices, antimicrobial therapy and 
vaccination against M. hyopneumoniae (Haesebrouck et al., 2004). It is estimated that 70 percent of swine herds are 
practising vaccination against M. hyopneumoniae worldwide (Martelli et al., 2014). Vaccination reduces clinical 
signs, lung lesions and improves performance, although colonization is not prevented and there is no significant 
reduction in transmission (Haesebrouck et al., 2004; Jensen et al., 2002; Kyriakis et al., 2001; Meyns et al., 2006; 
Villarreal et al., 2011b). The benefits obtained through vaccination can vary from herd to herd (Martelli et al., 
2006). Most commercially available bacterin vaccines are based on an adjuvanted whole-cell preparation of an 
inactivated M. hyopneumoniae strain (Haesebrouck et al., 2004). This strain is mostly the J-strain of M. 
hyopneumoniae, which was isolated in 1958 (Goodwin and Whittlestone, 1963; Marchioro et al., 2013b). Recently a 
commercial bacterin became available, using M. hyopneumoniae strain 2940, isolated in the 1999’s from a farm in 
the United States facing a severe outbreak of enzootic pneumonia. Also, most vaccination studies so far used 
one single strain for experimental infection. As most pigs are infected with more than one M. hyopneumoniae strain 
(Chapter 3.1; Vranckx et al., 2011; Vranckx et al., 2012a), it may be more appropriate to challenge the pigs with 
different M. hyopneumoniae strains.  
The aim of the present study was to determine the efficacy of a commercial vaccine (Hyogen®) against an 
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Material and methods 
Study animals and Experimental design 
The study was performed after approval by the Ethical Committee for Animal Experiments of the Faculty of 
Veterinary Medicine, Ghent University (approval number EC2014/165). Forty-five M. hyopneumoniae-free 
Rattrelow-Seghers (RA-SE Genetics NV, Ooigem, Belgium) piglets were enrolled in the study. The herd of 
origin has been free of M. hyopneumoniae for many years based on repeated serological testing, absence of clinical 
signs and pneumonia lesions, and nPCR testing on tracheobronchial swabs. The piglets were free of following 
pathogens as well: porcine reproductive and respiratory syndrome virus, Pasteurella multocida and Actinobacillus 
pleuropneumoniae. The piglets were weaned at 28 days of age and moved to the experimental facilities of the 
Faculty of Veterinary Medicine, Ghent University, Belgium. They were housed in experimental chambers with 
absolute filters (HEPA U15) and were fed ad libitum using a non- antimicrobial supplemented diet. At 33 days of 
age (D0), the piglets were randomly allocated to three different groups (D0): 1) negative control group (NCG; 
n=5): not vaccinated, not infected, 2) positive control group (PCG; n=20): not vaccinated, infected, and 3) 
vaccination group (VG; n=20): single vaccination with a one- dose commercial vaccine (Hyogen®, D1, CEVA 
Santé Animale, Libourne Cedex, France), infected. 
Hyogen® is a whole-cell bacterin based on strain BA 2940-99, oil adjuvanted with paraffin and Escherichia coli J5 
LPS with thiomersal as excipient. The animals of the VG were intramuscularly vaccinated with two ml of the 
commercial vaccine. The animals of the PCG and NCG were injected intramuscularly with two ml of phosphate-
buffered saline (PBS) on D1.  
Mycoplasma hyopneumoniae strains and challenge infection 
The highly virulent F7.2C and the low virulent M. hyopneumoniae strain F1.12A were used for challenge infection 
(Vicca et al., 2003). The pigs were anesthesized with 0.22 ml/kg of a mixture of Zoletil 100® (Virbac, Louvain la 
Neuve, Belgium) and Xyl-M® 2% (VMD, Arendonk, Belgium). The pigs of the PCG and VG were 
endotracheally inoculated with 7 x107 CCU in 7 ml inoculum of strain F7.2C at D24 and with 7 x107 CCU in 7 
ml inoculum of strain F1.12A at D25. Pigs of the NCG were endotracheally inoculated with 7 ml sterile culture 
medium (Friis medium) at D24 and D25. At four weeks post-inoculation (PI) (D53), all piglets were euthanized. 
Therefore, deep anaesthesia was applied by intramuscularly administrating 0.3 ml/kg of a mixture of Zoletil 100® 
(Virbac, Louvain la Neuve, Belgium) and Xyl-M® 2% (VMD, Arendonk, Belgium), followed by exsanguination.  
Clinical and performance parameters 
The piglets were observed for at least half an hour daily from D0 until D53. Body condition, appetite, manure 
consistence, and presence of dyspnea or tachypnea were evaluated. A respiratory disease score (RDS) was 
recorded daily by the same person at eight a.m. from D1 until D53 and could range from 0-6 with 0 (no 
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encouraged move), 4 (moderate coughing in rest), 5 (severe coughing after encouraged move), 6 (severe 
coughing in rest) (Halbur et al., 1996). The daily RDS values were averaged for the following periods: D1- D23, 
D24– D53, D1-D53. All pigs were weighed (g) at D0, the day of the first inoculation (D24) and the day of 
euthanasia (D53), to calculate the anesthesia dose discussed above. The average daily gain (ADG) (g/pig/d) from 
day 0-24, 24-53 and from day 0-53 was calculated according to Del Pozo Sacristán et al. (2014)(Del Pozo 
Sacristán et al., 2014) by subtracting the starting weights from the final weights divided by the number of days 
during the respective periods. 
Macroscopic and histopathologic lung lesions 
The lungs were collected and scored for macroscopic lung lesions (MLL) (0-35) according to Hannan et al. 
(1982) (Hannan et al., 1982). Samples from the right apical, cardiac and diaphragmatic lung lobe were collected. 
If lesions were present, the samples were collected from the border of a lesion. Samples were fixated in 10% 
neutral formalin and processed and embedded in paraffin for histopathological examination. The samples were 
stained with hematoxylin and eosin and scored using light microscopy according to the degree of peribronchiolar 
and perivascular lymphohistiocytic infiltration and nodule formation (cuffing) (Morris et al., 1995). The scoring 
system ranged from 1-5 with 1) limited infiltration of macrophages and lymphocytes around bronchioles, with 
airways and alveolar spaces free of cellular exudates; score 2) light to moderate infiltrates with mild diffuse 
cellular exudates into airways; score 3, score 4 and score 5 [respectively mild (score 3), moderate (score 4) and 
severe (score 5)] lesions characteristic of broncho-interstitial pneumonia, centered around bronchioles but 
extending to the interstitium, with lymphofollicular infiltration and mixed inflammatory cell exudates. Scores 1 
and 2 are considered not to be related with M. hyopneumoniae infection, while scores 3 to 5 are presumptive of a 
M. hyopneumoniae infection. The percentage of lung area occupied by air (percentage air) was examined by means 
of an automated image analysis system (Leica application suite AF Lite (Diegem, Belgium) and image J 
(Bethesda, Maryland, USA)) (Rasband, 1997-2016). This parameter is inversely proportional to the 
lymphohistiocytic infiltration in the lung tissue and the intrabronchiolar-and bronchial exudate. 
Quantitative PCR for Mycoplasma hyopneumoniae 
Bronchoalveolar lavage fluid was collected from all animals two weeks PI (D39) by inserting a catheter (Portex® 
Dog Catheter with Female Luer Mount, Smiths Medical International Ltd. Kent, United Kingdom) in the trachea 
by means of a mouth gag and whilst snaring the pigs. Next, the lungs were flushed with 20 mL sterile PBS to 
collect the bronchoalveolar lavage fluid. Additionally, during necropsy (D53), bronchoalveolar fluid was collected 
from the left part of the lung before collection of the histopathological samples by flushing the head bronchus of 
the left part of the lung with 20 mL sterile PBS. The bronchoalveolar lavage fluid was divided into seven aliquots 
and stored at -70°C awaiting analysis. From one aliquot of the bronchoalveolar lavage samples, DNA was 
extracted with the QIAGEN protocol (QIAGEN, DNeasy Blood & Tissue kit, Belgium) and quantitative PCR 
(qPCR) was performed as previously described to detect the numbers of M. hyopneumoniae organisms (Marois et 
al., 2010). A tenfold dilution series of M. hyopneumoniae DNA of strain F7.2C was used to convert the threshold 
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values to the number of M. hyopneumoniae organisms. Values below the dilution of 1.50x101 (1.18 log copies) were 
considered as negative.  
Immunological parameters on bronchoalveolar lavage fluid 
M. hyopneumoniae- specific antibodies in bronchoalveolar lavage fluid 
The isotype of M. hyopneumoniae-specific antibodies in bronchoalveolar lavage fluid collected at D39 and D53 was 
determined via an indirect ELISA (expressed in optical density “OD”-values) according to the protocol of 
Bereiter et al. (Bereiter et al., 1990; Marchioro et al., 2013a). Briefly, a Nunc Maxisorp® flat-bottom 96 well plate 
(eBioscience, Vienna, Austria) was coated with Tween® 20 extracted M. hyopneumoniae antigens on which the 
bronchoalveolar lavage fluid (D39, D53) was added, undiluted. Peroxidase labeled goat anti-porcine IgA or IgG 
polyclonal antibodies (Bethyl Laboratories, Texas, TX, USA) were added and the OD at 450 nm was measured.  
Cytokines in bronchoalveolar lavage fluid 
The bronchoalveolar lavage fluid collected at D39 and D53 was tested undiluted for presence of porcine TNF-α 
(TNF-α Swine Antibody Pair, Invitrogen), IL-1β  (Porcine IL-1 beta/IL-1F2 DuoSet, R&D Systems) and IL-6 
(Porcine IL-6 DuoSet, R&D Systems). A sandwich ELISA was performed according to the manufacturers’ 
recommendations. The sample reactions were measured using OD at 450 nm and quantified by the use of a 
standard curve as described in the manual. 
Serology 
At D1, D24 and at euthanasia (D53), blood was collected from all pigs and tested for the presence of antibodies 
against M. hyopneumoniae with a blocking ELISA (IDEIA™ Mycoplasma hyopneumoniae EIA kit, Oxoid Limited, 
Hampshire, UK), according to the protocol manual. The blood samples were stored at 4°C for a maximum of 24 
hours. Subsequently the blood was centrifuged at 2000 rpm for 30 minutes and the serum was collected. The 
serum was stored at -70°C until analysis. Sera with optical density < 50% of the average value of the OD-
buffercontrol were considered to be positive. All values above or equal to 50 % of the average value of the OD-
buffercontrol were classified as negative.  
Routine bacteriological culture and bronchoalveolar lavage fluid 
For the bacteriological examination, ten µL of bronchoalveolar lavage fluid collected on D53 of each pig was 
inoculated on Columbia agar supplemented with 5% sheep blood (Oxoid, Hampshire, UK) with a Staphylococcus 
pseudintermedius streak (Villarreal et al., 2011a). Plates were incubated overnight in a 5% CO2-enriched 
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Statistical analyses 
Descriptive statistics were performed in order to check the normality of the data. One-way analysis of variance 
(ANOVA) was used to analyse weight and ADG. Repeated measurements ANOVA was performed to analyze 
the RDS data. Scheffé’s post hoc test was used to make pairwise group comparisons. The parameters MLL, 
histopathological lesions, percentage air analysis, ELISA M. hyopneumoniae, TNF-α, IL-1β, IL-6, Ig A, Ig G and 
qPCR results were analyzed using  a non-parametric Kruskal-Wallis, as the data did not fulfil the assumptions of 
normality. Theses analyses were performed with SPSS 22 for Windows (SPSS inc. Illinois, USA). Percentage of 
seropositive pigs and percentage of pigs testing positive with qPCR in each group were analyzed using binomial 
logistic regression (R version 3.3.1) (Team, 2016). Results were considered to be statistically significant when 
P<0.05.  
Results 
No animals died during or shortly after the inoculations. One out of 45 piglets in the NCG was euthanized 
(D22) (Release®300 mg/ml, WDT, Garbsen, Germany) due to nervous symptoms and lateral decubitus. 
Necropsy was performed and H. parasuis was isolated in pure culture from the meninges and pericardium. All 
animals in the PCG coughed, showed macroscopic lung lesions and seroconverted. Mycoplasma hyopneumoniae-
DNA was detected in 19 out of 20 animals from this group. 
Clinical and performance parameters 
The results of the clinical parameters are summarized in table 1. There was no coughing in the NCG throughout 
the study. The RDS24-53 was 1.20 ± 0.83 and 0.55 ± 0.42 for the PCG and VG (P<0.001), respectively. This 
corresponds with a reduction of 52.9% in RDS when vaccinating the piglets compared to the PCG. All groups 
significantly differed from each other. These analyses and the RDS 1-53 and RDS 1-23 results are shown in table 1 
and figure 1. 
The average group weight at D0, D24 and D53 and the ADG calculated during these three periods (0-24, 24-53 
and 0-53 days of age) for each group are shown in table 1. 
Macroscopic and histopathologic lung lesions 
There were no macroscopic lung lesions in the NCG. The MLL of the PCG and VG was 7.56 ± 4.73 and 0.68 ± 
0.73, respectively (P<0.001) (Table 1). A reduction of 91.0% in MLL of the VG was observed compared to the 
PCG. The histopathological lung lesion scoring in the NCG, PCG and VG was 1.31 ± 0.18, 3.32 ± 0.85 and 1.92 
± 0.47 (P<0.001), respectively. The percentage of lung area occupied by air (percentage air) was 47.72 ± 7.29, 
34.49 ± 8.22 and 45.23 ± 5.99 % for the NCG, PCG and VG (P<0.001), respectively. For the MLL and 
percentage of air analysis, the PCG was significantly different from the VG and NCG. For the histopathology 
score, all groups significantly differed from each other (Table 1). 
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Quantitative PCR for detection of Mycoplasma hyopneumoniae DNA 
The samples of the NCG remained negative throughout the study. The number of  log copies of M. 
hyopneumoniae detected in the bronchoalveolar lavage fluid with qPCR in the PCG and VG were: 3.99 ± 1.20 
(PCG) and 1.78±1.36 (VG) (P<0.001) at D53 (Table 1). The results of D39 and the percentage of animals that 
tested positive by qPCR are also shown in table 1. 
 
Fig. 1: Average respiratory disease score (RDS) during the trial for the negative control group (NCG), 
positive control group (PCG) and vaccination group (VG) 
The average RDS was assessed daily from day 1 until day 53. The piglets were vaccinated at D1 and the 
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Table 1: Results of different parameters in the different experimental groups: the respiratory disease score 
(RDS), body weight, average daily gain (ADG), M. hyopneumoniae specific antibodies, macroscopical lung lesions 
(MLL), histopathology and air analysis, log copies of M. hyopneumoniae DNA (qPCR), percentage of of M. 
hyopneumoniae qPCR positive samples, M. hyopneumoniae specific AB expressed in OD-values and Percentage of 
ELISA M. hyopneumoniae positive samples  
Parameter Experimental Groups 
 NCG (#=5) PCG (#=20) VG (#=20) P-value 
RDS     
D1-53 0 ± 0 a 0.68 ± 0.41 b 0.32 ± 0.86 c <0.001 
D1-23 0 ± 0 a 0 ± 0 a 0.017 ± 0.060 a 0.983 
D24-53 0 ± 0 a 1.20 ± 0.83 b 0.55 ± 0.42 c <0.001 
Weight ± SD     
D0 7.04 ± 1.22a 6.97 ± 0.84 a 7.04 ± 1.02 a 0.966 
D24 15.25 ± 3.96 a 16.39 ± 2.16 a 15.61 ± 2.96 a 0.581 
D53 36.51 ± 8.63 a 34.63 ± 6.63 a 34.27 ± 5.35 a 0.808 
ADG (g/pig/d)     
D0-24 357 ± 123 a 393 ± 62.8 a 357 ± 92.0 a 0.372 
D24-53 733 ± 194 a 629 ± 199 a 643 ± 102 a 0.504 
D0-53 563 ± 144 a 522 ± 121 a 514 ± 87.0 a 0.714 
MLL, histopathology and air analysis D53     
MLL 0 ± 0 a 7.56 ± 4.73 b 0.68 ± 0.73 a <0.001 
Histopathology 1.31 ± 0.18 a 3.32 ± 0.85 b 1.92 ± 0.47 c <0.001 
Percentage of air (%) 47.72 ± 7.29 a 34.49 ± 8.22 b 45.23 ± 5.99 a <0.001 
log copies of M. hyopneumoniae DNA/ml BALF 
(qPCR) ± SD 
    
D39 0.36 ± 0.64 a 1.81 ± 1.32 a 1.23 ± 1.61 a 0.062 
D53 0.40 ± 0.43 a 3.99 ± 1.20 b 1.78 ± 1.36 a <0.001 
Percentage of M. hyopneumoniae qPCR positive 
samples in BALF 
(#positive samples/total number of samples) 
    
D39 (0/4) 0a (14/20) 70b (7/20) 35c <0.01 
D53 (0/4) 0a (19/20) 95b (12/20) 60c <0.001 
M. hyopneumoniae specific AB expressed in OD-
values ± SD in serum 
    
D1 1.51 ± 0.037 a 1.48 ± 0.058 a 1.48 ± 0.16 a 0.578 
D24 0.91 ± 0.044 a 0.95 ± 0.069 a 0.50 ± 0.17 b <0.001 
D53 0.90 ± 0.10 a 0.23 ± 0.11 a 0.087 ± 0.041 b <0.001 
Percentage of ELISA M. hyopneumoniae positive 
samples in serum 
    
D1 (0/5) 0a (0/20) 0a (0/20) 0a 1.000 
D24 (0/4) 0a (0/20) 0a (15/20) 75b <0.001 
D53 (0/4) 0a (20/20) 100b (20/20)100b <0.001 
Different superscripts a, b, c in one row are statistically different (P<0.05) 
NCG: negative control group, PCG: positive control group, VG: vaccination group, SD: standard deviation, D=Day of the study, ADG: average daily gain, 
kg: kilogram, RDS: respiratory disease score, M. hyopneumoniae: Mycoplasma hyopneumoniae 
AB: antibodies, OD: optical densities, #: number, MLL: macroscopic lung lesions, qPCR: quantitative polymerase chain reaction, DNA: DeoxyriboNucleic 
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Immunological parameters on bronchoalveolar lavage fluid 
All results of the immunological parameters on D39 and D53 are summarized in table 2 . 
Table 2: Immunological parameters measured in the BALF at D39 and D53 
Parameter Experimental groups 
 NCG (#=5) PCG (#=20) VG (#=20) P-value 
Ig G ± SD (OD-values)     
D39 0±0 a 0.069±0.14 a 0.31±0.65 a 0.366 
D53 0.38±0.17 a 2.25±0.91 b 2.41±0.88 b 0.005 
Ig A ± SD (OD-values)     
D39 0±0 a 0.067±0.18 a 0.55±0.99 a 0.359 
D53 0.18±0.14 a 2.10±0.75 b 2.08±0.58 b 0.005 
TNF-α ± SD (pg/ml)     
D39 23.61±1.74 a 18.56±4.40 a 21.12±4.56 a 0.029 
D53 16.03±1.10 a 14.53±5.95 a 15.15±2.40 a 0.065 
IL-1β  ± SD (pg/ml)     
D39 32.47±1.77 a 239.63±511.35 a 247.13±606.71 a 0.367 
D53 17.61±1.98 a 1283.39±1075.65 b 53.04±54.23 a <0.001 
IL-6 ± SD  (pg/ml)     
D39 130.33±18.65 ab 242.24±122.23 a 164.64±84.48 b 0.03 
D53 148.10±8.89 a 493.35±494.70 b 259.80±333.38 a 0.004 
D39: two weeks after challenge 
D53: necropsy 
Different superscripts a, b, ab in one row are statistically different (P<0.05) 
NCG: negative control group, PCG: positive control group, VG: vaccination group 
SD: standard deviation 
D=Day of the study 
OD: optical densities 
#: number 
Detection of M. hyopneumoniae- specific antibodies in bronchoalveolar lavage fluid 
There were no significant differences in the Ig G and Ig A results between the three groups at D39 (Table 2).  
At D53, the Ig G values were 0.38 ± 0.17, 2.25 ± 0.91 and 2.41 ± 0.88 for the NCG, PCG and VG, respectively 
(P=0.005). At D53, the results for Ig A were 0.18 ± 0.14, 2.10 ± 0.75, 2.08 ± 0.58 for the NCG, PCG and VG, 
respectively (P=0.005). Both the Ig G and Ig A concentrations at D53 of the PCG and VG differed significantly 
from the NCG. 
Detection of cytokines in bronchoalveolar lavage fluid 
The TNF-α, IL-1β  and IL-6 results at D39 and D53 are shown  in table 2. There were no significant differences 
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At D53, the IL-1β  concentration in the bronchoalveolar lavage fluid was 17.61 ± 1.98, 1283.39 ± 1075.65 and 
53.04 ± 54.23 pg/ml in the NCG, PCG and VG, respectively (P<0.001).  
At D39, the  IL-6 concentration was significantly different between the PCG and VG (Table 2). At D53, the IL-
6 concentration was  148.10 ± 8.89, 493.35 ± 494.70 and 259.80 ± 333.38 for the NCG, PCG and VG, 
respectively (P=0.004) with significantly higher concentrations in the PCG compared to the NCG and VG. 
Serology 
The serological results are presented in Table 1. All pigs of the NCG remained serologically negative throughout 
the study (D1-D53) and at necropsy (D53) all pigs of the PCG and VG were serologically positive for M. 
hyopneumoniae. The OD values at D53 were 0.90 ± 0.10, 0.23 ± 0.11 and 0.087 ± 0.041 in the NCG, PCG and 
VG, respectively (P<0.001). In the VG significantly lower OD-values were detected, thus higher M. hyopneumoniae 
specific antibodies compared to the PCG and NCG. (Table 1). 
Bacteriological culture 
Streptococcus suis was isolated in only one pig of the PCG. No relevant bacterial growth was observed in all other 









This study showed that the vaccine was efficacious for the most part against an experimental challenge with both 
a low and highly virulent M. hyopneumoniae strain. The vaccinated pigs coughed significantly less, showed 
significantly less lung lesions, a significantly lower number of log copies in the bronchoalveolar fluid at 
euthanasia was shown and the IL-1β and IL-6 concentrations at euthanasia were lower compared to the non-
vaccinated inoculated pigs.  
The challenge infection was performed with two genetically different (Stakenborg et al., 2005) M. hyopneumoniae 
isolates. The virulence of these strains was evaluated by Vicca et al. (2003) and both strains were characterised at 
proteomic and genomic level by Calus et al. (2007), Vranckx et al. (2011) and Stakenborg et al. (Stakenborg et al., 
2006), respectively. The double challenge infection model was successful as all animals in the PCG showed lung 
lesions, coughed and seroconverted. In 19 out of 20 animals of the PCG at euthanasia, DNA of M. hyopneumoniae 
was detected in the bronchoalveolar lavage fluid. It is well known that there can be quite some variation between 
pigs in terms of responses to an experimental infection. Why this particular pig tested negative is not known. 
Possibly, the conditions for multiplication of the M. hyopneumoniae strains were not optimal in that pig. Although 
bronchoalveolar fluid is an appropriate sampling technique to detect M. hyopneumoniae during the early stages of 
infection, it fails to recover some positive animals in case of chronic infection (Bandrick et al., 2014). Taken 
these factors into consideration, this might be the reason why, although the pig was challenged, it did not test 
positive. Although comparing to other experimental settings should be done with caution, clinical symptoms and 
lung lesions were comparable or more severe than the single F7.2C challenge model performed in our research 
group (Arsenakis et al., 2016; Del Pozo Sacristán et al., 2012; Marchioro et al., 2014; Marchioro et al., 2013a; 
Meyns et al., 2006; Meyns et al., 2007; Meyns et al., 2004; Vicca et al., 2005; Vicca et al., 2003; Villarreal et al., 
2009; Villarreal et al., 2011; Vranckx et al., 2012b) and the standard deviation was lower (Arsenakis et al., 2016; 
Del Pozo Sacristán et al., 2012; Marchioro et al., 2014; Vicca et al., 2003; Villarreal et al., 2009; Vranckx et al., 
2012b). It was shown that most pigs in the field are simultaneously infected with two or sometimes three 
genetically different M. hyopneumoniae strains and that when batches of slaughter pigs are infected with more than 
one M. hyopneumoniae strain, this can result in more (severe) pneumonia lesions and fissures (Chapter 3.1). The 
current experimental setting might therefore better resemble the field situation than infection with a single strain. 
Finally, it was shown that anesthetizing and inoculating the piglets with seven ml of inoculum on two 
consecutive days is feasible, as none of the piglets showed adverse reactions or died during or shortly after the 
inoculations. 
The pigs in the vaccinated group coughed significantly less (-53%) from inoculation until euthanasia compared to 
the positive control group, demonstrating the efficacy of the vaccine. The degree of coughing is an important 
efficacy parameter (Baskerville, 1972; Sarradell et al., 2003) not only under experimental but also under field 
conditions. A coughing index can be used  to estimate if a higher  prevalence of enzootic pneumonia in a herd 
might be present (Nathues et al., 2012) and to determine the most optimal timing of serological sampling of the 
pigs or collecting bronchoalveolar fluid to be tested with PCR (Leon et al., 2001; Nathues et al., 2012). In this 
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in the VG grew slightly faster compared to the PCG from day of inoculation until day of euthanasia onwards. 
Although the parameter weight and ADG are of great use to be evaluated under field circumstances, in 
experimental trials they are merely of descriptive value as the low number of animals used, the duration of the 
trial and the sometimes high standard deviations are the reason why only numerical differences are found 
(Arsenakis et al., 2016; Jensen et al., 2002; Vicca et al., 2003). 
The MLL score in the vaccinated pigs was very low (0.68) and statistically different from the PCG (7.56), 
implying a reduction with 91%, and demonstrating the efficacy of the vaccine. A recent field study showed that 
when pigs are infected with more strains, more lung lesions are detected (Chapter 3.1). When comparing the 
MLL scores from the double inoculated challenge in PCG with those from challenged unvaccinated pigs in the 
single inoculation model from previous studies (highest MLL was 6.69 for F7.2C challenge in Villarreal et al., 
(Villarreal et al., 2011a), higher MLL in this study are obtained. However, comparing different experimental 
settings, should be done with caution. To make a true comparison, the resulting MLL from the double infection 
model should be compared with the single inoculation model from both strains F7.2C and F1.12A in one 
experimental setting. 
In the vaccinated animals significantly less lymphohistiocytic infiltration (1.92) was observed compared to the 
PCG (3.32). These results are in accordance with the results of previous studies (Arsenakis et al., 2016; 
Marchioro et al., 2014; Villarreal et al., 2011a). Although many aspects of the effect of vaccination on the 
immunological response remain unclear (Thacker et al., 2000b), the present results confirm that vaccination has a 
regulating function on the immune system, causing less infiltration of macrophages in the lung tissue (Vranckx et 
al., 2012). A significantly lower area occupied by air or air percentage was measured in the non-vaccinated 
animals of PCG (34.49%) compared to VG (45.23%). Infection with M. hyopneumoniae results in intrabronchiolar- 
and bronchial exudate and infiltration of lymphohistiocytic cells in the lung tissue. These responses may result in 
compressing the airways and alveoli, leading to less air volume in the lungs (Marchioro et al., 2013b). Vaccination 
also significantly reduced the log copies of M. hyopneumoniae DNA compared to the non-vaccinated animals (1.78 
versus 3.99), which may lead to less shedding of M. hyopneumoniae in vaccinated pigs. Similar reductions were 
found in previous studies (Vranckx et al., 2012b) (Woolley et al., 2014). These results, although very promising, 
confirm once more that vaccination is not able to prevent pigs from being colonized as commonly known 
(Haesebrouck et al., 2004).  
Mycoplasma hyopneumoniae-specific antibody (IgG and IgA) levels in tracheo-bronchial washings were not 
significantly different between vaccinated and non-vaccinated pigs. Our findings are in accordance with 
Djordevic et al. (1997) (Djordjevic et al., 1997; Marchioro et al., 2013a), but Thacker et al. (2000) suggested that 
secretion of M. hyopneumoniae- antibodies induced by vaccination into the bronchoalveolar washings might be 
implied in resolving mycoplasmal pneumonia (Thacker et al., 2000a; Thacker et al., 2000b; Thacker et al., 2000c). 
Further research is needed to clarify a possible protective role of  M. hyopneumoniae-specific antibodies in trachea-
bronchial washings. 
There were no significant differences between the vaccinated and non-vaccinated animals for the TNF-α 
concentration in the bronchoalveolar fluids. In the study of Marchioro et al. (Marchioro et al., 2013a), 
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vaccination significantly decreased TNF-α concentrations, but the difference was small and only borderline 
significant. This highlights the need to further elucidate the pathogenesis of M. hyopneumoniae and the exact 
mechanisms in which way M. hyopneumoniae-bacterins provide protection to the animal. 
The cytokines IL-1β and IL-6, next to TNF-α are pro-inflammatory cytokines (Yang et al., 2004). Previous 
research stated that they mediate lymphocyte infiltration and activation in the pneumonic lung  (Ahn et al., 2009; 
Van Reeth et al., 2002), and thus are associated with the induction of pneumonia lesions (Asai et al., 1993; 
Marchioro et al., 2013a; Rodríguez et al., 2004). The pro-inflammatory cytokines TNF-α, IL-1β and IL-6 were 
correlated with MLL at D39 and D53. TNF-α was weakly and not significantly correlated with MLL on both 
sampling days (D39 and D53). Interleukin-1ß was strongly and significantly correlated with MLL at euthanasia, 
and IL-6 was moderately and significantly correlated with MLL on D39 and D53 (data not shown). Vaccinating 
the M. hyopneumoniae infected pigs, resulted in a lower infection level in these vaccinated pigs, a lower production 
of pro-inflammatory cytokines IL-1ß and IL-6 (but not TNF-α), and subsequently less damage in the lung. The 
IL-1β concentration and the standard deviation in the non- vaccinated pigs was very high. This result is in 
accordance with the result of Meyns et al. (2007) at 28 days post inoculation with the F7.2C isolate. One can 
conclude that a part of the piglets in the non- vaccinated group showed very high IL-1β levels. The reason why 
this occurred is not clear, however the individual susceptibility of the pig to an M. hyopneumoniae-infection must 
be kept into account causing  the challenge infection to be more successful. The IL-1β and IL-6 concentrations 
at necropsy in the vaccinated pigs were significantly lower than in the non-vaccinated pigs and not significantly 
different from the levels in negative control group. These results substantiate the statement that was made in 
Marchioro et al. (2013a) based on the IL-1β result of the vaccinated pigs at D36 that IL-1β and IL-6 may have a 
regulatory role upon M. hyopneumoniae vaccination. 
In this study, the pigs were vaccinated approximately 4 weeks before challenge, as vaccination is most likely to be 
effective if active immunity is established before the piglets are exposed to the pathogen. Under field conditions, 
however, the time between vaccination and infection is not known, and very likely highly variable between pigs. 
Hence, it is possible that the vaccine used in the field is less efficacious when the timing of vaccination is not 
optimal. As this is an experimental study, the results cannot be extrapolated as such to field conditions. Under 
field circumstances, more factors challenging the efficacy of a vaccine are present, compared to the controlled 
environment of an experimental facility. First, multi-factorial and multi-pathogen enzootic pneumonia outbreaks 
are typically found in the field, rather than isolated M. hyopneumoniae outbreaks (Maes et al., 1999).  The piglets 
originated from a herd free of important diseases which can influence the outcome of an M. hyopneumoniae 
infection, such as PRRSv Pasteurella multocida, and Actinobacillus pleuropneumoniae (Maes et al., 2008; Sibila et al., 
2009; Steenhard et al., 2009) and according to some authors infection with certain pathogens can determine the 
effectiveness of M. hyopneumoniae vaccination as well (Martinod, 1996; Steenhard et al., 2009; Stevenson, 1998). 
Second, the impact of weaning stress should be taken into account when vaccinating piglets at weaning age in the 
field. Although the impact of weaning stress on vaccine efficacy might not be clear (Arsenakis et al., 2016), it 
could not have influenced the efficacy of the vaccine, as the pigs were transported and vaccinated some days 
after weaning. Thirdly, passively acquired maternal derived immunity could not have influenced the efficacy of 
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hyopneumoniae in the sows, nor the piglets were performed. This is a double sided given. On the one hand, 
Hodgins et al. (Hodgins et al., 2004) stated that maternal antibodies in the piglets were associated with reduced 
antibody responses to vaccination. On the other hand, the piglets in the study could not benefit from the 
passively transferred cell-mediated immunity. Bandrick et al. (Bandrick et al., 2014) showed that vaccination of 
piglets against M. hyopneumoniae in the face of antigen-specific maternal-derived immunity results in cell-mediated 
immunity priming and anamnestic cell-mediated immunity responses following the exposure to M. hyopneumoniae 
antigen. On the other hand, some factors in the experimental study were comparable to field circumstances or 
challenged the vaccine more. First, although the piglets were free from certain pathogens, other than that, the 
piglets originated from a conventional farm. Second: the piglets were transported from the herd of origin to the 
experimental facilities and the piglets needed to establish a new hierarchy after comingling. These events are 
associated with stress, which might influence the efficacy of the vaccine. This can resemble the stress that piglets 
experience in the field, when sorted and moved from one facility to another in a multi-site production system. 
Thirdly: the vaccine was highly challenged in this experimental study, because as stated by Villarreal et al. (2009) 
and Meyns et al. (2004), it can be assumed that the M. hyopneumoniae challenge dose used to infect the pigs was 
higher than might be reached under natural conditions resulting in a faster and higher colonization level and 
presumably challenging the vaccine more than under field circumstances. Although extrapolation of the efficacy 
testing of the vaccine results obtained in experimentally M. hyopneumoniae infected pigs should be done with 
caution, this infection model enabled to study the effect of the vaccine in M. hyopneumoniae infected pigs in a 
reproducible and standardized way. 
Conclusions 
Using a double challenge infection model with a low and highly virulent M. hyopneumoniae strain, one-dose 
vaccination of piglets was clinically efficacious, as coughing was reduced by more  than 50% and macroscopical 
lung lesions by 91%. In addition, the lymphohistiocytic infiltration in lung tissue was lower, the number of log 
copies of M. hyopneumoniae DNA detected in bronchoalveolar lavage fluid and the IL-1β and IL-6 concentrations 
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GENERAL DISCUSSION 
Mycoplasma hyopneumoniae is the primary agent involved in enzootic pneumonia and plays a key role in the porcine 
respiratory disease complex as well. The pathogen is considered to be a leading cause of economic losses to 
swine producers worldwide (Thacker and Minion, 2012). Many factors involved in the clinical course of the 
disease and the economic losses, are known. These factors are management practices, interactions with other 
both viral and bacterial respiratory agents (Opriessnig et al., 2011), antimicrobial treatment and vaccination (Maes 
et al., 2008). The impact of other factors such as  M. hyopneumoniae strain diversity, indoor pollutants components 
and, mycotoxins in the feed was less clear at the start of this PhD. The objective of this thesis was to investigate 
several of these less studied factors. In addition, as the search to control the disease continues, new vaccines 
against M. hyopneumoniae are being developed. Therefore, one chapter focussed on the efficacy of a new bacterin 
on a challenge infection with M. hyopneumoniae.  
In this present chapter, the results and implications of the different studies will be discussed, general conclusions 
will be presented and perspectives for further research will be provided. 
4.1. Mycoplasma hyopneumoniae diversity 
4.1.1. Portraying the diversity of Mycoplasma hyopneumoniae in slaughter pigs 
from Flemish pig farms 
Numerous reports regarding M. hyopneumoniae genetic diversity have been described, however no agreement has 
been obtained between different studies regarding the presence of a limited number or a higher number of M. 
hyopneumoniae strains at herd level (Burgher Pulgarón et al., 2015; Charlebois et al., 2014; Dos Santos et al., 2015; 
Marois-Créhan et al., 2012; Mayor et al., 2007; Nathues et al., 2011; Pantoja et al., 2016; Takeuti et al., 2017; 
Tamiozzo et al., 2015; Vranckx et al., 2011; Vranckx et al., 2012b). On top of that, most research focusses on 
displaying a snapshot of the present M. hyopneumoniae strains within a herd at a certain time point. Only one 
report investigates repeated samplings from the same farms. In that study, from a limited number of farms three 
slaughter batches within the same farm were investigated (Vranckx et al., 2011). It was found that the same 
strains persisted in two out of three herds. However, in one herd this was not the case and two different strains 
were detected at the next two slaughter points. It was interesting to explore this more in depth in a higher 
number of farms. Therefore, M. hyopneumoniae diversity from three slaughter batches originating from ten farms 
was studied in chapter 3.1.  
In chapter 3.1, we demonstrated that M. hyopneumoniae strains are highly diverse. Out of the 495 nPCR positive 
BALF samples, 135 different M. hyopneumoniae strains were obtained in the entire dataset. The average number of 
different strains per batch was seven with a minimum of one and a maximum of 13. At herd level on average 14 
different M. hyopneumoniae strains with a minimum of 6 and a maximum of 23 were detected. In each batch of 
each herd new strain introductions were observed compared to the previous batches: on average 4.6 (ranging 
from 2-8) new strains were detected when batch 2 was compared with batch 1 and on average 2.7 (ranging from 
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1-5) new strain introductions were detected when comparing batch 3 with the previous two batches in each herd. 
The possible reason why a much higher diversity of M. hyopneumoniae was observed in our study compared to the 
above mentioned studies will be explained in the following section.  
Extrapolation of M. hyopneumoniae diversity results from non-endemically M. hyopneumoniae to endemically infected 
pig populations such as in Belgium should be done with caution. Lower M. hyopneumoniae circulation will most 
probably result in a lower M. hyopneumoniae diversity. It might be expected that when infection pressure is low, M. 
hyopneumoniae strains are pressurised less on using genetic diversity as a tool to escape the immunity of the host. 
Mayor et al. (2007) concluded that a single strain was responsible for an outbreak of enzootic pneumonia when 
investigating multiple samples from different farms. All field samples however originated from Switzerland, a 
region where M. hyopneumoniae was eradicated and only sporadic reinfections occur (Hege et al., 2002; Nathues et 
al., 2011). In the study of Nathues et al. (2011) it was concluded that herds and pigs were colonised with 
different M. hyopneumoniae strains. These results were obtained in North Western Germany, a region endemically 
infected with M. hyopneumoniae with a similar pig density compared to Belgium (grosse Beilage et al., 2009) and 
were more comparable with the results obtained in chapter 3.1 of the current thesis.  
In general the more regions of the genome are investigated, the higher the chance to detect differences between 
M. hyopneumoniae strains. Indeed, in the studies of Mayor et al. (2007), Pantoja et al. (2016) and Takeuti et al. 
(2017), respectively one, two and two VNTR’s were examined, while in our study four VNTR’s were examined. 
On the other hand, in the study of Vranckx et al. (2011; 2012b) four VNTR regions were examined, and a lower 
diversity was observed compared to our results. Therefore other factors such as herd characteristics might be 
involved in finding a higher diversity in M. hyopneumoniae strains. 
In Takeuti et al. (2017), where a lower M. hyopneumoniae diversity was observed in the herds compared to our 
findings, two of the three herds did not purchase any gilts, the third farm did purchase gilts, but they had a M. 
hyopneumoniae negative status. In Vranckx et al. (2011) a higher frequency of purchasing gilts was indeed suggested 
to be involved in the higher diversity seen in one of the three herds. In the study in chapter 3.1, more than half 
of the farms purchased breeding gilts on a regular basis, which may have influenced the number of M. 
hyopneumoniae strains entering the farms. The stocking density of piglets in the nursery may be important as well, 
as a higher stocking density might result in a higher transmission of M. hyopneumoniae (Stärk, 2000). In Vranckx et 
al. (2012) the stocking density in the nursery was 0.3 m2/animal. In the study in chapter 3.1, half of the farms had 
a stocking density lower than 0.3 m2/animal, which may have influenced the higher diversity detected in this 
study. 
Vranckx et al al. (2011) suggested that all-in/all-out-management practices might be involved as well in the 
occurrence of a higher M. hyopneumoniae strain diversity. In the study of Vranckx et al., (2012b) all herds were 
practicing an all-in/all-out -management in the nursery and finishing units. In the study of chapter 3.1 all farms 
except one practised all-in/all-out however in the finishing units, four out of ten farms did not. This might as 
well be one of the plausible factors why a higher M. hyopneumoniae diversity was encountered in our study. 
Vaccination of the piglets against M. hyopneumoniae might be of importance as well. The decision not to vaccinate 
against M. hyopneumoniae can be made because there is a low infection level and there are no M. hyopneumoniae-
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prevent entrance of new M. hyopneumoniae strains resulting in less circulation. As at least 70% of the herds are 
implementing vaccination against M. hyopneumoniae (Maes et al., 2008), our study aimed to investigate diversity in 
farms vaccinating their piglets against M. hyopneumoniae, while in the study of Vranckx et al. (2011; 2012b) farms 
were selected based on not vaccinating the piglets against M. hyopneumoniae. Hypothetically, farms that are 
vaccinating their piglets may pressurize M. hyopneumoniae to develop a higher genetic diversity, directly or 
indirectly influencing effects at the antigenic level. Antigenic variation is thought to help the bacterium to persist 
in its host by evading the immune response (Assunção et al., 2005; de Castro et al., 2006). On the other hand less 
variation may as well be a consequence. In farms where strains are present which are closely related to the 
vaccine strain, vaccination might suppress these strains, which might result in a lower degree of diversity. Clearly, 
the effect of vaccination on genetic and antigenic diversity of M. hyopneumoniae strains remains to be elucidated 
(Simionatto et al., 2013) and further research is necessary, e.g. by examining the diversity in vaccinated and non-
vaccinated batches within a herd.  
Other herd and batch factors, and most probably a combination of these factors, might have influenced the high 
diversity seen in the farms in the study in chapter 3.1. For studying the possible impact of the number of 
circulating M. hyopneumoniae strains per batch on the presence and severity of lung lesions, we also collected data 
on herd characteristics considered to be risk factors affecting the severity of respiratory disease in general. This 
was done to correct for confounding factors. However no direct associations were studied between these herd 
characteristics and the M. hyopneumoniae diversity at herd level as this was not the main objective of the study. 
More research is thus needed to clarify these factors. 
In general, most studies showing a rather limited M. hyopneumoniae diversity at herd level, examined a limited 
number of herds (three or four) (Pantoja et al., 2016; Takeuti et al., 2017; Vranckx et al., 2011; Vranckx et al., 
2012b). A high M. hyopneumoniae diversity was observed when ≥ 5 herds were examined: 109 herds (Nathues et 
al., 2011), 48 herds (Charlebois et al., 2014), 5 herds (Burgher Pulgarón et al., 2015) and in the chapter 3.1 ten 
herds. The reason for this finding is unclear. Most probably, when investigating a higher number of herds, more 
pigs from different origins are investigated and the probability to detect different M. hyopneumoniae is higher.  
In the study in chapter 3.1 we demonstrated that in 102 lungs two different M. hyopneumoniae strains were 
detected. This corroborated previous results of Vranckx et al., (2011) and Nathues et al. (2011). In our study, in 
lung washings from six pigs, three different strains were detected. To date MLVA is able to detect up to at least 
three strains in one sample provided that the difference in concentration between the strains in the sample is less 
than tenfold (Vranckx et al., 2011). However, it is possible that even more M. hyopneumoniae strains might have 
been present within one pig.  
4.1.2. Impact of the genetic diversity of Mycoplasma hyopneumoniae on the 
severity and prevalence of lung lesions 
A possible link between the presence of multiple subsequent or simultaneous infections with different M. 
hyopneumoniae strains and the presence or severity of M. hyopneumoniae-like lesions had been suggested before the 
start of this thesis (Villarreal et al., 2009; Vranckx et al., 2011). However, Charlebois et al. (2014) could not 
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confirm this, when looking at individual lung level. Many herd characteristics possibly influencing the severity 
and/or prevalence of lung lesions were included into the statistical model in the study in chapter 3.1. The results 
in chapter 3.1 showed that the prevalence and severity of M. hyopneumoniae-like lesions were higher when batches 
of pigs were infected with different M. hyopneumoniae strains. The exact mechanisms leading to this phenomenon 
remains to be elucidated. For instance different strains might stimulate the immune system of the host to a 
different extent, resulting in a prolonged inflammatory reaction. However, in order to solve this question, more 
insight in the pathogenesis and potential virulence factors of M. hyopneumoniae would be helpful.  
4.1.3. Use of MLVA in the field 
The VNTR (Variable Number of Tandem Repeat) typing appeared to be very useful to assess strain diversity of 
M. hyopneumoniae in BALF collected from slaughter lungs. Previous studies reported that the technique was also 
useful to investigate the molecular epidemiology of M. hyopneumoniae outbreaks (Dos Santos et al., 2015; Mayor et 
al., 2007). The VNTR technique is relatively inexpensive compared for instance to next generation sequencing, 
although the costs depend on the numbers of VNTR amplified. No prior isolation of the M. hyopneumoniae strains 
is required, which makes the technique more accessible for laboratories not specialised in M. hyopneumoniae 
isolation. The multiplex PCR is easy to perform, but the gel or capillary electrophoresis and especially the 
interpretation of the obtained electropherograms require specialised knowledge. The latter is most probably the 
reason why to date the technique is not available as a routine diagnostic tool. The most suitable samples to 
perform MLVA are tracheobronchial swabs or BALF from live animals. In dead animals, lung washings at the 
main bronchi, are also suitable. Although nasal swabs are easy to obtain, they are considered less suitable for 
MLVA. They might contain too many inhibiting factors and the detection limit of MLVA is 100 M. hyopneumoniae 
organisms per µl DNA extract (Vranckx et al., 2012a; Vranckx et al., 2011; Vranckx et al., 2012b). It is well 
known that higher amounts of M. hyopneumoniae-DNA are detected closer to the M. hyopneumoniae multiplication 
sites namely the trachea-bronchial sites compared to the nasal cavities (Fablet et al., 2010).  
The results in chapter 3.1 imply that external biosecurity measures to avoid introduction of new strains in the 
herd are important to reduce the severity and the prevalence of the M. hyopneumoniae lesions. Purchase of gilts or 
weaned pigs from multiple sources, proximity of other pig herds or contact with pig transport to the slaughter 
house, especially multiple source pig transport are some points of attention that can be raised. Internal 
biosecurity measures, such as not mixing pigs from different ages combined with high stocking densities are 
important as well, as it is possible that M. hyopneumoniae strains from one group of pigs can be transmitted to 
another group of pigs, within the same herd. 
4.2. Impact of PM10 and NH3 on lung lesions and production parameters in 
finishing pigs 
Mycoplasma hyopneumoniae, PM and NH3 might impair the function of the mucociliary clearance apparatus in a 
synergistic manner, resulting in a defect of the first line defence mechanism of the respiratory tract (Gonyou et 
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and adaptive immune response (Miyata et al., 2011). In intensive pig production systems, pigs are chronically 
exposed to environmental stressors (Done, 1991). However, no long-term studies determining the simultaneous 
impact of PM and NH3 on production parameters and respiratory health in finishing pigs were available at the 
start of this PhD. In addition, no agreement in existing literature on the separate effects of PM or NH3 on these 
parameters was obtained. Therefore the study in chapter 3.2 assessed the simultaneous influence of PM10 and 
NH3 on production parameters and respiratory health from entrance of the pigs into the finishing unit until 
slaughter.  
In the study in chapter 3.2 the focus was on the main aerial pollutants PM10 and NH3. PM2.5 and PM1 were 
measured as well during the study and associated with the outcome variables in this chapter. However these 
results were not included in the manuscript as no significant results were obtained.  
4.2.1. Measured concentration of PM10 and NH3 in the finishing unit 
The average PM10 and NH3 concentrations for the entire finishing period in both replicates in chapter 3.2 
determined in one farm were 2,230 µg/m3 (ranging from 1,707-3,280 µg/m3) and 28.2 ppm (ranging from 17.2 -
38.2 ppm), respectively. Previous studies which also measured PM and/or NH3 concentrations in finishing pigs 
are scarce. According to Takai et al. (1998), mean total PM in various sections of swine facilities in different 
countries was 2,190 µg/m3  and in Van Ransbeeck et al. (2013b) under Flemish conditions concentrations ranged 
from 22 to 2288 µg/m3. Explanations for the higher concentrations measured in our study might be that our PM 
measurements were determined at animal height in finishing pigs only, while in the study of Takai et al., (1998) 
the average value was obtained through sampling at different sampling points (at animal height, at human head 
height and at the ventilation exhaust) and different age categories were measured (sows, weaners and fatteners) in 
both studies. In our study the measurement equipment was placed inside the central pen in the facility with pigs 
inside, while in the study by Van Ransbeeck et al., (2013b), this was not the case. An empty pen was used to 
place the cage with the measurement equipment inside. In another study of Van Ransbeeck et al., (2013a), NH3 
was measured in finishing pig stables. The average NH3 concentration for conventional and low emission stables 
were 18.7 and 16.3 ppm, respectively. These values were lower compared to the average NH3 values obtained for 
the entire finishing period of both replicates in our study. The reason why much higher PM10 and NH3 
concentrations were measured in the study in chapter 3.2 compared to the study of Van Ransbeeck et al. (2013a; 
2013b) are unclear. The farm in our study had a higher number of finishing places, possibly resulting in a higher 
aerial pollutant concentration, as a strong correlation exists between animals/m3 airspace and concentrations of 
airborne bacteria (Cargill et al., 2002; Wathes, 1994). No other information, such as type of feed or hygiene level 
in the different farms in the study by Van Ransbeeck et al. (2013a) was provided to possibly explain the lower 
aerial pollutant concentrations compared to our farm. Other factors which might have played a role in the high 
PM10 and NH3 concentrations in the farm in chapter 3.2 were a high stocking density, especially towards the end 
of the finishing period. Two other factors, a quick disintegration of the feed pellets caused by bad quality and 
automated feed delivery system implied in becoming airborne of particulates might also be taken into 
consideration (Aarnink and Ellen, 2007). Wet floors caused by a too short stand empty period causing the pigs to 
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dung on the solid floor and not on the slatted floors and bad pen hygiene related or not to the former are 
involved in NH3 formation as manure and faeces on solid floor parts will increase NH3 concentration (Aarnink 
and Ellen, 2007; Banhazi et al., 2008a; Banhazi et al., 2008b; Cargill et al., 1998; Cargill et al., 2002; Li et al., 1993; 
Wenger, 1999). Some of these factors implied in the formation of PM and/or NH3 are not easily changed, for 
instance the stand empty period in a four week batch production system, and the automated feed delivery 
system. The quality of the pellets is another factor which may be difficult to influence by the farmer..  
Nevertheless, it can be concluded that the PM10 and NH3 concentrations were above average in this farm. 
Therefore it was interesting to investigate whether they exerted an effect on production and health parameters in 
the pigs. 
4.2.2. Impact of PM10 and NH3 on production and respiratory health parameters 
in grower-finisher pigs 
No significant impact was demonstrated of PM10 and NH3 on ADG and mortality. This finding is in line with 
the results of Van ‘t Klooster et al., (1993), Janssens and Feddes (1995), and Takai et al., (1995). In Carpenter and 
Moulsley (1986) it was stated that if PM alone is considered, it is capable of affecting the performance only at 
very high levels, commonly not encountered in practice (300 mg/m3). The association of PM10 and NH3 with 
ADG in the study in chapter 3.2, was borderline not significant (P=0.08 for both associations). Therefore it may 
be concluded that under the circumstances of the study in chapter 3.2, PM even in combination with NH3 is not 
able to affect ADG. On the other hand, it may be possible that under unfavourable conditions in the field such 
as other (respiratory) infections next to M. hyopneumoniae-infections, added on top of the adverse stable climate, 
an effect on daily weight gain or other performance factors will be noticeable. Further research may enlighten the 
outcome of these complicated interactions. 
The findings in chapter 3.2 indicate that PM10, especially in the second half of the finishing period influenced the 
prevalence and severity of pneumonia. This might make sense as lesions which may have occurred by exposure 
to aerial pollutants in the first part of the finishing period might have been resolved already at the timing of 
slaughter. In general, Mycoplasma-like lesions are reported to be healed after twelve weeks (Sørensen et al., 1997) 
and upon healing, fissures appear and may remain for a period of twelve weeks as well (Kobish et al., 1993; Van 
Alstine, 2012). Associating the PM10 and NH3 concentrations with the prevalence of fissures was performed to 
determine the impact of these aerial pollutants on the M. hyopneumoniae lesions occurring earlier in the finishing 
period, but no significant associations were obtained. Another option to assess the association of aerial pollutants 
with early M. hyopneumoniae lesions was euthanizing pigs in earlier stages throughout the finishing period and 
associate the priory measured PM10 and NH3 concentrations with lung lesions at timing of necropsy. This was 
not performed as it requires to sacrifice healthy pigs. The NH3 concentrations seemed to influence the 
prevalence and severity of pneumonia to a lesser extent than the PM10 concentrations. A hypothesis might be 
that PM is more toxic compared to NH3 alone. Next to exerting its own damage to the respiratory tract 
described before, PM is also able to adsorb NH3 on its porous surface (Cai et al., 2006). In that way NH3 is not 
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where it can cause more damage (Curtis et al., 1975; Wenger, 1999). Both PM10 and NH3 measured in the second 
half of the finishing period and during the entire finishing period were significantly associated with the 
prevalence of pleurisy. When observing the multivariable associations, the only remaining significant association 
was PM10 with prevalence of pleurisy. The entrance in the respiratory tract of pathogens causing pleurisy lesions 
such as A. pleuropneumoniae, H. parasuis, M. hyorhinis and P. multocida (Enøe et al., 2002), may have been facilitated 
by PM10 influencing the function of the mucociliary apparatus. This is merely hypothetical, as no diagnostics for 
pathogens, other than M. hyopneumoniae were performed in our study. Pleurisy is an uncommon lesion in 
Mycoplasma hyopneumoniae-infections, although it has been reported (Falk and Lium, 1991; Ross, 1992). Other 
associations which had a tendency to be significantly associated were the PM10 concentrations measured during 
the entire finishing period and NH3 concentrations during the second half of the finishing period with the 
prevalence of M. hyopneumoniae positive nPCR results. Again, the high PM10 burden in the pig facilities in the 
study, as demonstrated by our measurements and by comparing our results with other research, might have 
favoured M. hyopneumoniae circulation. Although it could be possible to conduct a study with a higher sample size 
or include more replicates to investigate these trends further, such a study will have practical implications in 
terms of feasibility. 
4.2.3. Practical implications for the herd veterinarian 
In those farms where vaccination against M. hyopneumoniae infections is applied, but which still experience major 
problems with M. hyopneumoniae, it might be valuable before pointing towards the efficacy of the used vaccine, to 
evaluate the stable climate, next to evaluating other factors already discussed in the introduction of this thesis. 
User friendly, low maintenance and long-term monitoring of air quality is possible with data loggers for 
temperature, relative humidity and certain gasses (CO, CO2 and NH3,…), however it is questionable whether all 
data loggers, especially in the cheaper price range will continue to function properly under the harsh conditions 
in a pig facility. For PM measurements, the devices are not suitable to measure continuously in a pig facility and 
require too much maintenance to be used for a continuous monitoring of indoor air quality by farmer or herd 
veterinarian (clogging of the air pump, changing of the filter daily,…). The intensive measuring strategy used in 
chapter 3.2 might even not be necessary for the herd veterinarian to obtain an idea of the concentrations of aerial 
pollutants during the finishing period. Van Ransbeeck et al. (2012) observed that the best measuring strategy for 
a finishing stable is to obtain PM concentrations of four to five equally distributed sampling periods of 48 h. 
during the finishing period. For NH3 two measurement periods in the first half of the finishing period and two in 
the second half of the finishing period are sufficient. This allows the reconstruction of the evolution of PM and 
NH3 concentrations of the entire finishing period without losing important data characteristics. Advices directed 
to the farmer on actions to reduce the PM and NH3 concentration in the stable are revised in Aarnink and Ellen 
(2007) and Ulens et al., (2015).  
From the study it can be concluded that PM10, especially high concentrations in the second half of the finishing 
period, might affect the severity and prevalence of pneumonia lesions, the prevalence of pleurisy and the M. 
hyopneumoniae circulation towards the end of the finishing period. 
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4.3. Impact of Deoxinivalenol on a Mycoplasma hyopneumoniae infection 
Antonissen et al. (2014) indicated a knowledge gap regarding the interactions between mycotoxins and infectious 
diseases. To the best of our knowledge, no studies were available investigating the impact of DON in-feed on M. 
hyopneumoniae infections at the start of this PhD. Part of the thesis therefore focused on investigating the impact 
of DON on a M. hyopneumoniae-infection, as it is likely that pigs under commercial husbandry circumstances are 
simultaneously exposed to both health hazards during their life course. 
4.3.1. Deoxynivalenol- concentration administered to the pigs 
The concentration of DON detected in feedstuffs and feed worldwide is mostly in the lower to moderate 
concentration range (Placinta et al., 1999; Rodrigues and Naehrer, 2012a; Streit et al., 2012). In 535 corn samples 
and 436 wheat/bran samples originating from Central-Europe, the average DON-concentrations of the positive 
samples were 1,421 µg/kg and 1,534 µg/kg, respectively (Rodrigues and Naehrer, 2012b). The level of 1,800 
µg/kg in chapter 3.3 was chosen based on exceeding the maximum guidance no-effect level for feed intake in 
pigs according to EU regulation (900 µg/kg) and the report of Madson et al., (2014) in which it was stated that 
delayed or suppressed immune responses might be visible from 1,000 µg/kg onwards. It was chosen not to 
exceed 2,000 µg/kg-4,000 µg/kg, as a dose-related decrease in daily feed intake is observed from these 
concentrations onwards (Bergsjø et al., 1992; Dänicke et al., 2004; Prelusky et al., 1994).  
4.3.2. Impact of Deoxynivalenol on the pigs and possible factors influencing 
Deoxynivalenol to exert its function 
The DON inoculation procedure of the feed was already successfully used in pigs in a study of Goossens et al. 
(2012) where it was investigated if DON affects the oral bioavailability of frequently used antibiotics in pigs. 
Before the start of the study, no in vitro studies were performed to examine the possible effect of DON on M. 
hyopneumoniae. A study using tracheal explants and DON influencing the attachment of M. hyopneumoniae could be 
considered, as attachment is the first step in causing disease. On the other hand, M. hyopneumoniae is localised 
superficially at the cilia of the upper respiratory tract. Although it is known that DON may reach the lung in pigs, 
the mycotoxin might not reach that site of the respiratory tract. From the point of view of immune modulation, 
DON could also affect the pathogenesis of M. hyopneumoniae, which is very interesting as it is known that M. 
hyopneumoniae is able to modulate the innate and adaptive immune response. However, as the pathogenesis of M. 
hyopneumoniae is not yet fully elucidated, this would be difficult to test in vitro, also because M. hyopneumoniae grows 
very slowly.  
The DON inoculation medium in the feed in our study was thoroughly mixed, as evidenced by the measured 
DON concentration (1,514 µg/kg) which only slightly deviated from the target DON concentration after the 
mixing procedure. Another approach would have been to house the pigs separately and add the DON-inoculated 
feed in an individual manner daily. This would ensure that each pig ingested the same amount of feed and thus 
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HEPA-filtered units in the research facility are limited, and follow up of each pig would have been more 
laborious to perform, compared to the study design we performed. This would have minimised the number of 
animals used in the study decreasing the statistical power of the study to detect significant differences between 
groups.  
Possible explanations why no visible effect of the DON administration to the pigs was noticed in our study will 
be discussed in following sections.  
The level from when onwards clinical effects of DON are visible might depend on the pigs used in the study. 
There is a need to investigate the influence of age of the pigs on the effects of DON and possibly adapt the EU 
guidance value according to the age group (piglets, nursery pigs, growers, finishers, adults). Weanling mice are 
more prone to the effects of DON compared to adult mice (Pestka, 2008). The reports, in which age and the 
effects of DON in pigs are compared are scarce. Tiemann and Dänicke (2007) observed that prepuberal gilts 
react more sensitively to DON-contaminated diet compared to pregnant sows. For instance, histopathological 
changes such as glycogen decrease and interlobular collagen uptake were only observed in prepuberal gilts. Other 
factors may also influence the clinical outcome of consuming DON-contaminated feed such as 
gender/hormonal status, health status, nutritional balance, genetics or combinations of these factors (Dersjant-Li 
et al., 2003).  
An adaptive response or tolerance to the effects of DON in pigs has been observed after DON-administration 
of one week. However, no further explanation is given for this observed effect, other than the possible rapid 
clearance of DON from the body of the pigs (Foster et al., 1986; Friend et al., 1986; Pollmann et al., 1985). As 
the pigs in the study in chapter 3.3 were fed the DON-contaminated feed for five weeks, it is a possibility that 
the pigs were adapted to the effects of DON after one week of exposure. Another possible pathway for reduced 
effects of supplemented DON in-feed is detoxification of DON, which is possible by bacterial transformation 
from DON to metabolites with reduced toxicity. In pigs only a moderate transformation of DON to de-epoxy-
DON occurs in the hind gut (Dänicke et al., 2003). 
In our study, the pigs were only exposed to one mycotoxin (DON), whereas in the field pigs are likely exposed 
to different mycotoxins simultaneously, which may enhance the toxic effect (D'Mello et al., 1999). In pigs, the 
combination of DON and fusaric acid (Smith et al., 1997) and DON and FB1 (Harvey et al., 1996) resulted in 
synergistic effects. 
In the study in chapter 3.3 the pigs were fed an artificial DON-spiked diet. Before spiking the diet with DON, it 
was tested for the presence for other Fusarium trichotecenes and zearalenone. Feed naturally contaminated with 
Fusarium species, seems to have a more pronounced effect on different parameters, such as feed intake and 
weight gain versus feed artificially contaminated with mycotoxins (Forsyth et al., 1977; Foster et al., 1986; Rotter 
et al., 1994; Trenholm et al., 1994). The reason why this occurs is not known. Some authors hypothesise that 
other unidentified mycotoxins, toxic metabolites or substances, such as bacterial polysaccharide or metabolites 
produced by the plant host, may affect the toxicity of trichothecenes (EFSA, 2007; Foster et al., 1986; Rotter, 
1996; Trenholm et al., 1994). In our study, 3ADON and 15ADON were included in the inoculum to prepare the 
DON-spiked feed. Although Pestka et al. (1987) found that the emetic activity of 15ADON in swine in a dose 
range of 25-200 µg/kg was very similar to that of DON, the toxicological relevance of the acetyl derivatives has 
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been underestimated due to lack of information on toxicity and toxicokinetics (Broekaert et al., 2015). In a 
Dutch field investigation, both ADONs were detected in 21 and 7% of the maize samples, more frequently than 
DON itself (Van Asselt et al., 2012). In a study of Broekaert et al. (2015) it was demonstrated that in pigs the 
absorbed fraction after oral administration was 100% in case of DON, but as well for both ADONs. Broekaert 
et al. (2015) answered the key question regarding the in vivo hydrolysis of 3ADON and 15 ADON to DON in 
pigs: 3ADON and 15ADON were completely hydrolysed presystemically, possibly indicating an underestimation 
of the degree of contamination and the toxicity of DON.  
Masked mycotoxins may be present in naturally contaminated feed. These substances will usually not be 
detected. In plants, glycosylation is an important defence mechanism against xenobiotics, including mycotoxins 
(Michlmayr et al., 2015). Deoxynivalenol can be glycosylated and stored in plant vacuoles. From these masked 
mycotoxins, the precursor mycotoxin, DON, can be reactivated by hydrolysis when digested. Nagl et al. (2014) 
indeed showed that Deoxynivalenol-3-glucoside (D3G) is nearly completely hydrolysed in the intestinal tract of 
the pigs. 
It might be possible that DON under field circumstances has a more pronounced effect in M. hyopneumoniae 
infected pigs compared to our findings described in chapter 3.3. Intake of DON may affect the acquired 
immunity response upon vaccination against M. hyopneumoniae. ØVernes et al. (1997) found a dose dependent 
decrease in secondary antibody response to tetanus toxoid in pigs when pigs were fed a DON-spiked diet. In 
Savard et al. (2015), a reduced efficacy of a modified live vaccine against PRRSv was observed in pigs fed a 
DON-spiked diet. Pigs fed a diet containing DON or Fumonisin B1 (FB1) showed a reduced anti-ovalbumin 
antibody production with a decreased lymphocyte proliferation (Grenier et al., 2011). 
No reports investigating the impact of DON-ingestion in pigs on M. hyponeumoniae vaccine efficacy are available 
yet. However, a decreased specific antibody response after vaccination with formol inactivated Mycoplasma 
agalactiae in pigs was observed after ingestion of low doses of FB1 (Taranu et al., 2005).  
4.3.3. Impact of DON on a Mycoplasma hyopneumoniae infection 
From the results in the study in chapter 3.3, it can be concluded that under the circumstances of this experiment, 
DON did not influence the severity of a M. hyopneumoniae infection. After absorption in the gut, DON reaches 
primarily the most perfused organs, such as the myocardial muscle, kidneys, brain and the lung (Goyarts and 
Dänicke, 2006; Prelusky and Trenholm, 1991). As M. hyopneumoniae does not invade the lung parenchyma and is 
merely attached superficially to the cilia of the upper respiratory tract (Blanchard et al., 1992; Jaques et al., 1992; 
Maes et al., 2017), it is possible that mycotoxin concentrations were too low to affect the M. hyopneumoniae 
infection. Remarkably, in mice, the effects of intranasal exposure of DON compared to oral distribution resulted 
in 1.5-3 times higher concentrations of DON in plasma and tissue. The induction of pro-inflammatory cytokines 
(IL1-β, IL-6 and TNF-α) in several tissues including the lung, was higher after intranasal compared to orally 
application of DON (Amuzie et al., 2008). No such studies are available in pigs. It cannot be ruled out that 
mycotoxins can act as indoor air contaminants. Feed contaminated with DON can generate PM that can be 
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pig under field circumstances, next to oral intake of DON, although it is stated by Jarvis and Miller (2005) that 
this is very unlikely for this mycotoxin. 
4.4. Effect of vaccination with a commercial bacterin on a Mycoplasma 
hyopneumoniae infection 
4.4.1. Characteristics of the commercial bacterin used in chapter 3.4 
The high heterogeneity seen in M. hyopneumoniae strains might be a possible explanation for the variable results 
obtained with commercial vaccines at herd level. Charlebois et al. (2014) indeed demonstrated that almost half of 
the M. hyopneumoniae isolates from slaughter lungs in Canada presented less than 55% genetic homology with a 
selected J-strain based vaccine and other reference strains, among which USA232. On the other hand, Villarreal 
et al. (2012) did not detect significant differences in protective efficacy against an experimental M. hyopneumoniae 
infection when animals were vaccinated with an experimental vaccine containing the challenge strain or a 
commercial bacterin based on the J-strain. The antigen concentration included in the experimental bacterin 
might however have been lower compared to commercial bacterin. The M. hyopneumoniae vaccine strain BA2940-
99, used in chapter 3.4 from this thesis, was isolated in 1999 in the USA from a pig with enzootic pneumonia 
and genetic and proteomic differences between this strain and J-strain were detected. This vaccine was very 
efficacious against a challenge with two M. hyopneumoniae strains, the highly virulent F7.2C and the low virulent 
F1.12A, isolated in Belgium, in 2000 and 1999, respectively. Unfortunately, studies comparing genetic and 
proteomic relatedness between the vaccine strain and our challenge strains are not available. Obviously the 
importance of the M. hyopneumoniae strain included in the vaccine for induction of protection warrants further 
investigation.  
The impact of the adjuvant on the efficacy of a vaccine should as well not be underestimated. Adjuvants are 
added to the vaccine to augment the adaptive immune response, to direct the type of adaptive immune response 
in order to obtain the most effective forms of immunity for the specific pathogen, to generate effective 
immunological memory and may decrease the amount of antigen needed in the vaccine (Coffman et al., 2010; 
McKee et al., 2007; Spickler and Roth, 2003). The vaccine used in chapter 3.4 is a detoxified Escherichia coli 
lipopolysaccharide (LPS) oil-in-water emulsion adjuvanted bacterin, with thiomersal as excipient (Product Leaflet 
Hyogen). Cell wall peptidoglycan or lipopolysaccharide obtained from Gram negative bacteria as (part of the) 
adjuvant, enhance the immune response against less immunogenic co-administrated antigens. This adjuvant 
activity is mediated through activation of Toll-like receptors (TLR-4), stimulating both cellular and humoral 
immune responses (Petrovsky and Aguilar, 2004). Oil-in-water emulsions contain microdroplets of oil in water. 
They release the antigen fairly quickly, but the droplets of oil may be able to carry antigens to the lymph nodes 
and antigen depots may be formed on antigen presenting cells in the lymph nodes rather than at the reaction site 
(Spickler and Roth, 2003). Oil emulsion adjuvants may be more efficacious compared to the aluminium 
hydroxide adjuvanted M. hyopneumoniae vaccines (Spickler and Roth, 2003). The downside is that these oil-based 
adjuvants are known to cause more injection-site reactions. Water-in-oil type emulsions may possibly induce 
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necro-ulcerative lesions at the injection site. Oil-in-water type emulsions on the other hand are generally well-
tolerated (Jansen et al., 2006). In the study performed in chapter 3.4 no macroscopically visible injection-site 
reactions were noticed. 
4.4.2. Efficacy of the commercial bacterin used in chapter 3.4 
To mimic the field situation, it was decided to challenge the pigs with two contemporary genetically different M. 
hyopneumoniae strains. As shown in chapter 3.1 multiple strains are circulating in a herd and pigs can be infected 
with two or even three genetically different M. hyopneumoniae strains. The exact mechanism of multiple strains 
interacting in the pig is not known, a more pronounced inflammatory reaction might be involved causing more 
lung lesions. At the start of this thesis no information was available regarding the effect of vaccination when 
challenging the pigs with two genetically different M. hyopneumoniae strains. Both strains had been characterized at 
genomic and proteomic level (Calus et al., 2007; Stakenborg et al., 2006; Vranckx et al., 2011). Under the 
conditions of an experimental challenge, it might be expected that a higher infection dose than encountered in 
the field is used (Meyns et al., 2004; Villarreal et al., 2009). Even under these challenge conditions, the vaccine 
was very efficacious, as shown by significantly reduced disease signs, lung lesions and M. hyopneumoniae 
multiplication in the lungs of vaccinated pigs, compared to non-vaccinated animals. 
It was described that increased pro-inflammatory cytokines IL-1β and IL-6 levels in BALF of M. hyopneumoniae 
challenged pigs were associated with the development of pneumonia lesions (Ahn et al., 2009; Asai et al., 1994; 
Asai et al., 1993; Thanawongnuwech et al., 2004). In our study, IL-1β and IL-6 antibody levels in BALF were 
indeed significantly lower in the vaccinated challenged pigs compared to the non-vaccinated challenged pigs and 
did not statistically differ from those found in the non-challenged pigs. Although TNF-α levels have also been 
associated with severity of lung lesions, no effect of vaccination on this parameter was detected here. 
Although the vaccine was very efficacious to reduce the severity of lung lesions and clinical signs under these 
experimental conditions, confirmation of our results in field studies is desirable. Under field conditions, other 
respiratory pathogens are circulating, possibly challenging the immune system of the pigs or aggravating lung 
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General conclusions 
From the studies performed in this thesis, it can be concluded that both number of different M. hyopneumoniae 
strains and air quality, more specifically PM10 and NH3, may play a role in the severity or prevalence of the M. 
hyopneumoniae lesions. Deoxynivalenol under the circumstances of an experimental M. hyopneumoniae-infection, 
seemed to play a less significant role and the commercially available M. hyopneumoniae bacterin was able to 
significantly reduce the severity of lung lesions and clinical signs in an experimental M. hyopneumoniae challenge 
infection with two genetically different strains. 
More specifically it can be concluded that: 
 Many different M. hyopneumoniae strains were circulating within and between several slaughter batches 
from closed pig farms in Flanders, practising vaccination against M. hyopneumoniae in their piglets 
 In slaughter batches where more than one M. hyopneumoniae strain was detected, more severe pneumonia 
lesions and a higher prevalence of pneumonia was observed 
 Pigs may be simultaneously infected with two and even three genetically different M. hyopneumoniae 
strains  
 Under the circumstances of this research PM10 and NH3 did not significantly affect production 
parameters mortality and ADG. PM10 and NH3 numerically decreased ADG in the finishing pigs 
(borderline not significant) 
 The respiratory health of finishing pigs was significantly affected by PM10: an increasing PM10 
concentration measured during the entire fattening period resulted in a higher prevalence of pleurisy in 
the pigs 
 The effect of PM10 on prevalence and severity of pneumonia was more pronounced than the effect of 
NH3  
 PM10 tended to be associated with the presence of M. hyopneumoniae as detected by nPCR in nasal swabs 
of the finishing pigs 
 Deoxynivalenol administration in the feed at two times the EU recommended maximum level (1,800 
µg/kg) did not aggravate the severity of an experimental M. hyopneumoniae infection 
 A commercial bacterin based on strain BA2940-99 and adjuvanted with non-toxic Escherichia coli LPS oil-
in –water emulsion was very efficacious in reducing the clinical parameters and pathological parameters 
of an experimental challenge infection with two genetically different M. hyopneumoniae strains on two 
consecutive days 
 The commercial vaccine was able to reduce but not prevent M. hyopneumoniae infection with two 
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Future research 
From the present thesis, some items for future M. hyopneumoniae research may be proposed: 
It is not clear why batches of pigs infected with multiple M. hypopneumoniae strains have more severe lung lesions 
compared to when only a single strain is present. Further elucidating the pathogenesis of M. hyopneumoniae 
infections and identifying possible virulence factors of this bacterium might be helpful to obtain better insights in 
this matter. Furthermore, there is a need to investigate the dynamics and the stability of M. hyopneumoniae strains 
in a herd, the transmission of M. hyopneumoniae strains from sow to piglets and the triggering factors for M. 
hypopneumoniae strain diversity to occur in the herd. The impact of vaccination strategies, other interventions or 
herd practices on M. hyopneumoniae strain diversity are not yet known.  
Further research could elaborate on the impact of PM10, other PM fractions PM2.5 and PM1 and NH3 on M. 
hyopneumoniae infections, e.g. by monitoring different successive batches and/or by euthanizing a representative 
number of pigs throughout the finishing period to observe the impact of aerial pollutants in the first weeks of 
the finishing period. It would be interesting to investigate the impact of aerial pollutants in piglets or nursery pigs 
and the consequences for the production parameters and respiratory health in the finishing period thereafter. 
The impact of maximum measured PM concentrations on respiratory disease (coughing, nPCR positivity for M. 
hyopneumoniae, lung lesions,…) could be determined. Furthermore, the impact of different mitigation strategies on 
the indoor aerial pollutant concentrations inside pig facilities could be investigated more into depth, more 
specifically the impact on (respiratory) health and production in different age categories of pigs.   
Also, further research should be done on the possible effects of DON on pig health in general and a M. 
hyopneumoniae infection more specifically. These factors include: natural vs. artificial contamination, tolerance of 
the pigs, genetic factors, nutritional status, hormonal balance and age of the pigs, as well as multi-mycotoxin 
exposure. More research is also warranted to assess the impact of DON and mycotoxins in general on vaccine 
efficacy in M. hyopneumoniae vaccinated pigs. 
The possible influence of different vaccine strain on protection induced by bacterins against infection with M. 
hyopneumoniae field strains also requires further studies. A deeper investigation regarding protection conferred by 
vaccination with homologous/heterologous strains is necessary. The relative importance of the vaccine strain 
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Mycoplasma hyopneumoniae (M. hyopneumoniae) is the primary agent in enzootic pneumonia and plays a key role in the 
porcine respiratory disease complex. Infections with M. hyopneumoniae occur worldwide and negatively impact 
growth and feed efficiency, increase antimicrobial use, and causes infections with other respiratory agents being 
facilitated. It is known that the outcome of a M. hyopneumoniae infection can be quite variable, ranging from 
subclinical infections to serious clinical cases, causing tremendous losses. Many factors involved in the severity of 
a M. hyopneumoniae infection are known. Such factors are management practices, interactions with other bacterial 
or viral respiratory agents, antimicrobial therapy and vaccination strategies. Other factors such as M. 
hyopneumoniae diversity, concentration of toxic air pollutants in the stable, and mycotoxins in the feed are less well 
studied, and the impact on M. hyopneumoniae infections are less well known. As M. hyopneumoniae is still causing 
economic losses worldwide, research is also aimed at developing new vaccines to control the disease in a better 
way.  
The general aim of this thesis was to investigate factors that influence the occurrence of pneumonia lesions and 
M. hyopneumoniae infections in order to achieve a better control of the disease.  
The specific objectives were: 
1. To determine the diversity of M. hyopneumoniae in Flemish pig farms and to investigate its impact on lung 
lesions at slaughter  
2. To investigate the impact of particulate matter and ammonia levels in the stable on pneumonia and 
pleurisy lesions 
3. To assess the impact of deoxynivalenol and acetyl-derivates in the feed on an experimental M. 
hyponeumoniae infection  
4. To investigate the effect of vaccination with a commercial vaccine on an experimental M. hyopneumoniae 
infection with two genetically different M. hyopneumoniae strains 
First, in the general introduction a summary of the literature is provided starting with describing how the severity 
of M. hyopneumoniae infections can be determined. This can be performed by scoring the pigs in a clinical way 
with a respiratory disease score. Next, the different scoring systems to determine the severity of macroscopical 
and microsocopical M. hyopneumoniae lesions are described. This part is concluded with determining the number 
of M. hyopneumoniae organisms in the respiratory tract. Subsequently all possible factors influencing the severity of 
M. hyopneumoniae infections are summarized.  
In the first study in chapter 3.1 M. hyopneumoniae diversity in three batches of slaughter pigs originating from ten 
closed farms or closed production systems, vaccinating their piglets against M. hyopneumoniae was investigated 
with Multiple Locus Variable Number of Tandem Repeats (MLVA). The impact of the number of strains 
detected in these batches on the prevalence and severity of M. hyopneumoniae lung lesions was determined, taking 
into account several important risk factors at herd level for respiratory disease. A very high M. hyopneumoniae  
genetic diversity was observed in our study. In total, 135 genetically different M. hyopneumoniae strains were 




of different strains per batch was seven with a minimum of one and a maximum of 13 different M. hyopneumoniae 
strains. In 102 lungs, two and in six lungs, three genetically different M. hyopneumoniae strains were detected. In 
batches where more than one different M. hyopneumoniae strain was detected, more severe and a higher prevalence 
of Mycoplasma-like lesisons, and a higher prevalence of fissures was observed. These results imply that MLVA-
testing revealed a high genetic M. hyopneumoniae diversity in batches of Flemish slaughter pigs and that 
Mycoplasma-like lung lesions were more severe and a higher prevalence of pneumonia and fissures was detected 
when a higher M. hyopneumoniae diversity is observerd in a batch of slaughter pigs. 
In chapter 3.2 the simultaneous and long-term impact of PM10 (ranging from 1,707-3,820 µg/m3) and ammonia 
(NH3) (ranging from 17.2-38.2 ppm) on productions parameters (daily weight gain and mortality), respiratory 
health and the presence of M. hyopneumoniae in finishing pigs was investigated. For this study a closed pig herd 
experiencing clinical problems of M. hyopneumoniae was selected.  In total, 1095 finishing pigs were included in the 
study. The PM10 concentrations were measured continuously and the NH3 concentrations semi-continuously 
over the entire finishing period. The PM10 and NH3 concentrations did not seem to affect the performance 
parameters mortality and ADG under these circumstances. Increasing PM10 concentrations influenced the 
prevalence of pleurisy. When PM10 was considered in the univariable models it seemed to influence the 
prevalence of pneumonia and pleurisy more than NH3 in the second half of the finishing period. This was also 
observed for the severity of Mycoplasma-like lesions (entire finishing period and second half of the finishing 
period). In the univariable models PM10 and NH3 seemed to increase the number of M. hyopneumoniae nPCR 
positive pigs, however in the multivariable associations, this effect was reduced to non-significance. These 
findings indicate that respiratory health was influenced by increasing PM10 concentrations. 
In chapter 3.3 the clinical impact of a moderately high deoxynivalenol (DON)-concentration for five weeks 
administered in feed to weaned piglets was determined. The DON-concentration was aimed at two times the 
maximum guidance level for DON in pig feed by the European Commission (1,800 µg/kg). Although the M. 
hyopneumoniae experimental inoculations were successful, no effect of DON-ingestion in the M. hyopneumoniae 
challenged pigs were observed. 
In chapter 3.4, the efficacy of vaccination against experimental infection with two genetically different M. 
hyopneumoniae strains in weaned piglets was determined. A commercial available vaccine was used. This vaccine, is 
a whole cell bacterin, using M. hyopneumoniae strain 2940, isolated in 1999. It is adjuvanted with a detoxified 
Escherichia coli lipopolysaccharide (LPS) oil-in-water emulsion and thiomersal as excipient. The M. hyopneumoniae 
challenge infections were performed with two genetically different M. hyopneumoniae strains as in chapter 3.3. The 
vaccine was very efficacious against the experimental challenge: the vaccinated piglets coughed significantly less, 
significantly less macroscopic lung lesions were detected, a significant lower amount of M. hyopneumoniae-DNA 
and IL-1ß and IL-6 concentrations in the BALF was detected in the non-vaccinated, challenged pigs. 
From the studies performed in this thesis it can be concluded that a very high M. hyopneumoniae diversity is 
present in batches of Flemish slaughter pigs and that a higher prevalence of pneumonia and fissures and more 






hyopneumoniae strain is detected. The respiratory health of the pig was more influenced by PM10 compared to 
NH3. Under the circumstances of an experimental study DON in a concentration of 1,800 µg/kg did not 
influence the severity of an M. hyopneumoniae infection. The tested commercial bacterin was very efficacious 
against an experimental challenge with two contemporary and genetically different M. hyopneumoniae strains. 
Nevertheless, the vaccine was not able to prevent the pigs from being colonized. 
Future research may focus on the triggering factors for M. hyopneumoniae diversity to arise and why PM10 seems to 
influence respiratory health more compared to NH3. Other interesting pathways to investigate further are the 
effects of DON on pig health in general and on M. hyopneumoniae infections under field circumstances, as multi-
pathogen and multi-mycotoxin factors may influence these interactions. New vaccines to provide an even higher 
protection against M. hyopneumoniae may be developed, however, elucidating the pathogenesis of M. hyopneumoniae 





























Mycoplasma hyopneumoniae (M. hyopneumoniae) is het primair agens van enzoötische pneumonie en speelt een 
belangrijke rol in het porcien respiratoir ziekte complex. Infecties met M. hyopneumoniae komen wereldwijd voor 
en hebben een nefaste invloed op de dagelijkse groei en voeder efficiëntie van geïnfecteerde varkens. Deze 
infecties brengen een verhoogd antibiotica gebruik met zich mee en infecties met andere ademhalingspathogenen 
vinden gemakkelijker plaats. Het is reeds lang gekend dat het resultaat van een M. hyopneumoniae-infectie erg 
variabel kan zijn: een spectrum gaande van erg milde subklinische tot zeer ernstige klinische infecties wordt 
aangetroffen. Deze laatste kunnen hoge economische verliezen teweeg brengen. Vele factoren betrokken bij de 
ernst van een M. hyopneumoniae infectie zijn gekend. Deze factoren zijn management, interacties met andere 
bacteriële en virale respiratoire agentia, gebruik van antimicrobiële middelen en het toepassen van vaccinatie. 
Andere factoren zoals M. hyopneumoniae diversiteit, toxische componenten in de stallucht en mycotoxines in het 
voeder werden nog minder goed onderzocht en hun impact op M. hyopneumoniae-infecties is dan ook minder 
gekend. Net omdat M. hyopneumoniae nog steeds veel economische verliezen met zich mee brengt, en dit op 
wereldwijd vlak, wordt er nog veel onderzoek uitgevoerd, gericht op het ontwikkelen van nieuwe vaccins in de 
hoop de ziekte beter onder controle te kunnen houden. 
De algemene doelstelling van deze thesis was onderzoek uitvoeren naar factoren die het voorkomen van 
longletsels kunnen beïnvloeden en factoren die een invloed kunnen uitoefenen op het voorkmen van M. 
hyopneumoniae-infecties om zodoende een betere basis te leggen voor verder onderzoek om de ziekte onder 
controle te krijgen. 
De specifieke doelstellingen waren: 
1. Het nagaan van de M. hyopneumoniae diversiteit in Vlaamse varkensbedrijven en de impact hiervan op 
longletsels gedetecteerd aan de slachtlijn onderzoeken 
2. De invloed van stof en ammoniak concentraties in de stal op pneumonie en pleuritis laesies nagaan 
3. De invloed van deoxynivalenol en acetyl-derivaten hiervan in het voeder op een experimentele M. 
hyopneumoniae-infetie nagaan. 
4. Het effect van vaccinatie met een commercieel vaccin op een experimentele M. hyopneumoniae infectie 
nagaan met twee genetisch verschillende M. hyopneumoniae stammen 
In de algemene inleiding werd er een overzicht gegeven van hoe de ernst van M. hyopneumoniae letsels kan worden 
nagegaan. Dit kan door de dieren klinisch te scoren op de aanwezigheid van hoest. Vervolgens werden de 
verschillende systemen om macroscopische en microscopische longlaesies te wijten aan M. hyopneumoniae te 
scoren beschreven. Dit hoofdstuk werd afgesloten met een beschrijving van hoe het aantal M. hyopneumoniae 
kiemen in het respiratoir stelsel kan bepaald worden. Vervolgens werden alle factoren die potentieel een invloed 
kunnen uitoefenen op de ernst van een M. hyopneumoniae-infectie besproken. 
In de studie in hoofdstuk 3.1 werd de M. hyopneumoniae diversiteit door middel van Multiple Locus Variable 




productiesystemen, waar de biggen gevaccineerd werden tegen M. hyopneumoniae, bepaald. Eveneens werd de 
impact van het aantal stammen op de prevalentie en ernst van de M. hyopneumoniae laesies bepaald, waarbij in de 
associaties rekening werd gehouden met allerlei factoren op bedrijfsniveau die het voorkomen van respiratoire 
aandoeningen kunnen beïnvloeden. Een erg hoge M. hyopneumoniae diversiteit werd gedetecteerd in onze studie. 
In de volledige dataset werden er van 600 longspoelsels, 135 verschillende M. hyopneumoniae stammen 
gedetecteerd. Het gemiddeld aantal verschillende stammen per slachtlot was zeven met een minimum van één en 
een maximum van 13 verschillende M. hyopneumoniae  stammen. In 102 longen werden er twee verschillende M. 
hyopneumoniae stammen aangetroffen en in zes longen drie verschillende M. hyopneumoniae stammen. In loten 
slachtvarkens waar meer dan één verschillende M. hyopneumoniae stam werd aangetroffen was er een hogere 
prevalentie van Mycoplasma laesies. De letsels waren bovendien ernstiger. Eveneens werd er een hogere 
prevalentie van fissuren opgemerkt. Deze resultaten tonen aan dat door middel van MLVA een hoge genetische 
M. hyopneumoniae diversiteit werd aangetroffen in loten slachtvarken afkomstig van Vlaamse bedrijven. Eveneens 
waren de letsels ernstiger en kwamen er meer letsels voor in geval meerdere M. hyopneumoniae stammen werden 
gedetecteerd in een lot slachtvarkens.  
In hoofdstuk 3.2 werd de langdurige en simultane invloed van stof PM10 (variërend van 1,707-3,820 µg/m3)  en 
ammoniak (NH3) (variërend van 17.2-38.2 ppm) nagegaan op productieparameters (dagelijkse groei en sterfte), 
respiratoire gezondheid en aanwezigheid van M. hyopneumoniae bij vleesvarkens. Voor deze studie werd een 
gesloten varkensbedrijf geselecteerd waar er klinische M. hyopneumoniae problemen werden geconstateerd. In 
totaal werden er 1095 varkens opgevolgd. De PM10 en NH3 concentraties werden respectievelijk continu en 
semi-continu opgevolgd gedurende de volledige mestperiode. De PM10 en NH3 concentraties hadden geen 
invloed op sterfte en dagelijkse groei onder de omstandigheden van de studie. Stijgende PM10 concentraties 
bleken de prevalentie aan pleuritis te beïnvloeden. Wanneer enkel naar PM10 werd gekeken in de univariabele 
modellen, bleek deze een grotere invloed uit te oefenen op de pneumonie en pleuritis prevalentie dan NH3 in de 
tweede helft van de mestronde. Dit werd ook vastgesteld voor de ernst van Mycoplasma laesies (volledige en 
tweede helft mestronde). In het univariabele model bleken PM10 en NH3 beiden een invloed uit te oefenen op 
het aantal M. hyopneumoniae kiemen gedetecteerd met nPCR. In de multivariable modellen, werd deze associatie 
herleid tot non-significantie. De bevindingen van deze studie geven aan dat de respiratoire gezondheid beïnvloed 
wordt door stijgende PM10 concentraties. 
In hoofdstuk 3.3 werd de klinische impact van een matig hoge DON-concentratie nagegaan bij toediening aan 
gespeende biggen voor een periode van vijf weken. De concentratie aan DON in het voeder was twee maal de 
aanbevolen maximum grens voor DON in het voeder voor varkens (Europese Commissie). Alhoewel de 
experimentele M. hyopneumoniae-inoculaties successvol waren, werd er geen effect gezien van DON op de ernst 
van de M. hyopneumoniae-infectie.  
In hoofdstuk 3.4 werd de doeltreffendheid van vaccinatie op een experimentele M. hyopneumoniae infectie met 
twee genetisch verschillende M. hyopneumoniae-stammen nagegaan in gespeende biggen. Het vaccin dat werd 






stam 2940, geïsoleerd in het jaar 1999. Als adjuvant bevat het vaccin een niet-toxisch Escherichia coli 
lipopolysaccharide (LPS) olie in water emulsie met thiomersal als hulpstof. De M. hyopneumoniae challenge infectie 
werd met twee genetisch verschillende M. hyoopneumoniae stammen uitgevoerd (dezelfde stammen als in 
hoofdstuk 3.3). Het vaccin bleek zeer goed werkzaam tegen deze challenge: de gevaccineerde dieren hoestten 
significant minder, vertoonden significant minder longlaesies, een lagere hoeveelheid M. hyopneumoniae DNA in 
de longspoelsels werd gedetecteerd en een significant lagere IL-1ß en IL-6 concentratie werd aangetroffen in de 
longspoelsels vergeleken met de niet gevaccineerde geïnfecteerde varkens.  
Na het uitvoeren van deze studies kunnen we besluiten dat er een hoge M. hyopneumoniae diversiteit werd 
aangetroffen in de loten slachtvarkens van Vlaamse varkensbedrijven en dat een hogere pneumonie en fissuren 
prevalentie en ergere Mycoplasma-like longlaesies worden aangetroffen in loten waar er meer dan één stam wordt 
aangetroffen. Het respiratoir systeem kan worden aangetast door PM10 en NH3, alhoewel het effect van PM10 
hier in onze studie belangrijker bleek. Onder de omstandigheden van een experimentele studie oefende DON in 
de concentratie van 1,800 µg/kg geen effect uit op een M. hyopneumoniae-infectie. Het commercieel vaccin dat 
gebruikt werd in het laatste hoofdstuk bleek zeer doeltreffend te zijn tegen een challenge infectie met twee 
genetisch verschillende en recente M. hyopneumoniae isolaten. Niettemin, kon het vaccin niet verhinderen dat het 
ademhalingsstelsel van de geïnfecteerde varkens gekoloniseerd werd. 
Verder onderzoek kan zich richten op factoren die het ontstaan van M. hyopneumoniae diversiteit uitlokken en 
waarom PM10 het respiratoir stelsel van het varken meer blijkt te beïnvloeden vergeleken met NH3. Een ander 
interessant gegeven om verder te onderzoeken is het effect van DON op de gezondheid van het varken en 
specifiek het effect van DON op een M. hyopneumoniae infectie onder veldomstandigheden, aangezien er een 
mogelijkheid bestaat dat een multi-mycotoxine en multi-pathogene problematiek in het veld deze interacties 
kunnen beïnvloeden. Verder onderzoek naar nieuwe vaccins die het varken nog een betere bescherming tegen M. 
hyopneumoniae-infecties kunnen bieden is aangewezen, alhoewel dat het opklaren van de pathogenese van M. 
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Over dit moment heb ik al veel zitten mijmeren…Het moment waarop ik mijn dankwoord kon schrijven, wat 
dan zou betekenen dat het einde nabij is….Helaas heb ik nooit iets neergepend. Wat betekent dat ik nu in mijn 
heheugen (Pj zou al weer gniffelen) moet gaan graven want 6 jaar is een lange tijd…Sommige zaken echter zijn 
niet moeilijke te vergeten.  
Als eerste wil ik graag mijn promotoren bedanken. Dominiek, bedankt om destijds iets in mij te zien. 
Waarschijnlijk een moeilijke beslissing om iemand aan te nemen die bij wijze van spreken enkel wist dat een 
varken een krulstaart heeft (en dàt is zelf niet waar bij de meeste varkens op onze hedendaagse bedrijven 😉). 
Dankzij u heb ik een passie mogen ontdekken. Het was voor mij een waar genoegen om onder uw grote naam in 
het Mycoplasma onderzoek te mogen werken. Dank voor de goede ideeën, suggesties, relativering… Uw 
toewijding in ieder project dat u aangaat, werkt inspirerend! Hoe druk u het ook had, u had ook steeds een 
luisterend oor voor zaken buiten het onderzoek. Ik sta btw nog steeds versteld over hoe u met het verplaatsen 
van enkele woorden in een zin een flauwe tekst kan transformeren in een prachtig gestructureerde discussie! 
Professor Haesebrouck, het was voor mij een hele eer om u als promotor te hebben. Uw reputatie behoeft 
weinig woorden. Dank om bij het opstellen van studies en het nalezen van papers kritische opmerkingen te 
maken, over zaken die niemand anders had gezien. U zal wellicht vaak gedacht hebben tijdens uw laboronde ’s 
avonds, ja ze zitten er weer die van Mhyo…Maar ik apprecieerde het heel erg dat u altijd begaan was met ons als 
we laat avond werk moesten verrichten (omdat die Mhyo’s weer eens besloten hadden dat ’s avonds laat de beste 
tijd was om op de piek van de groei te zitten). Bedankt! Filip…Hoeveel keer je me al niet gekalmeerd 
hebt…(bijvoorbeeld wanneer de Mhyo’s weer niet deden wat van hen werd verwacht). Ik heb in al die jaren jouw 
inzet voor mij en het Mhyo-team enorm gewaardeerd. Je had altijd uitstekende suggesties i.v.m. papers en 
studieopzetten, maar ik kon ook gewoon voelen dat je inzit met de mens achter de onderzoeker! Dus bedankt!  
Bedankt aan de leden van het guidance comité Prof. Deprez en Dr. Vranckx voor jullie input in de thesis en jullie 
goede ideeën en suggesties. Dear members of exam comité Dr. Del Pozo Sacristán, Dr. Antonissen,  Dr.  Sibila, 
Dr. Devriendt and Dr. Demeyer. I am gratefull to have such a nice and broad scientific pannel for the evaluation 
of the thesis. I am 100% sure and confident that your remarks (though they were plenty and not always easy 😉) 
lifted the manuscript to a higher level. Thank you! 
Ik wil graag de sponsors bedanken, Zoetis and Ceva. Zonder hen zou deze thesis maar uit één paper bestaan 😉. 
Bedankt aan alle varkenshouders en de mensen van het slachthuis in Covameat en Torhout, in het bijzonder 
Tine, Patrick en Benny. Zonder jullie zou de opvolging van de varkens in het slachthuis van de eerste en tweede 
studie nooit geluk zijn. Ook bedankt aan de mensen van RA-SE: Geert en Bart, bedankt voor de flexibiliteit en 
het meedenken in de zoektocht naar Mhyo-vrije biggen. Leievoeders en in het bijzonder Norbert (wellicht 
momenteel in pensioen? Geniet ervan!), bedankt i.v.m. de flexibiliteit voor het leveren van het DON-vrije 
voeder! 
Sofie Piepers…Zonder jou zou deze thesis er niet geweest zijn. Je begeleiding bij de PIGDUST paper zorgde 
ervoor dat die eerste paper er kwam, en ik denk als jij er niet was geweest, dit niet zou gebeurd zijn en de rest van 
de papers ook niet zouden gevolgd hebben. Alhoewel je niets met varkens te zien had en je enorm veel werk had, 
heb je me toch geholpen, ook met de tweede paper. 
Rubén…Where do I start (sorry for the English, I guess it is a habit talking to you in English). I guess without 
you, no PhD would have been written and no studies would have been carried out successfully. You teached me 
everything I needed to know in pig medicine, the Mhyo-research and conducting field and experimental studies 
from scratch. Your patience, devotion and passion for pigs was inspiring! Thank you for guiding me, the talks on 




teaching me everything I needed to know regarding lab work for Mhyo! I hope we can meet again in the next 
years! Katleen, bedankt dat ik altijd bij jou terecht kon om zaken over het opgroeien van Mhyo’s te bespreken. 
Bedankt voor alle uitleg i.v.m. de interpretaties van de electropherogrammen, de MLVA, de nodige primers, 
alles...Hanne, alhoewel we nooit hebben samen gewerkt, kon ik toch altijd bij jou terecht i.v.m. onzekerheden 
over het opgroeien! Sorry voor de vele stalk-mails, maar het heeft toch zijn vruchten afgeworpen ! John, thank 
you for the discussions on Mhyo and other pig related issues, the critical review of the protocols and the papers. 
I hope I can attend your defence soon!! Anneleen…Haha, ik zal nooit die nacht vergeten van het telefoontje 
i.v.m. de ultracentrifuge :’)!! Ik ben wel een beetje trots dat ik jou toch een paar dingen in verband met het Mhyo 
onderzoek heb kunnen leren, maar dat je nu een ‘beter labomensje’ bent geworden dan ik bijvoorbeeld i.v.m. het 
opgroeien van de Mhyo-babies . Nu ik weg ben, gaan ze ons (hoop ik) niet meer dooreen wisselen, zowel in 
het labo, in de stallen als bij ons op de vakgroep . De manier waarop jij je ergens kan in vastbijten, dat kan ik 
enkel maar benijden! Ik hoop dat de laatste proef voor jou de laatste experimentele was (of anders zou ik toch 
lobbyen voor een stalmannetje)! Danku voor de vele leuke bureau-momenten, en nu we geslaagd zijn voor de 
vakdierenarts gaan we er mee door en zien we elkaar daar nog veel!! (en hopelijk erbuiten ook nog). 
Alfonso, I enjoyed your company at the office. I don’t know… You were the type of person that was always 
calm in any circumstance. You showed me that I did not need to stress about everything . Though our period 
together was short, I will never forget this. Ilse, ik zal nooit de momenten vergeten dat we voor jou of mijn proef 
(of de proef van Rubén, Ruben, Lotte…) de baan op moesten. En al was het soms lastig (lees 500 vleesvarkens 
wegen), het was toch altijd gezellig. Ik heb zelf een klein beetje heimwee naar de pauzes tussen het wegen door 
dat we van die lekkere koeken konden eten die jij altijd mee bracht in de schaduw van de autokoffer! Danku voor 
alles! Je hebt me super veel geleerd! Danku om mij op sleeptouw te nemen op de bedrijfsbegeleiding zodat ik zelf 
‘mijn plan’ kon trekken . Hoe jij alles wist/weet te combineren, ’t is mij een raadsel! Veel succes nog met het 
werk, de kippen en de koeien en geniet van je gezinnetje. Wat dat laatste betreft, je weet denk ik wel dat je ik je 
eeuwig dankbaar ben dat je mijn twijfels had weggenomen om ook de stap te zetten!!! Ik hoop dat we elkaar nog 
veel zien, en sowieso zeker via whatsapp spreken 😉 😉 😉! Ruben, jij hebt mij geleerd om niet altijd alles perfect 
te willen doen! Soms is 95 percent goed ook genoeg!! Danku voor de wijze raad en voor de fijne tijd. Geniet van 
je gezin!! Lotte, ik zal nooit die dag vergeten dat we met de twee auto’s, de ene van de buitenpraktijk en jouw 
polo vol zakken ingewanden richting faculteit zoefden…Achteraf gezien toch lachen (op ’t moment zelf wat 
minder). Ik zal nooit jouw moto vergeten, aan alles komt een eind, behalve aan een worstje, dat heeft er twee  
(en gelijk heb je, dit schrijfsel is het bewijs!!!)! Dankuwel voor de fijne momenten! Ellen, je verliet de faculteit net 
voor mijn komst denk ik, maar ik herinner me jou als ‘die lieve van varken’ (ik verval in herhaling, ik denk dat er 
nog mensen dit hebben geschreven , maar het is waar)! Bedankt voor de fijne samenwerking hierna. Janne, ik 
vond het fijn om jou als collega te hebben, ik ben oprecht blij dat je jouw weg hebt gevonden! Veel succes nog 
met de kleine Remi (wat een mooie naam trouwens!). Marlijn, soms was jouw directe manier van communiceren 
echt een verademing! Soms heeft een groep meer ‘Marlijns nodig, zodat er niet altijd rond de pot wordt gedraaid! 
Ik zal nooit jouw gekke fratsen vergeten, hihi. Je bent een meester in fotoshop ;)! Ik hoop dat jij nu je weg hebt 
gevonden. Tommy, bedankt voor de fijne discussies, de bedrijfsbezoeken,…alles! Veel succes met je nieuwe 
bedrijf en geniet van je gezinnetje! Linda…(de atypische hollander 😉 ). Ik heb nog nooit iemand als jij ontmoet 
die onder de meest uiteenlopende situaties kalm blijft. Ik heb je denk ik in al die tijd nog maar één keer 
gestressed gezien (en dat wil wat zeggen met die vele slachthuisbezoeken ). Bedankt voor de bufferende functie 
in het begin 😉! Jij bent gewoon een fijne persoon in de omgang zowel tijdens het werk en ernaast! Hopelijk 
kunnen we hierna nog vele keertjes iets gaan drinken of zo, ik hoop echt dat we contact houden (maar dat moet 
lukken met de messenger groep samen met Marlijn en Anneleen ). Lexi, wauw, the way you tackle things… 
With you a came a long very well from the beginning! I hope we’ll see each other still in the future! I’m sad that 
we could not have spent more time together! Willem, sterkte daar met al die vrouwen op de bureau!! Het was fijn 
om met je samen te werken. Emily, Ruth, Liesbet, An, Josine, Loes, Emilie-Julie, Elena, Merel, Béné, Ilias, 






Marjolein…Jullie waren (zijn) stuk voor stuk heel fijne collega’s om mee samen te werken! Ik hoop dat ik 
niemand ben vergeten!! 
Dan mogen we het ondersteunend personeel niet vergeten…Sandra en Leila, wanneer ik zeg ondersteunend, is 
dat ook letterlijk te nemen, zonder jullie zou de boel in elkaar stuiken!! Danku voor alles!! Jullie doen zoveel en 
niet iedereen laat het blijken maar jullie werk wordt enorm geapprecieerd! Ria, zonder jouw zou de buitenpraktijk 
niet draaien!! Danku om zonder afschrikken mijn vuile stinkoverals te wassen (je weet wel die keer van mijn 
proef dat ze aan het gisten waren in de zak )! Danku voor de fijne babbels, danku dat iedereen altijd zijn 
materiaal heeft! Danku voor alles. Elske, je bent een topper!! We gaan snel nog eens een eurotuintje doen of een 
picknick in het bos! Ik vond het altijd heel plezant om te praten met jou en je stond altijd klaar voor andere 
mensen hun problemen (inclusief de mijne). Steven B. Haha, je stond altijd klaar voor een grap of een frats…We 
hebben nogal wat afgelachen! Danku voor de ontspannende volleybal momenten overheen de bananenplant. Ik 
mis de cartoons op de deur. Kenny, ’ t is heel raar, maar ik kon het meteen goed vinden met jou! Je hebt denk ik 
dezelfde humor. Danku om de ICT draaiende te houden (sorry voor de verkeerde/vergeten reservaties ;)). Véro, 
Marnik, Willy (bedankt om de gele bakken altijd klaar te zetten!), Dirk, bedankt voor alles. Aan alle andere andere 
collega’s van de ROHH, het was fijn om in zo’n leuke groep te kunnen werken! Bedankt aan de kuisvrouwen –en 
mannen om het boeltje op orde te houden in onze bureau’s!! Aan de mensen van de DI05, bedankt voor de 
vriendschap en leuke babbels in het labo! Marleen, amai, de manier waarop jij aan de slag ging met het opgroeien 
van de Mhyo’s???!!!! Respect!!! Ook enorm bedankt voor alle hulp met de ELISA’s. Jou tips en tricks zijn goud 
waard! Ook bedankt voor de leuke babbels en interesse die je altijd toonde in alles, zowel het onderzoek als het 
gezin! Aan alle andere laboranten van de DI05, het was fijn om met jullie te kunnen babbelen, samen te 
werken,…Zonder jullie zouden de doctoraatsstudenten nogal afzien!!! 
Aan alle andere mensen waarmee ik heb samengewerkt (en wellicht nog zal samnwerken): Joris, Paul, Stephanie, 
Tamara, Caroline, Charlotte, Mia, Emily, Trees,...alle varkensdierenartsen,…Bedankt! Joris, bedankt dat ik af en 
toe eens mee mocht de baan op! Momenten om niet te vergeten! 
Christiaan & Isabelle, Patrick & Carine, ik ben heel graag bij jullie komen zeugen scannen! Bedankt voor de toffe 
babbels! 
To the people from ECO AH, Mark, Marcon Jordi,…It was a pleasure to cooperate and to attend your 
meetings! Thank you for these opportunities! 
Aan mijn vroegere collega’s van het CODA Pierre, Françoise, Isabelle, Els, Sarah,…Jullie bezorgden mij een hele 
fijne eerste werkervaring!! Els, ik vond het heel leuk om jou als baas te hebben, en vond het leuk om je nadien 
nog te zien en ook te merken dat je toch ook een beetje trots was! 
Aan mijn nieuwe collega’s bij Hipra: Sjouke, Vincent, Stan, Saskia, Christine en Nele, ik voelde mij meteen al 
goed in jullie gezelschap! Op naar (meer) nieuwe avonturen! Sjouke, danku voor al de kennis die je mij 
overdraagt, en ook bedankt voor de tijd die je me gunt gezien de omstandigheden van de laatste maand! Vincent, 
bedankt voor de kalmerende GIF’s 😉. Stan, danku om mij aan te nemen. Dit was de boost die ik nodig had om 
‘het’ eindelijk af te werken 😉! Herman, Leonard, Stefan, Annemarie, Pauline, Dominique, Gert, Herman, Jamie, 
Stefanie, Denise, Jessica, Petra, and the collegues at HQ, ik kijk uit naar onze samenwerking! 
Aan de collega’s van de vakdierenarts, ik kijk uit naar het tweede jaar en samen slaan we ons wel door het 
examen, de thesis en de casevoorstelling! De siglec kent voor ons geen geheimen meer ! Hopelijk kunnen we 
snel nog eens een uitje doen!! 
Lien en Candida, hopelijk kunnen we binnenkort eens afspreken (bij ons thuis, dat jullie nu eindelijk eens ons 
huis kunnen zien)! Julie, Mieke, Laura en Annelies Di., hopelijk kunnen we binnenkort nog eens samen een 
uitstapje doen! Mieke, toch wel fijn om altijd een klankbord te hebben op de vakgroep, iemand die mij door en 
door kent! Ik ga ons uitstapje bij Bert om de koeien te meten met onze vriend Mostofa en de jenever nooit 
vergeten :’)! Ik ga onze gesprekjes missen! Veel succes nog op de ROHH en hopelijk is het binnenkort ook aan 
jouw toer! Annelies De. en Valérie, jullie zijn toch wel diegenen die mij doen inzien dat alles relatief is! Ik vind 
onze uitstapjes zalig, met jullie nuchtere kijk op de zaak (alle zaken ), bij een aperitiefje alle dagelijkse 




Nemo, mijn trouwe VW golf 4 (bijna 500 000 km ). Dank voor de trouwe dienst die je hebt geleverd tijdens 
mijn doctoraat. Ik zal nooit de momenten vergeten die we samen beleefden op weg om de respiratoire enquêtes 
af te nemen doorheen de West-vlaanders (voornamelijk). Alle zooi voor de experimentele proeven die ik jou heb 
doen vervoeren, en mijn slaapplaats als ze weer eens hadden vergeten bellen dat de varkens niet om 5u30 maar 
om 10 u gingen geslacht worden…Nu kan je van je pensioen genieten! 
 
Mama en Papa, ik denk niet dat er woorden genoeg zijn om te beschrijven hoe graag ik jullie zie! Bedankt voor 
alle steun doorheen de jaren en bedankt om in mij te blijven geloven! Als ik klein was zei ik het al ‘Dierenarts net 
zoals mama is voor de meisjes, dokter net zoals papa is voor de jongens’ en zo geschiedde het (met soms een 
beetje vallen, maar vooral opstaan waarbij jullie mij in zijn blijven steunen). Papa, ’t is geen dokter geworden 
zoals je voor ogen had, maar ik hoop en denk dat je toch ook wel trots bent !  Danku voor de hulp met de 
varkens op nieuwjaar! Jij injecteren (zo weinig zullen ze er nog nooit van gevoeld hebben) en ik ze vangen, wat 
een team ! ‘t Was lastig, maar we zijn er geraakt! Hopelijk kan het leven weer z’n gewone gangetje gaan (lees 
gaan shoppen met de mama en op bezoek met Juletje en een BBQ’tje op zondag). Danku dat jullie Juletje 
konden opvangen in het weekend zodat ik kon schrijven/studeren. Wouter en Jeroen, danku voor de morele 
steun en de grappige berichtjes en filmpjes via de whatsapp! Moest ons moeder weten hoe onze groep heet, ze 
zou achter ons aan zitten! Binnenkort zien jullie mij weer meer (haha, tot spijt van wie het benijdt)! Aan mijn 
schoonouders, danku om mij te aanvaarden binnen het gezin (niet makkelijk als jullie iemand niet kunnen 
verstaan, nee grapje  😉 ). Sorry voor mijn afwezigheid het laatste halfjaar, tijdens de feestjes en zondagse 
bezoekjes, het zal binnenkort weer beter worden! Ook danku om Jules (en PJ 😉) af en toe op te vangen de 
zondag als ik aan het stressen was achter mijn bureau! 
 
Pj je bent mijn maatje, mijn soulmate,... Ik heb nog nooit iemand ontmoet waarmee ik zo compatibel ben! Pj als 
ik jou niet had ontmoet was dit doctoraat er zeker niet geweest. Ten eerste al omdat de vacature al over datum 
was en je zei: ‘zou je toch niet eens contact opnemen, het staat er nog op’ en ‘die varkens, da gade gij wel 
kunnen’! Ten tweede omdat ik zonder jouw hulp de afgelopen jaren en zeker het laatste halfjaar het niet zou 
gehaald hebben. Voor mij heb je je angst voor dieren opzij gezet. Ondertussen is Schnitzeltje jouw keppe en heb 
je me zelf geholpen met de varkens en in het slachthuis. Binnenkort kennen we als gezin weer wat rust, en 
kunnen we leuke dingen doen!! Eens naar de zee misschien of d’Ardennen😉! Ondertussen zijn we al dik een 
jaar en een half mama en papa van Juletje, en ik vind dat we a pretty damn job doen! Zeker gezien de 
omstandigheden het laatste half jaar (en af en toe met wat hulp van de ouders van beide kanten 😉). 
Juletje…Jij bent mijn alles. Het moment dat ik mama werd van jou, stond de wereld stil en veranderde 
alles…Onbeschrijflijk dat gevoel! Waarschijnlijk deed het vooral mama pijn, maar sorry dat ik de laatste tijd zo 
weinig aandacht kon hebben voor jou. Straks heeft mama veel meer tijd en gaan we samen heel veel naar de 
varkentjes, de geitjes, de cavia’s en de kipjes kijken, de poes aaien, buiten en in het water spelen, nic nacjes eten 
en de plantjes water geven! Hopelijk zal je dit ooit eens lezen en zeggen ‘tiens ik heb er niets van gemerkt’ !  
 
 
 
